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Abstract 
Abstract 
The presence of organic salts as drug counter-ions and buffers in 
hydroxypropylmethylcellulose (HPMC) matrices is often overlooked. This study 
investigates their potential to influence polymer solution properties and matrix drug 
release kinetics. 
A homologous series of aliphatic organic salts influenced solution and matrix 
properties in rank order of hydrocarbon chain length. Monovalent salts containing 
1 t04 C-atoms had little effect on polymer surface activity, but lowered sol:gel 
transition temperatures (SGTT), and accelerated matrix drug release in comparison 
with a dextrose control. Divalent salts were more potent. These observations are 
consistent with Hofmeister effects in which anions restructure water in the polymer 
hydration sheath, induce 'salting-out' and suppressing particle swelling and matrix gel 
layer formation. Organic salts with StoB C-atoms increasingly influenced polymer 
surface activity, elevated SGTT, and retarded matrix drug release. This suggests these 
salts enhance HPMC hydration, possibly through interaction with hydrophobic 
regions. The effects of these salts on matrix drug release show that these ions impact 
on water:polymer interactions important to gel layer formation and diffusion barrier 
properties. HPMC matrices containing SOS and its homologues were also 
investigated. Turbidimetric, tensiometric and rheological studies supported a 
mechanism in which these surfactants solubilise HPMC at post-micellar 
concentrations. Incorporating 10% SOS into HPMC matrices was shown to increase 
the resistance of HPMC matrices to sucrose medium up to 2.0M, suggesting a role for 
surfactants in avoiding food solute effects 
This study shows that organic salts incorporated in HPMC matrices have the potential 
to influence drug release in a rank order that reflects their modulation of the HPMC 
polymer hydration sheath in solution. SOS and its homologous series could retard 
drug release from HPMC matrices only when their critical aggregation concentration 
(CAC) was reached. However, it suggests this excipient may have uses as an excipient 
for improving HPMC matrix release performance. 
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Chapter 1 
Introduction 
At the present time, modified (controlled) release drug delivery systems are 
increasingly being developed and applied. The advantages of these products 
include their potential to optimise drug release rates to maintain blood drug levels 
and prolong therapeutic effects, to minimise side effects, decrease the number of 
daily administrations and improve patient compliance (Alderman 1984; Long & 
Chen 2009; Maderuelo et al 2011). Whilst the development of novel delivery 
systems and novel extended release materials are of increasing interest, 
commercial products often rely on established extended release technologies, such 
as pellets, osmotic pumps or hydrophilic matrices. Hydrophilic matrices are 
compressed mixtures of one or more water-swellable hydrophilic polymers with a 
drug and other tablet excipients (Alderman 1984; Melia 1991; Li et al 2005). 
These dosage forms are popular because of their simple formulation, inexpensive 
cost, conventional production, ability to load high level drugs and good in vitro-in 
vivo correlations (Li et al 2005; Maderuelo et al 2011). Many natural, semi-
synthetic and synthetic types of water-swellable polymer have been used in 
hydrophilic matrices. Common examples include cellulose derivatives, sodium 
alginate, xanthan gum, polyethylene oxide, and carbopol. However, the most 
widely used are cellulose ethers (Melia 1991; Maderuelo et a12011) and the many 
cellulose ether derivatives available, hydroxypropylmethylcellulose (HPMC) has 
perhaps become the most widely employed in hydrophilic matrix formulations 
(Siepmann & Peppas 2001; Li et al 2005; Maderuelo et al 2011). Studies of the 
effect of polymer grade and excipients are widespread, but this study will focus on 
the effect of organic anions used as drug counter ions, and some related short-
chain surfactants, on certain HPMC solution and matrix release properties. 
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1.1. Cellulose ethers and derivatives 
Cellulose is a linear polysaccharide in which P-O-glucose units are linked by P 1-+4 
glycosidic bonds. Native cellulose has a highly crystalline structure arising from an 
extensive intramolecular and intermolecular hydrogen bonding network between 
linear polymer chains, and it therefore exhibits poor aqueous solubility. Ethers of 
cellulose are alkyl modifications of cellulose in which the hydrogen atoms of 
hydroxyl groups on the anhydroglucose unit are substituted by methyl, 
hydroxyethyl, hydroxypropyl, carboxymethyl or mixed ether groups. This 
chemical substitution disrupts the regular H-bonding arrangement and therefore 
destroys the crystalline properties of cellulose, resulting in an increased aqueous 
solubility as more side groups available for H-bond with water (Ott 1943; Oonges 
1990). Common cellulose ethers include methylcellulose (MC), 
hydroxyethylmethylcellulose (HEMC), hydroxypropylmethylcellulose (HPMC), 
ethylhydroxyethylcellulose (EHEC), hydroxyethylcellulose (HEC), 
hydroxypropy1cellulose (HPC), and sodium carboxymethylcellulose (NaCMC). 
Each derivative can be characterised by its degree of substitution (the average 
number of sites reacted per ring, OS) and molar substitution (the average number 
of alkylene oxide molecules reacted with each anhydroglucose unit, MS). The 
physical properties of these polymers are governed by the type and amounts of the 
substituent groups, for examples, their solubility depends on their OS and/or MS, 
with polar substituents strongly increasing hydrophilicity (Ooelker 1987; Ooelker 
1993). Cellulose ethers have been known for their ability to sustain drug release 
since the earliest patent in 1962 (Christenson & Dale 1962) and they provide (i) a 
high ability to adopt desired drug release profiles (ii) a pH-independent matrix 
component (iii) a compatibility with conventional production techniques (iv) a 
broad FDA acceptance (or GRAS status) (Alderman 1984). 
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1.2. Hydroxypropylmetbylcellulose (HPMC) 
Hydroxypropylmethylcellulose (HPMC, hypromellose or Methocelno) is the water 
soluble, nonionic cellulose ether with hydroxypropyl and methyl substituent 
groups. The structure is shown in Figure 1.1. HPMC swells when hydrated, 
forming a gel which is stable over the range pH 3.0-11.0 (Doelker 1987; Doelker 
1993; Li et al 2005). HPMC is perhaps the most commonly-employed cellulose 
ethers in hydrophilic matrices, as a gel-forming polymer which rapidly provides a 
surface hydrated polymer layer increasing the duration of drug release. 
Hydroxypropyl methyl cellulose (HPMC) 
OR 
o 
OR 
n 
1 ,4 j3 glucosidic linkage 
Where R is H, CH3, or [CH3CH(OH)CH2] 
Figure 1.1 HPMC structure (after Wade 2000) 
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1.2.1. HPMC Types and applications 
HPMC types are classified in the United States Pharmacopeia (USP) on the basis of 
their % methoxyl and % hydroxypropyl substitution. Methyl substitution is also 
characterized by degree of substitution (OS), which indicates the average number 
of methoxyl substitutions on a single glucose unit. As there are three available 
hydroxyl groups for substitution, then DS=O for native cellulose and DS=3 for a 
completely substituted polymer. However, the number of hydroxypropyl 
substitutions on the anhydroglucose units is defined in terms of molar substitution 
(MS) because additional hydroxyproxyl substitutions can occur on backbone-
substituted hydroxypropyl groups. The distribution of the substituent groups 
along the cellulose chain can also influence the physiochemical properties of the 
HPMC (Viriden et al 2009a). As a result, each HPMC type exhibits different 
characteristics with respect to polymer properties that depend on substitution, for 
example, the sol:gel transition temperature (SGTT) or 'thermal gelation 
temperature' (Doelker 1987; Doelker 1993; Li et al 2005). The USP types of HPMC 
and their characteristics are listed in Table 1.1. The rank order of hydration rate 
has been indicated by Doelker (Doelker 1987) to be: 
HPMC 2208 > HPMC 2910 > HPMC 2906 > MC 
Companies worldwide manufacture pharmaceutical grade HPMCs. The HPMCs 
used in this thesis were manufactured by The Dow Chemical Company under the 
brand name Methocel"'. This is probably the most widely used range in hydrophilic 
matrices. Methocel'" A is methylcellulose, while E, F, and K are HPMCs with 
different substitution levels that comply with USP specifications (Figure 1.2). The 
current study used HPMC E4M CR and HPMC K4M CR where liE" and "K" identify 
the substitution, "4" identifies the viscosity of 2% w/w solution at 20°C in 
millipascal-seconds (mPa.s), "M" designates the viscosity factor of 1,000x, and 
"CR" identifies controlled release (Dow Chemical Company 2002a). Controlled-
release dosage forms mainly use HPMC K and E grade (Li et al 2005). 
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USP polymer type MC HPMC 2910 HPMC2906 HPMC2208 
Dow Chemical type MethocelA Methocel E Methocel F Methocel K 
Methoxyl content (%) 27.5 - 31.5 28.0 - 30.0 27.0 - 30.0 19.0 - 24.0 
Hydroxypropyl 7.0 -12.0 4.0 -7.5 4.0 -12.0 
content (%) 
DS methoxyl 1.8 1.9 1.8 1.4 
MS hydroxypropyl 0 0.23 0.13 0.21 
Viscosity range of 
2% solution (mPa.sec) 15 - 4000 5 - 4000 SO - 4000 100 -100000 
SGTT of 2% solution SO - 55 58 - 64 62 - 68 70 - 90 
(Oe) 
Surface tension 47-53 44 - SO 44- 50 50- 56 (mN/m)b 
Interfacial tension 
19 - 23 18 - 19 19 - 23 26-28 
(mineral oil) (mN/m)b 
Table 1.1 Substitution levels and important physical properties of different HPMC 
types (Doelker 1987; Doelker 1993; Li et al 2005; Dow Chemical Company 2002a). 
MC = Methyl cellulose 
HPMC = Hydroxypropylmethylcellulose 
OS = Degree of substitution 
SGTT = Sol :gel transition temperature 
a Tested with diluted solutions at 25°C, for Methocel with viscosity grades below SOOmPa.s 
1 6 r - - - - r - - - - . - - - - . - - - , - - - - ~ - - ~ - - - - ~ - - ~ ~
~ ~o 
........ 
14 
C 12 
Q) 
C 1 1 + + - - - - - - - - r - - - - r - - - - - - - - ~ - - ~ - - - - ~ - - ~ ~o 
u 
~ ~ 8 +----+--+--I-----I----r---ir ::J:==t--i 
e 
~ ~ 6 + - - - - + - - - - r - - - ~ - - ~ - - - - 4 4 ~ - + - - - - ~ - - ~ ~
~ ~
e 4 
"0 
>-
I 2 
o + - - - ~ - - ~ - - - - + - - - ~ - - ~ - - - - + - - - ~ - - ~ ~
16 18 20 22 24 26 28 30 32 
Methoxyl content (%) 
A 
E 
F 
-K 
Figure 1.2 The substitution ranges of commercial Methocel™ HPMC grades. 
A=methylcellulose, E=HPMC (USP 2910). F=HPMC (USP2906) and K=HPMC (USP 2208). (Taken 
from Dow Chemical Company 2002a). 
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1.3. The properties of HPMC solutions 
1.3.1. Thermal gelation 
Most cellulose ethers solutions show a specific property called 'thermal gelation' 
or 'thermogelation'. This property is a reversible sol:gel transition in which a 
structured gel is formed when the temperature is elevated, which reverts to 
solution when cooled (Sarkar 1979; Doelker 1987). Repeating the heating and 
cooling cycle has no significant effect on gel or solution properties (Haque & 
Morris 1993) and the sol:gel transition temperature (SGTT) can be detected by 
changes in solution viscosity and solution turbidity. Sarkar (1979) has defined 
three different temperatures that can be used to measure this event: (i) the 
incipient gelation temperature (IGT) which is the temperature at which the 
viscosity reaches a minimum (ii) the incipient precipitation temperature (IPT), the 
temperature at which light transmission reduces to 97.5% and (iii) the cloud point 
(CPT) the temperature at which light transmission reduces to 50%. The 
rheological and turbidimetric end-points are not always coincident. At high 
concentrations, a gel often forms before turbidity occurs, whilst at low 
concentration a turbid solution can be observed before gelation (Sarkar 1979; 
Mitchell et al 1990). The SGTT, however, provides a sensitive measure of the 
relative hydrophilicity of cellulose ethers, because of the mechanism of gelation 
described below. 
1.3.1.1 Mechanism of thermal gelation 
Thermal gelation is believed to be caused by hydrophobic interactions between 
methoxyl groups. In solutions at ambient temperatures, highly ordered water 
molecules are adsorbed on the polymers, to form a layer loosely called the 
'hydration sheath'. Around the hydrophobic methoxyl-rich regions, water 
molecules form molecular 'cages' which inhibit hydrophobic polymer-polymer 
associations (Haque & Morris 1993). At low temperature, the polymers are 
hydrated and there is little polymer-to-polymer interaction other than simple 
entanglement. As the temperature is raised, polymer molecules lose water of 
hydration, when the sol:gel transition temperature (SGTT) has been reached. 
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Dehydration of the polymer is sufficient to allow association of hydrophobic 
domains (methoxyl-rich regions). These areas form 'junction zones' and their 
hydrophobicity causes the exclusion of local water, resulting in a progressive 
decrease in polymer solubility. This leads to the formation of a 3-dimensional gel 
network stabilised by intra- and inter-polymer hydrophobic interactions and the 
solution forms a gel which often phase separates (Sarkar 1979; Doelker 1993; 
Haque & Morris 1993; Sarkar 1995; Hirrien et al 1998; Silva et al 2008). Both 
single chains and large aggregates are found in polymer solutions at low 
temperature whereas only large aggregates appear in solutions above the SGTT 
(Zhou et al 2008). 
Figure 1.3 shows a schematic illustration of the proposed mechanism according to 
Haque et al (1993), who investigated the gelation of MC and HPMC using 
oscillatory rheology, differential scanning calorimetry, lH-NMR and light 
scattering, and were the first to propose a two-stage gelation process. The first 
stage was attributed to the unfolding of cellulose bundles on the terminal ends of 
polymer chains, whilst the second stage was attributed to the disruption of 
polymer hydration sheaths and the formation of a 3-dimensional gel network 
(Haque & Morris 1993; Haque et aI1993). This proposal is supported by the work 
of Bajwa et al (2009) using ATR-FTIR to monitor changes in the vibration of 
chemical bonds in HPMC solutions during the sol-gel transition. 
A different postulate has been suggested by Kobayashi et al (1999) who 
investigated the gelation of MC using light scattering, oscillatory rheology and 
small-angle neutron scattering. They claimed that the first stage of gelation can be 
attributed to the dehydration of the hydration sheaths by heating and the 
formation of hydrophobic associations, whereas the second stage can be attributed 
to the phase separation of these hydrophobic regions from solution, leading to the 
formation of the 3-dimensional gel. Buslov et al (2008) also studied thermal 
gelation of MC using FTIR-ATR and found that the formation of a 3-dimensional gel 
network not only resulted from hydrophobic association of methoxyl substituents 
but also from inter-chain H-bonds involving unsubstituted primary hydroxyl 
groups accompanied by a conformational change of the polymer backbone. 
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Figure 1.3 Schematic illustration of the postulated structures and processes 
Involved in the thermal gelation of MC (HPMC A4M) (from Haque & Morris 1993). 
Faint lines denote unsubstituted or sparingly-substituted chain segments; bold lines 
denote regions of dense substitution. 
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1.3.1.2 Factors affecting the sol:gel transition of cellulose ethers 
(a) Type, degree and uniformity of substitution 
The type, degree and uniformity of substitution are important factors in the 
behaviour of cellulose ether derivatives. Increasing the degree of methoxyl 
substitution usually results in a decrease in SGTT because hydrophobic 
interactions can increase (Sarkar 1979; Sarkar 1995). On the other hand, 
increasing the hydroxyaikyl substitution can increase SGTT because this group can 
hydrogen bond with water and inhibit intermolecular association (Ooelker 1987; 
Haque & Morris 1993; Haque et al 1993). The degree of hydrophobic junction 
zone formation is reflected in the gel strength and their SGTT. It has been reported 
that above the SGTT, MC forms a firm gel whereas HPMC E and F, which are more 
hydrophilic, form semi-firm gels. The most hydrophilic forms of pharmaceutical 
HPMC, the K grades, form a mushy gel with no measurable strength (Sarkar 1979). 
The SGTT values are shown in Table 1.1. Hirrien et al (1996) have reported that 
MC exhibited different behaviour as a function of temperature depending on the 
OS values, intermolecular interactions occurred at T>45°C when OS > 1.5, but 
there was no clear evidence for aggregation at this temperature when OS<1.5. 
Viriden et al (2009b) has claimed that more hetereogenously substituted polymers 
exhibit a higher SGTT and slower rates of gelation and suggested this arises from 
their amphiphilic properties, resulting in a reduced capacity of dehydration from 
the polymer and the delay of hydrophobic aggregation. 
(b) Molecular mass and polymer concentration 
There appears to be little relationship between molecular mass ofthe polymer and 
SGTT (Sarkar 1979). The viscosity of HPMC solutions increases with HPMC 
concentration (Silva et al 2008) but the IGT, IPT and CP have been also shown to 
vary considerably with polymer concentration. Values of IPG and CP decrease 
with increasing concentration until a critical concentration is reached. High 
polymer concentrations (over the critical limit) can decrease SGTT, but gel 
formation occurs before turbidity is observed. In contrast, at low polymer 
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concentrations turbidity can occur before gel formation (Sarkar 1979; Li et al 
2005). 
(c) Presence of additives 
In solutions. HPMC is a hydrated colloid and is susceptible to 'salting out' from 
solution by solutes (Sarkar 1979; Nakano et al 1999). Inorganic salts, electrolytes 
and most water-soluble substances (e.g. sorbitol, sucrose, glycerol), depress SGTT 
by competing for the available water, dehydrating the polymer hydration sheath, 
and thus favouring polymer-polymer interactions. This 'salting-out' efficiency 
varies widely for different cellulose derivatives and depends on the nature of both 
the cations and anions (Alderman 1984; Doelker 1987; Mitchell et al 1990; 
Doelker 1993; Li et al 2005). Nonionic cellulose ethers tolerance for cations has 
been ordered as follows: 
PbZ+ > Znz+ >Cu2+ >Fe3+ >NHt > Ca2+ > Ba2+ > K+ > Mg2+ > Na+ > AP+ 
For anions. the rank order is : 
1-> CNS- > borate> NOi > C O ~ - > > Cl- >acetate > tartrate > S O ~ - > > P O ~ ~
Ion tolerance generally follows the classical order of Hofmeister's series. The 
amount and the length of the hydrophobic alkyl substituent will modify the salt 
tolerance and hydroxyalkylation will enhance the electrolyte concentration limit 
for gelation. (Touitou & Donbrow 1982b) 
Conversely, certain large ions (e.g. basic drugs) may raise SGTT by adsorption of 
these ions, which carry water, onto the polymer leading to an overall increase in 
polymer hydration. Some drugs can also affect SGTT, for examples, MC has been 
reported to interact with tetracaine hydrochloride and dibutoline sulphate; HEMC 
and HEC have shown association tendencies with phenothaizine tranquilisers; 
NaCMC reacts with certain cationic drugs (Doelker 1987; Li et al 2005). 
Solvents such as ethanol, polyethyleneglycol (PEG), and propylene glycol (PG) can 
raise SGTT (Doelker 1987; Dow Chemical Company 2002a). L-amino acids can 
lower SGTT if they are small hydrophilic molecules, and raise SGTT if they are 
large, hydrophobic or aromatic molecules (Richardson et al 2006). 
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Surfactants also interact with cellulose ethers. The addition of sodium dodecyl 
sulphate (SDS) was found to increase the SGTT of HPMC solutions by solubilising 
the methoxyl rich "junction zones" which are responsible for aggregation and 
precipitation, thereby leading to an increase in solubility of the polymer (Nilsson 
1995). The increase of polymer hydrophobicity induced polymer-surfactant 
aggregation (Evertsson & Nilsson 1998). 
The abilities of additives to depress or elevate the cloud point, or salt out the 
polymer can be expressed as the constant Kep, which can be calculated from the 
relationship in Equation 1.1. 
log CP = log CPo + Kcpm Equation 1.1 
CP is the observed cloud point, CPo is the theoretical cloud point in absence of 
additive and m is the molar concentration. 
(d) Experimental conditions 
In rheological studies, higher shear rates corresponding to non-Newtonian 
regimes, can prevent gelation and cause SGTT to be raised to higher temperatures 
(Silva et al 2008). It has also been reported that SGTT may be affected by heating 
and stirring rate (Doelker 1993). 
1.3.2. Rheology 
Cellulose solutions exhibit the typical rheological behaviour of linear polymers. 
The viscosity of cellulose ether solutions is dependent on their concentration, 
molecular weight and substitution. The molecular weight is controlled during 
manufacture through exposure to the air, leading to oxidation and cleavage of the 
glycosidic bonds in the polymer chains (Donges 1990). Above a certain 
concentration, non-ionic ether solutions, especially low molecular weight cellulose 
derivatives, tend to be thixotropic and exhibit a time-dependent reduction of 
viscosity under fixed flow conditions (Doelker 1987). Above the critical 
entanglement concentration, polymer chains show an equal rate of entanglement 
11 
Chapter 1 
and disentanglement at low shear, giving rise to Newtonian-like properties. At 
higher shear rates, HPMC forms fewer polymer associations between consecutive 
shear deformations, and shows evidence of shear thinning (Haque et al 1993). 
Thuresson and Lindman (1999) have suggested that the viscosity of cellulose 
ether solutions may be attributed to polymer entanglements in the short term and 
to strong associations between unsubstituted regions of the native cellulose in the 
longer term. These interactions are thought to arise from strong hydrogen bonds 
between unsubstituted hydroxyl groups. The viscosity of polymer solutions is also 
affected by temperature and additives (e.g. electrolytes and other solutes) whereas 
the solution pH (in a range of pH2-12) has no practical effect on the viscosity of 
nonionic cellulose ethers (Doelker 1987). Table 1.1 shows the viscosity range of 
2% solutions for commercially available grades of HPMC. 
1.3.3. Surface activity 
HPMC and other cellulose ethers contain hydrophobic (alkyl) and hydrophilic 
(hydroxyl) side groups so that they can reduce the surface tension of water and 
the interfacial tension of aqueous systems. The degree of surface activity is 
dependent on the distribution of these groups along the cellulose backbone and 
the relative balance of the substituent groups, whereas concentration has little 
effect (Sarkar 1984; Doelker 1987). The total surface free energy was generally 
assimilated to the surface tension of a polymer solution in the range of 
concentration independence whereas the non-polar and polar contributions were 
obtained from contact angle measurements. Table 1.1 shows the surface tension 
and interfacial tension on mineral oil, of dilute HPMC solutions in which the 
surface tension of the aqueous solution is 72.0mN/m at 25°C and the interfacial 
tension on mineral oil is -41mN/m for pure water (Doelker 1987). HPMC 2910 
exhibits a greater ability than HPMC 2208 to reduce surface tension and interfacial 
tension because HPMC 2910 has more methoxyl substitution. 
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1.4. The properties of HPMC matrices 
1.4.1 Hydrophilic matrices 
A hydrophilic matrix is a solid extended release dosage form comprising of a 
mixture of ingredients including one or more water-swellable hydrophilic 
polymers. This matrix may be compressed to tablets, or filled in hard shell 
capsules. HPMC is one of the most popular polymers used to incorporate into a 
matrix tablet to provide extended release and it has become the 'industry-
standard' material for hydrophilic matrices (Alderman 1984; Li et al 2005). 
1.4.2 Mechanism of drug release 
Figure 1.4 shows the principal mechanisms of drug release from a hydrophilic 
matrix tablet. When the matrix is exposed to a liquid medium, rapid diffusion of 
medium into the matrix tablet will occur and lead to the hydration and relaxation 
of polymer chains, followed by the formation of a continuous layer of concentrated 
hydrated polymer around the tablet surface, commonly termed the 'gel' layer 
(Alderman 1984; Ford 1999; Siepmann et al 1999). Within the gel layer is a 
concentration gradient of polymer, water soluble and it is a complex aggregate of 
water, water-soluble polymer, drug and excipients (Alderman 1984; Fyfe & Blazek 
1997). The gel layer expands and increases in thickness with time as the medium 
penetrates. At the same time, there is disentanglement of polymer chains at the 
surface of the gel layer and polymer release in the stirred medium, a process 
collectively known as 'erosion' (Colombo 1993). The gel layer acts as a diffusion 
barrier to control both the water uptake and the release of drugs (Colombo et al 
2000). During the early stages of hydration (gel layer formation) drug on the 
tablet surface is rapidly released into the hydration medium as an 'initial burst' 
whereas subsequent drug release is controlled by the gel layer and occurs more 
slowly. The simple view is that the release mechanism from the matrix is 
diffusion-controlled in the case of water-soluble drugs, and erosion controlled in 
the case of intermediate and poorly drugs (Alderman 1984; Linhardt 1989; Li et al 
2005). The release rate of water-soluble drugs mainly depends on diffusion rate 
through the gel whereas the release rate of water-insoluble drugs depends on the 
13 
Chapter 1 
rate of mechanical erosion from the surface gel layer. However, most drugs with 
aqueous solubility are considered to be released simultaneously by diffusion and 
erosion processes (Gao et a11996; Kim & Fassihi 1997a). 
The critical processes in the drug release mechanism has been described by 
Colombo et al (1995; 1999a; 1999b; 2000) who initially used an optical 
microscopy method to visualise the distribution of a coloured, water-soluble drug 
(buflomedil pyridoxal phosphate) within an HPMC matrix tablet Figure 1.5 shows 
a schematic illustration of a cross-sectioned hydrated HPMC matrix tablet in which 
Colombo et al identified three moving fronts within the gel layer. These fronts 
separate (i) the outer matrix and medium (erosion front), (ii) the glassy/ rubbery 
polymer transition (swelling front) and (iii) the solid drug and hydrated drug 
(diffusion front). In the beginning of gel layer formation, the gel thickness is small 
so that medium ingress into the dry matrix core occurs rapidly, and there is rapid 
inward movement of the swelling front and expansion of the gel (Colombo 1993). 
Water-soluble drugs, which are mainly released by diffusion, will exhibit initially a 
fast release rate of release because of the short diffusional distance across the thin 
gel layer, however, the release rate becomes progressively slower as the gel layer 
expands and will exhibit release linear with root time kinetics. On the other hand, 
water-insoluble drugs, which are primarily released through the relaxation and 
dissolution of polymer chains at the erosion front (including the mechanical 
removal by shear forces) exhibit zero-order drug release (Colombo et al 2000). 
The ability of the gel layer to retard water penetration means that these processes 
occur over a prolonged time extended release of drug is achieved. However, a 
poorly formed gel, in which the diffusion barrier layer is disrupted or incompletely 
formed, will permit a more rapid medium ingress, leading to more rapid drug 
release and in more extreme cases, the premature disintegration of the matrix (Li 
et aI2005). 
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Figure 1.4 The principal drug release mechanism of a hydrophilic matrix tablet 
(Adapted from Alderman 1984) 
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Figure 1.5 Schematic illustration of a cross-section HPMC matrix tablet during 
hydration and drug release. Three moving fronts are identified and the matrix is divided 
into three regions by the hydration stage of the polymer and drug (Adapted from Colombo 
et al (1995). 
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1.4.3 A mathematical model for determining the drug release mechanism 
from HPMC matrices 
Since the 1960's, mathematical models have been developed to describe drug 
release mechanisms from controlled release formulations. There is considerable 
literature, and complexity of modelling, and so only the most accepted and widely 
used models are summarised here. Higuchi (1961; 1963) derived a mathematical 
model to describe drug release from an ointment surface, on the assumption that 
(i) the drug was homogenously dispersed in the base and (ii) the adjacent liquid 
was a perfect sink. The simplified form of this equation (Equation 1.2) shows how 
the fraction of drug released is linearly related to the square root of time. The 
Higuchi equation has been applied to many types of matrices, but in the case of 
hydrophilic matrices is recommended to describe the release kinetics only up to 
60% drug release, and only when there is a purely Fickian diffusion-controlled 
mechanism (Siepmann & Gopferich 2001; Siepmann & Peppas 2001; Macheras 
2006). Korsmeyer et al (1983) widened this approach to include a power law 
equation (Equation 1.3) for determining the drug release mechanism in systems 
that deviate from Fickian diffusion. Studying the influence of hydration, swelling 
and glass transition (T g) of the polymer, it has been concluded that the release 
mechanism depended principally on diffusion, gel erosion and polymer relaxation 
(Peppas 1985; Siepmann & Gopferich 2001). Equation 1.3 can be used to analyse 
swelling-controlled release systems as long as the equilibrium swelling ratio is not 
higher than 1.33 (Ritger & Peppas 1987). Later, Pep pas and Sahlin (1989) derived 
Equation 1.4 to distinguish the Fickian and relaxation contributions to the drug 
release mechanism. 
~ ~ = kt°.S 
Moo Equation 1.2 
Equation 1.3 
Equation 1.4 
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In these equations, Mt is the amount of drug released at time t, Moo is the amount of 
drug released at infinite time, kl and kz are kinetic constants, t is the release time 
and nand m are diffusional exponents which have been used to describe the 
release mechanism. In the case of Equation 1.4, the first term describes the 
Fickian contribution, and the second term describes Case II relaxation. The 
diffusional exponent can range from 0.43 to 1 depend on the release mechanism 
and the shape of the drug delivery device, and the drug transport mechanism can 
be classified as in Table 1.2 (Peppas 1985; Peppas & Sahlin 1989; Peppas & 
Colombo 1997; Costa & Lobo 2001; Maderuelo et al 2011). This model assumes 
that drug release will start immediately after the matrix is exposed to solution, and 
the mechanism of drug release is constant during the first 60% of cumulative 
release. 
Diffusional exponent (n) 
n =0.5 
0.5 < n < 1.0 
n = 1.0 
n > 1.0 
Type of drug transport 
Fickian diffusion 
non-Fickian or anomalous 
transport 
case II transport 
super case II transport or 
zero-order release kinetics 
Table 1.2 The category of drug transport from the controlled release matrices 
classified by the diffusional exponent (n). 
Later, Ford et al (1987) showed that drug release rarely passed through the origin 
and the equation should therefore incorporate a lag time. The lag time account for 
the time required for the matrix perimeter to hydrate and the gel layer to reach 
equilibrium, before the advance of the solvent front through the matrix and 
erosion of the surface, predominates (Ford et al 1991a). Equations 1.3 and 1.4 
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have been modified to account for the lag time (I) in Equations 1.5 and 1.6 
respectively. 
~ ~ = k(t _l)n 
Moo 
Equation 1.5 
Mt 
-= Equation 1.6 
Other models which have been used in the literature but not investigated here 
included the Hixson-Crowell model and the zero-order equation. These have been 
traditionally used for poorly soluble drugs (Costa & Lobo 2001). More complex 
models have been developed by various authors, most notably Siepmann 
(Siepmann et a11999; Siepmann et al 2000; Siepmann & Peppas 2000; Siepmann & 
Gopferich 2001; Siepmann & Peppas 2001). 
1.4.4 Factors affecting matrix drug release 
There are numerous factors which affect drug release from HPMC matrices and the 
most important can be divided into polymer and non-polymer factors. 
1.4.4.1 Polymer factors 
(a) Polymer hydration rate 
Rapid hydration and formation of a protective gelatinous layer are necessary to 
control drug release from a hydrophilic matrix and the gel layer must form more 
rapidly than the dissolution of drugs and excipients (Alderman 1984; Li et al 
2005). Alderman (1984) has described that the relative hydration rate of HPMC 
was related to the amount of hydrophilic (hydroxyl and hydroxypropyl 
substituents) on the cellulose backbone and only HPMC 2208, the most 
hydrophilic and rapidly-hydrating polymer, provided significant sustained release. 
However, the matrix in the Alderman studies contained only 10%w/w HPMC, 
below what is regarded as a threshold polymer content, and so these experiments 
may have been unduly discriminating. Mitchell et al (1993b) investigated at the 
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higher and more normal HPMC levels (-30%w/w HPMC) and found no 
relationship between the proposed hydration rates of HPMC grades and the rate of 
drug release from matrix tablets. Rajabi-Siahboomi (1993) who investigated the 
swelling and hydration rate of different HPMC grades using lH-NMR microscopy 
also found no relationship between Methocel™ grade and hydration and swelling 
rate between HPMC types. 
(b) Polymer viscosity 
The viscosity of cellulose ethers is a function of their molecular weight and 
increasing the viscosity grade of the polymer, leads to a more viscous and higher 
gel strength gel layer. Thus the resistance to polymer erosion is greater and drug 
diffusion is slower (Alderman 1984; Reynolds et al 1998; Velasco et al 1999; Li et 
al 2005; Maderuelo et al 2011). This has been attributed to their increased 
hydrodynamic volume occupied by the higher molecular weight polymer chains 
(Wan et al 1991; Wan et al 1993; Gao et al 1996). With an increased HPMC, 
viscosity the percentage of swelling increases whilst the percentage of erosion 
decreases (Ravi et al 2008). This leads to the slower release of both water-soluble 
and poorly soluble drugs and high-viscosity HPMC is recommended for water-
soluble drugs to achieve release kinetics controlled by diffusion whereas low-
viscosity HPMC is recommended for sparingly water-soluble drugs to achieve 
sufficiently fast release kinetics in which erosion predominates (Tahara et a11995; 
Gao et a11996; Hiremath & Saha 2008; Mitchell & Balwinski 2008; Ravi et al 2008; 
Maderuelo et aI2011). 
(c) Polymer concentration 
Generally, an increase in the polymer concentration in the matrix corresponds to a 
lower porosity of the matrix, and thus drug release rate decreases (Reza et al 
2003; Ebube & Jones 2004). Mitchell et al (1993d) suggested that an increase in 
the polymer concentration elicits a greater degree of cross-linking of the polymer 
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side chains, leading to the increase in gel tortuosity which can slow down diffusion 
of drug across the gel layer. High polymer contents lead to a thicker and more 
viscous gel formation whereas low polymer levels result in slower gel formation, 
Increasing polymer concentration, produces gel layers more resistant to diffusion 
or erosion and thus drug release is slower (Alderman 1984; Doelker 1987; Li et al 
2005). The minimum concentration of HPMC required for a hydrophilic matrix to 
rapidly form an effective gel layer and barrier to medium ingress is considered to 
be approximately 20%w/w (Goncalves-Araujo et al 2008). At polymer contents 
higher than 20%w /w, the variations in the degree of viscosity and particle size of 
the polymer do not cause important changes in drug release. This emphasises the 
greater importance of the polymer content in comparison with polymer viscosity 
and particle size in determining drug release rate (Campos-Aldrete & Villafuerte-
Robles 1997). However, formulations that contain 30-40%w /w HPMC tend to 
exhibit exhibited the similar drug release profiles independent of HPMC grades 
and diluents, and is more widely accepted to be the level at which drug release 
from the HPMC matrix becomes less dependent on other factors (Li et al 2005). 
The drug/polymer ratio has also been considered as an important factor 
controlling drug release (Ford et al. 1985b; Ford et al. 1987). In the case of water-
soluble drugs, the system becomes more porous as drug loads increase with 
respect to the polymer, leading to faster release rates (Siepmann & Peppas 2000). 
Dabbagh et al (1996) similarly found that the drug release rate increased as the 
polymer fraction was decreased. 
(d) Polymer Substitution 
At low polymer levels, drug release rates depend on HPMC substitution type. The 
hydrophobic methoxyl groups can retard hydration as they decrease H-bonding 
within and between particles of close proximity, especially the dry regions. The 
different substitution levels also gave rise to different water mobilities, leading to 
different drug release characteristics (Mitchell et al 1990b; Mitchell et al 1993b; Li 
et al 2005; Rajabi-Siahboomi et aI1996a). Haque and Morris (1993) reported that 
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as the hydroxypropyl content of HPMC was increased, a weaker gel was formed 
which was more susceptible to erosion. This resulted in faster drug release (Dahl 
et al 1990; Haque & Morris 1993). The interaction between cellulose ethers and 
water, results in three types of water being present in a hydrated HPMC gel: (i) 
free water (no binding), (ii) interface water (weakly polymer-bound), and (iii) 
bound water (strongly bound to the polymer). The proportions of these types of 
water depend on the polymer substitution (Jhon & Andrade 1973). 
(e) Polymer particle size 
HPMC particle size and size distribution have been shown to significantly affect the 
hydration rate of polymer and drug release from matrices. Smaller particle size 
fractions of HPMC exhibit a higher surface area to the hydration medium, leading 
to a rapid gel layer formation and often better extended release properties (Heng 
et al 2001). At low polymer content, it has been found that the drug release rate 
decreased as HPMC particle size was reduced, whereas drug release rate increased 
when HPMC particle size increased. With the extremely large particle sizes burst 
release can occur but conversely, reductions in particle size below 150l1m caused 
no further decrease in dissolution rate (Mitchell et al 1993c; Campos-Aldrete & 
Villafuerte-Robles 1997; Li et al 2005). Faster release or burst release from large 
particle sized polymer has been attributed variously to a decrease in tablet 
compressibility, matrix water uptake, polymer swelling. gel layer viscosity and gel 
layer formation rate (Alderman 1984; Rajabi-Siahboomi 1993; Nokhodchi et al 
1995; Velasco et al 1999). Heng et al 2001 have reported that above a critical 
mean HPMC particle size, the release mechanism deviates from first order kinetics 
and that polymer size distribution affected drug release rate but not the release 
mechanism.). Mitchell and Balwinski (2007) found that HPMC particle size and 
particle size distribution influenced drug release and release mechanism only 
when less than 50% of HPMC was smaller than 63 11m for the ranges studied. 
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1.4.4.2 Non-polymer factors 
(a) Drug factors 
Properties of incorporated drugs that can affect drug release rate form an HPMC 
matrix include particle size, molecular weight and solubility (Li et al 2005; 
Maderuelo et al 2011). Ford et al (1985a; 1985b) found that increasing the 
particle size of water-soluble drugs (propranolol hydrochloride, promethazine 
hydrochloride and aminophylline) lead to slower release rates, but this occurred 
only at low polymer content. In the case of poorly soluble drugs (e.g. 
indomethacin), increased particle size resulted in decreased release rates. It was 
proposed that this was simply the result of the slower dissolution of larger 
particles as the drug surface area to volume ratio was decreased (Ford et al 
1985c). In contrast, Hiremath and Saha (2008) found faster (insoluble) rifampacin 
release with increasing drug particle size. It was suggested that this was the result 
of polymer depleted regions within the matrix which were rich with large drug 
particles. 
Talukdar et al (1996) suggested that water-soluble drugs with lower molecular 
weight will diffuse more rapidly through the gel layer and exhibit longer mean 
dissolution times than higher molecular weight drugs. They also found that the 
release of water-soluble drugs was faster than the release of water-insoluble drugs 
which the authors attributed to their different release mechanisms. Tahara et al 
(1996) described the relationship between drug solubility and release mechanism 
which was explained in terms of three scenarios : (i) with poorly water-soluble 
drugs, the drug dissolution rate is slower than the erosion rate and as a result 
matrix erosion is the limiting process in drug release. (ii) in the case of drugs with 
a solubility between O.5mg/ml and 5mg/ml. the dissolution rate is dependent on 
both the matrix erosion rate and the medium penetration rate as the dissolution 
rate increases with the increase in the drug solubility. and (iii) for highly water-
soluble drugs (>5mg/ml). the dissolution rate is similar to the rate of medium 
penetration. High solubility drugs can increase drug release rates through both 
diffusion and erosion mechanisms by acting as microcavities in the gel layer, 
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making the gel structure more porous and weaker (Doelker 1987; Linhardt 1989; 
Yang & Fassihi 1997; Li et aI2005). However, some studies found that use of some 
water-soluble drugs leads to a slower drug release, and postulated that they may 
aid rapid gel formation, whereas poorly soluble drugs cannot contribute in this 
way (Mitchell et al 1993a; Mitchell et al 1993d). 
Drug release kinetics depend not only on drug diffusion and matrix erosion, but 
also on the relaxation of the polymer, the dissolution rate of drugs in the gel layer 
(Colombo & Bettini 1999a) and solid drug translocation in the gel due to polymer 
swelling (Bettini et al. 2001). More soluble drugs will be more available because 
they dissolve more extensively in the limited water within the gel layer, but poorly 
soluble drugs which slowly dissolved in the gel layer will allow drug particles to be 
transported close to the matrix erosion front. If there was a considerable amount 
of solid drug particles remained in the gel phase when the matrix had been 
completely hydrated, the erosion became accelerated. 
In the case of matrices containing a high content of high solubility and drugs, 
significant burst release can occur from drug at or near the matrix surface being 
release immediately after matrix contact with the dissolution medium. Hence very 
high drug release rates can be seen during the first few hours when dissolution 
testing these types of formulations (Batycky et al 1997; Brazel & Peppas 1999; 
Velasco et a11999; Huang & Brazel 2001). 
(b) Additives 
Many studies have shown how diluents can modulate drug release from 
hydrophilic matrices and although it has been reported that generally an increased 
amount of diIuents involve an increase in drug release rate, this is usually a result 
of a lowering HPMC content (Lotfipour et al 2004). Early studies described by 
Alderman (1984) compared drug release from HPMC matrices containing a soluble 
diluent (lactose) with those containing a swell able insoluble diluent 
(microcrystalline cellulose or MCC) and a non-swellable insoluble diluent 
(dicalcium phosphate). Matrices containing swell able insoluble diluents exhibited 
greater initial burst drug release (compared with those containing soluble 
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diluents) but provided slower drug release afterwards. It has been suggested that 
the presence of even small amount of fibrous insoluble diluents may prevent 
homogeneous gel layer formation (Zuleger & Lippold 2001; Zuleger et al 2002). In 
a more extreme example. superdisintegrants have. not surprisingly. been found to 
increase the drug release rate from matrices (Li et al 2005) 
In contrast. dicalcium phosphate. the non-swelling insoluble diluent was found by 
Alderman to prevent the formation of a coherent gel layer. and destroy the 
extended release properties of the HPMC matrices. However. these formulations 
contained very low polymer content (10%w/w HPMC) and are hardly typical. 
Subsequently. many authors reported no problems in gel formation with dicalcium 
phosphate (Ford et al 1987; Rekhi et al 1999). Rekhi et al (1999) also found that 
HPMC matrices containing a soluble diluent. lactose exhibited faster release than 
those with insoluble dicalcium phosphate which was attributed to dissolving of the 
lactose decreasing gel strength. Levina and Rajabi-Siahboomi (2004) have 
described how a grade of partially pregelatinised starch (Starch 1500®) decreased 
drug release rate in comparison with HPMC matrices containing MCC (swell able 
but insoluble) and lactose (soluble) diluents. Myles et al (2005; 2006) has shown 
how Starch 1500. which is partially swellable. contributes physically to the gel 
layer structure. and can increase the robustness of low polymer HPMC matrices to 
ionic challenge. 
Sheskey et al. (1995) and Rekhi et al (1999) reported that magnesium stearate 
content over the range 0.2 and 2% w /w had no effect on drug release. However. at 
higher lubricant levels. we would expect that magnesium stearate would cause the 
commonly reported reduction in tablet tensile strength. and drug release may be 
increased if the tablet became sufficiently weak to be more permeable. 
Weak acid pH-modifying excipients (fumaric. sorbic and adipic acid) when 
incorporated into HPMC matrices with the resulted in significant increases in the 
release of weakly basic drugs in pH 6.8 and 7.4 phosphate buffers (Kranz et al 
2005). In a similar way, alkalizing buffers such as sodium citrate and THAM can 
aid release of a weak acid drug (felbinac) in acid media (Pygall et al 2010). These 
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effects resulted from a temporary localised pH modification of the gel layer, but 
sodium citrate matrices were shown to further accelerated matrix release, 
probably a result of multivalent ionic disruption of the gel layer formation (Pygall 
et al 2009). These effects depend on the pKa and solubility of the pH modifiers for 
the case of weak acid modifiers. Fumaric acid, which has a lower pKa and is more 
slowly soluble, was more effective than sorbic and adipic acids in enhancing drug 
release, and provided a release profile that almost overlapped the same 
formulation at pH 1.2 and was independent on the amount of fumaric acid in the 
formulation (Streubel et a12000; Varma et a12005; Siepe et aI2006b). In the same 
way, THAM with a higher pKa, provided more prolonged buffering of a weak acid 
drug than sodium citrate (Pygall et a12009; Pygall et aI2010). 
Surfactants incorporated into the matrix can modify drug release (Ford et a11991b) 
but explanations have focused on the potential for ion pair salt formation with the 
drug. For example, sodium dodecyl sulphate (SOS) incorporated in HPMC matrices 
could interact with propanolol hydrochloride, and decreased the release rate from 
HPMC matrices, whereas cetrimide showed an opposite effect (Nokhodchi et al 
2008). 
The inclusion of cyclodextrins with poorly-soluble drugs can result in faster 
release rates form HPMC matrices (Guo & Cooklock 1995). This can be explained 
by the improvement in solubility of these drugs in the presence of cyclodextrins, 
and is supported by the decrease in release rate found with water-soluble drugs, 
which is probably a result of the inclusion drug molecules in the cyclodextrin 
(Vueba et aI2004). 
Ionic salts or water-soluble substances can also cause precipitation, or salting out 
of cellulose ethers by competing for the available water and dehydrating the 
polymer hydration sheath. In brief this will change the SGTT of cellulose ethers, 
the hydration rate of the polymer, and thus the dissolution profile of the matrix 
(Alderman 1984; Li et al 2005). A more comprehensive review of the influence of 
these types of pharmaceutical additives on HPMC solutions and HPMC matrices is 
provided in the introduction of Chapter 3, 4 and 5. 
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(c) Tablet shape and modification 
The tablet surface area/volume ratio is one of the key factors in controlling drug 
release from HPMC matrix tablets Drug release rate is linearly related to tablet 
surface area so that increased surface area leads to increased drug release rates. 
As a result, smaller tablets require a higher polymer content than larger tablets to 
achieve the same release profile with the same drug (Ford et al 1987; Li et al 
2005). In addition larger matrix tablets have slower release profiles because the 
core is thicker, and also, it is reported, the gel layer (Siepmann et al 1999; 
Siepmann et al 2000. When the tablet surface area/volume ratio was held 
constant, similar release profiles were obtained (f2 > 70) (Reynolds et al 2002). 
Therefore modifications of tablet shape which involve changes in the matrix 
surface area/volume ratio will inevitably lead to changes in drug release (Rekhi et 
al 1999). It has been reported that the influence of matrix shape and size on 
hydrophilic matrices is greater than that on hydrophobic matrices (Staniforth 
2001). 
(d) Tablet porosity 
Air bubbles within the hydrated layer of hydrophilic matrices are formed during 
the swelling of the polymer. These bubbles arise from the void volume porosity of 
the matrix tablet and are an integral part of gel layer structure (Melia et al 1993). 
If present in large numbers they could potentially leading to modulation of the 
release kinetics by increasing the tortuosity of the drug diffusion path. However, 
tablet porosity may not be a significant factor under normal circumstances as 
many studies show that drug release from HPMC matrices is independent of tablet 
compression pressure (Ford et al 1985a; Rekhi et al 1999; Velasco et al 1999). 
However, Levina and Rajabi-Siahboomi (2004) reported slower release of 
chlorphenamine maleate with increasing matrix compreSSion pressure in a 
formulation that contained a low polymer content (200/0w /w HPMC). Dabbagh et 
al (1996) found that their matrix formulations had similar porosities and 
dissolution profiles when manufactured above a threshold compression force 
(78.7mNm-2) whereas tablet manufactured below this value, had higher porosities 
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and faster release rates. High compression pressures were postulated to reduce 
tablet porosity and the initial medium uptake, and therefore, reduce the initial 
burst of drug during the formation of a gel layer. 
(e) Dissolution testing conditions 
The ionic strength and temperature of the dissolution medium have all been found 
to influence drug release during USP dissolution testing. As non-ionic polymer 
HPMC is pH -insensitive, so that any direct pH effects (e.g. between simulated 
gastric fluid USP pH 1.2, simulated intestinal fluid USP pH 6.8) generally arise from 
the behavior of other components such as drug solubility (Bravo et al 2004). 
However, HPMC is sensitive to differences in ionic strength, and it has been shown 
that at high molar ion concentrations, or in the presence of other soluble such as 
dietary sugars, matrices exhibit accelerated drug release. This has been attributed 
to the decreased capacity of HPMC to form gel layer (Mitchell et a11990a; Bajwa et 
al 2006; Xu et al 2006; Pygall et al 2009; Williams et al 2009). Ford et al (1991a) 
reported that when the temperature of the dissolution medium is increased, the 
faster release of promethazine hydrochloride from HPMC matrices was found in a 
range of 25-50°C. The drug dissolution rate and the matrix diffusional 
contribution increased with the increased temperature which this soluble drug 
diffused through the gel rapidly (Ford et aI1985b). Increasing the agitation speed 
in a dissolution test will generally increase the erosion of an HPMC matrix, 
especially matrices containing low viscosity HPMC grades which have lower gel 
strength (Kavanagh & Corrigan 2004). 
Surfactants are often added to the dissolution medium in the case of insoluble 
drugs to increase drug solubility and improve drug wetting characteristics (Maggi 
et al 1996), however the work in this thesis shows that their presence may also 
lead to changes in polymer hydration behaviour. 
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1.5. Organic salts 
An organic salt is the reaction product of an organic acid and an inorganic base. 
Organic acids are compounds containing C, H, 0 as the major elements, with one or 
more functional groups which can form acidic salts. For example, maleic acid 
which has two carboxylic groups may form both neutral and acid salts (maleate), 
whilst methanesulfonic acid, a strong acid with one sulfonyl group (-S03H), can 
form stable salts (mesylate) with many weak bases. Some organic acids and their 
salts exhibit stereochemistry of in which different stereoisomers exhibit different 
physical properties. Examples of these include tartaric, lactic and malic acids 
(Stahl 2002). 
1.5.1 The applications of organic salts 
1.5.1.1 Organic salts used as drugs 
Some organic salts are used for a direct therapeutic effect. For example, sodium 
propionate is used as an antifungal agent (Wade 2000), sodium formate is used in 
certain external preparations for musculoskeletal and joint disorders (Martindale 
2005) and sodium valproate is utilized as an anti epileptic agent (BNF 57, 2009, 
p.258) Sodium octanoate is used as an adjuvant to stabilize albumin solutions 
against the effect of heat (Martindale 2005). Organic salts used as therapeutic 
agents or drug counter-ions, may be developed as HPMC controlled release dosage 
forms. However their influence on the drug release properties of these matrices is 
unknown and for this reason, the interaction between organic salts and HPMC 
should be studied. 
1.5.1.2 Organic salts used as drug counter-ions 
In pharmaceutical science, organic salts are used as drug counter-ions most 
commonly in order to improve drug solubility. For instance, mesylate, the salt of 
methanesulfonic acid, is a frequently used salt form of basic drugs. Salts of some 
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organic bases are also used as counter-ions to acidic drug substances such as 
triethylamin, diethylamine, piperazine, and trometamol (TRIS) (Stahl 2002). 
Typically, stronger anions and cations will be utilised to enable salt formation. For 
example, salt forms of new chemical entities approved by the FDA from 1995 to 
2006 were mostly prepared (>70%) with strong counterions (hydrochloride, 
hydrobromide/bromide, sulphate/bisulfate, nitrate, sodium, calcium, potassium) 
(Serajuddin 2007). However, Agharkar and co-workers reported for a basic drug, 
antimalarial agent alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-
phenanthrenemethanol, that solubility of lactate salt was 200 times as soluble as 
the hydrochloride salt (Agharkar et aI1976). 
Actually, the principles of salt formation involve various factors including pH-
solubility interrelationship, structure-solubility relationship, effects of organic 
solvent from synthesis or used in parenteral or other liquid dosage forms on salt 
solubility, effect of counterion on salt solubility, etc. (Serajuddin 2007). 
Additionally, the pH-modifiers will be used in dosage forms to avoid the 
conversion of salts to their respective free acid or base forms which may occur 
upon storage and also due to pH effects in the GI tract. 
1.5.1.2.1 A survey of the use of organic salts as counter-ions to drugs 
A survey of drug counter-ions was conducted in order to identify organic salts for 
further investigation. The results of this survey are summarized in Table 1.3. 
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Acidic salts 
Acetate, diacetate 
Benzoate 
Besilate, besylate, 
benzenesulfonate 
Butyrate 
Caproate 
Citrate 
Edisilate, ethane-
1,2-disulfonate 
Chemical structure 
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0-
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Examples of drugs utilising 
this counter-ion 
atosiban, cyproterone, 
fiecainide, desmopressin, 
cetrorelix, buserelin, 
leuprorelin, nafarelin, 
goserelin, glatiramer, 
tetracosactide, 
chlorhexidine, caspofungin 
metronidazole, rizatriptan, 
denatonium 
amlodipine, atracurium, 
cisatracurium, 
phenbutamide 
clobetasone, 
hydrocortisone 
hydroxyprogesterone 
piperazine, clomifene, 
fentanyl, tamoxifen, 
toremifene, sildenafil, 
orphenadrine, ranitidine 
bismuth citrate, 
dacarbazine 
clomethiazole 
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Embonate, 
pamoate* 
Estolate 
(Propionate 
laurylsulfate) 
Fumarate, 
hydrogen 
fumarate, acid 
fumarate, 
difumarate 
Gluconate 
(stereoisomer) 
Chemical structure 
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I 
I 
I 
I 
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o 
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-0 
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Examples of drugs utilising 
this counter-ion 
chlorpromazine embonate, 
triptorelin pamoate 
erythromycin estolate 
bisoprolol, ketotifen, 
ferrous (1:1), formoterol 
(2:1), tenofovir disoproxil 
(1:1), quetiapine (2:1), 
ibutilide, aminorex, 
bencyclane, clemastine 
(1:1), ketotifen, 
emedastine 
ferrous, calcium, 
chlorhexidine, quinidine, 
phenylamine, 
dexchlorpheniramine, 
dihydroquinidine 
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Glutamate 
(stereoisomer) 
Hippurate 
Isetionate 
Lactate 
(stereoisomer) 
Chemical structure 
iH2 
- O ~ ~ ~
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D-glutamate 
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L-glutamate 
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Examples of drugs utilising 
this counter-ion 
Arginine 
Methenamine 
pentamidine, 
propamidine, hexamidine 
pentazocine, milrinone, 
calcium lactate, sodium 
lactate, ethacridine, 
amoxicillin, haloperidol, 
isoxsuprine, trimethoprim, 
prenylamine 
32 
Organic salts Chemical structure 
Lactobionate OH OH H O ~ C O O O
6 OH 
HO 
OH 
Malate 
(stereoisomer) 0-
-0 
OH 0 
OH 0 
D-malate 
o 
01 
L-malate 
Maleate 0-0=0 
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Examples of drugs utilising 
this counter-ion 
dobutamine, erythromycin 
almotriptan hydrogen 
malate, pizotifen hydrogen 
malate 
azatadine, timolol, 
enalapril, 
chlorpheniramine, 
fluvoxamine, rosiglitazone, 
ergometrine, 
levomepromazine, 
trimipramine, 
prochlorperazine, 
methysergide, lisuride, 
brompheniramine, 
dimetindene, methyl 
ergometrine, 
dexchlorpheniramine, 
midazolam,mepyramine, 
nomifensine,perhexiline, 
pheniramine,pirisudanol, 
triethylperazine, 
trimebutine 
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Mesilate, 
mesylate, 
methanesulfonate 
Methylsul phate 
Mucate, 
galactarate 
Oleate 
Oxalate 
Pentanoate 
(valerate) 
Propionate, 
dipropionate 
Chemical structure 
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Examples of drugs utilising 
this counter-ion 
doxazosin,desferrioxamine 
(deferoxamine ), 
pralidoxime,phentolamine, 
dolasetron, benzatropine, 
neifinavir, saquinavir, 
bromocriptine, 
quinupristin with 
dalfopristin (both as 
mesilate salts, 3:7), 
imatinib, eprosartan, 
reboxetine, pergolide 
neostigmine 
isometheptene 
ethanolamine 
escitalopram, naftidrofuryl 
betamethasone, 
diflucortolone, estradiol, 
hydrocortisone 
clobetasol, fluticasone, 
testosterone, vitamin A, 
betamethasone 
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Resinate 
Salicylate 
Succinate, acid 
succinate, 
hydrogen 
succinate 
Tartrate, 
bitartrate, 
hydrogen tartrate 
(stereoisomer) 
Chemical structure 
A polymeric counter ion which is an ion 
exchange resin e.g. C19H29COO-
0-
-0 
0 
OH 
-0 
0-
0 OH 
-0 
0-
0 OH 
D-tartrate 
0 
-0 
01-
0 OH 
L-tartrate 
0 
-0 
01 
0 OH 
S,R Meso-tartrate 
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Examples of drugs utilising 
this counter-ion 
diclofenac (SR), 
dihydrocodeine (SR) 
choline 
sumatriptan, solifenacin, 
metoprolol, doxylamine, 
oxaflumazine, 
frovatriptan, benfurodil, 
bam ethan, cibenzoline, 
deanol, ergotamine, 
loxapine 
metoprolol, dimetacrine, 
alimemazine, zolpidem, 
ergotamine, tolterodine, 
brimonidine, rivastigmine, 
metaraminol, vinorelbine, 
epinephrine 
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Organic salts 
Teoclate 
Xinafoate 
Basic salts 
Diethylamine. 
diethylammonium 
Edetate 
Erbumine 
Trometamol. 
tromethamine. 
TRIS 
Chemical structure 
o 
OH 
COO-
HO?!:: NH2 
HO OH 
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Examples of drugs utilising 
this counter-ion 
promethazine. 
diphenylpyraline 
salmeterol 
diclofenac 
dicobalt. sodium calcium 
edetate. disodium 
edentate 
perindopril 
carboprost. fosfomycin. 
ketorolac.lodoxamide. 
desglugastrin. 
dexketoprofen. iloprost 
Table 1.3 Organic spedes currently used as drug counter-ions (references: Stahl 
2002; BNF 57; USP 2006; Martindale 2005; Merck Index 2006) 
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1.5.2 Hofmeister effect 
More than a hundred years ago, in 1888 Lewith and Hofmeister published 
accounts describing wide differences between the minimum concentrations of 
neutral salts required to precipitate a protein from solution. Since then, there has 
been a steady stream of studies and supporting data, expanding the scope from 
simple protein solubility, to a broad range of other phenomena involving biological 
macromolecules that take place in the presence of salts and other small molecules. 
The Hofmeister effect describes the phenomenon in which the solubilities of 
macromolecules (such as proteins, enzymes, and polymers) are modulated by salts 
(Baldwin 1996; Cacace et al 1997; Cho et al 2006; Zhang and Cremer 2006; Giner 
et al 2007; Liu et al 2008; T6th et al 2008). 
Salts have been classified according to their ability to alter water structure. Ions 
that enhance the hydrogen bond structure of water, reduce the solubilities of 
hydrophobic side groups and tend to cause 'salting out'. These are known as 
kosmotropes or water-structure makers. In contrast, ions that loosen hydrogen 
bond structure, increase non-polar solubilities and tend to cause 'salting in' of 
molecules. These are known as chaotropes or water-structure breakers. 
Kosmotropes are normally small ions with high charge densities such as CI-. These 
ions tend to succeed in competing for water molecules with polymer chains, 
decrease the number of free water molecules in the polymer hydration sheath, and 
can facilitate hydrophobic associations. In the case of HPMC this results in a 
decrease of the thermogelation temperature. The salting-in salts, which normally 
are large anions with low charge densities such as 1-. These function as water-
structure breakers and enhance the solubility of polymers (Cacace et al 1997; Cho 
et al 2006; Koga et al 2006; L6pez-Le6n et al 2007; Nucci & Vanderkooi 2008; Yang 
2009). Recent studies have found that bulk water structure is not central to the 
Hofmeister effect, and models are being developed that describe direct ion-
macromolecule interactions as well as interactions with water molecules in the 
hydration sheath of macromolecules. For example, in PNIPAM solution anions 
have been found to exhibit direct interactions with macromolecules and their 
immediately adjacent hydration sheath by (i) direct hydrogen bonding with amide 
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moieties (ii) increasing the cost of hydrophobic hydration (i.e. by raising the 
surface tension of the polymer/water interface), leading to salting-out of the 
polymer, and (iii) direct binding to the side chain amide moieties, leading to 
salting-in of the polymer (Zhang et al 2005; Zhang & Cremer 2006). Liu et al 
(2008) have studied the effect of a range of inorganic salts and isotropic solvents 
on the thermogelation behavior of HPMC in aqueous solutions, and found that to 
decrease the sol:gel transition temperature of HPMC by influencing the structure 
of water. The thermodynamics HPMC of gelation was determined by the salt types 
and concentration. 
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1.6. Surfactants 
1.6.1 The Solution Properties ofSurfactants 
Surfactants are amphiphiles which possess both hydrophilic (polar headgroup) 
and hydrophobic (non-polar tail) domains (Figure 1.6). They can be anionic, 
cationic, zwitterionic, or nonionic depending on their hydrophilic head group. At 
an appropriate concentration (the critical micelle concentration or cmc) 
surfactants can associate into regular structures called 'micelles'. In a hydrophilic 
solvent such as water, the important characteristic of micelles is that hydrocarbon 
chains (hydrophobic tails) constitute the inner part or core of the micelle whereas 
the polar headgroups are positioned in a thin layer at the surface of the micelle. 
Figure 1.6 shows the generalised structure of a micelle in water. The geometric 
form will depend on the surfactant concentration and the type and concentration 
of any additives present. The presence of salts results in the structural transition 
of micelles (Siddiqui et al 2001). In general, micelles are spherical at surfactant 
concentrations ranging from the cmc to at least ten times the cmc. At higher 
surfactant concentrations or in the presence of additives, rod-like micelles will 
form. At very high surfactant concentrations or with large amounts of additives 
present, liquid crystalline phases occur in which surfactant starts to separate out 
of solution with in most cases, a hexagonal or lamellar phase in phase equilibrium 
with the aqueous micellar phase (Florence & Attwood 2009). 
The solubilising power of micelles is associated with the hydrocarbon core. Non-
polar molecules generally solubilise in the core region of micelle, although simple 
geometry shows that parts of the solubilised molecule will be close to the 
headgroup region (Lindman 2002a; Birdi 2003). 
Moreover, many industrial applications use more than one surfactant to obtain the 
preferable effects. Mixed micelles can be (i) surfactant mixtures with no net 
interaction (similar head group, but different chain lengths) e.g. a mixture of SOS 
with a nonylphenol with 10 moles ethylene oxide (NP-El0) (ii) surfactant mixtures 
with a net interaction between for example anionics and nonionics (which shield 
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the repulsion of negative charges), or anionics and cationics (in which a strong 
interaction occurs between opposite charges) (Tadros 2005). 
Figure 1.7 diagramatically represents the concentration dependence of some 
physico-chemical properties of micelle-forming surfactant solutions. At low 
concentrations, most properties (except for the surface tension which rapidly 
decreases with surfactant concentration) are similar to those of simple 
electrolytes. At higher concentrations (above the cmc), surface tension and 
osmotic pressure take on an approximately constant value, while the propensity 
for light scattering increases and molecular self-diffusion decreases. All these 
observations suggest a change-over from a solution containing single surfactant 
molecules to self-assembled or self-associated structures (Lindman 2002a; Tadros 
2005; Florence & Attwood 2009). 
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Polar head-groups 
Hydrophobic tail 
Figure 1.6 Generalised structure of a surfactant micelle in water. (Adapted from 
Muller 2004) 
Osmotic pressure 
Solubilisation 
Surface tension 
Self-diffusion 
CMC Concentration 
Figure 1.7 Schematic representation of the concentration dependence of some 
physical properties for solutions of micelle-forming surfactants. (Adapted from 
Lindman 2002a; Tadros 2005 and Florence & Attwood 2009) 
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1.6.2 Surfactant-Polymer Systems 
Surfactant:polymer systems have been widely studied because they have many 
applications, for example, as enhanced thickening agents in suspensions and 
emulsions or in cosmetics. One of the most significant characteristics of 
surfactants is their ability to reduce the surface tension of aqueous solutions, but 
in the presence of polymers this behaviour can be modified as shown in Figure 1.8. 
Whilst this diagram represents the generalized behaviour of these systems, the 
underlying molecular interactions can be complex and they depend on the 
properties of the individual polymer and surfactant. At low surfactant 
concentrations, there mayor may not be a lowering of surface tension, depending 
on the surface activity of polymer. At a certain critical concentration (the so-called 
'critical association concentration', 'critical aggregation concentration' or CAC), 
there is an onset of surfactant-polymer association. Above this concentration, 
there is no further increase in surfactant activity and thus no further reduction of 
surface tension until the polymer is saturated with surfactant (T'z). Thereafter, the 
free surfactant concentration and surface activity start to increase again, and 
surface tension is further reduced until a critical micelle concentration (cmc) is 
reached (Tz). After this, the surface tension remains constant as surfactant 
micelles start to form (Lindman 2002b; Tadros 2005). 
The interaction between surfactant and polymer depends on both the polymer and 
the surfactant. The adsorption of ionic surfactants on the polymer is governed by 
the hydrophobic interaction between the alkyl chain of surfactant and the 
hydrophobic surface of polymer. Since adsorption depends on the magnitude of 
the hydrophobic bonding free energy, the amount of surfactant adsorbed directly 
increases with increasing alkyl chain length according to Traube's rule (Tadros 
2005). This rule, for hydrocarbon surfactants, states that the concentration of 
surfactant at which a given reduction of surface tension is observed, decreases in a 
regular progression with each -CHz- unit in the homologous series (Krishnan et al 
2003, Pin-eiro et aI2004). 
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Surfactant system 
Surfactant:po!ymer system 
- - - -- - - - - - -'--------
Concentration of surfactant 
Figure 1.8 Schematic plot of the surface tension of surfactant solutions as a function 
of surfactant concentration In the presence of polymer. CAC = critical aggregation 
concentration, cmc = critical micelle concentration, T 1 = the onset point of CAC, T' 2 = the 
saturated point of polymer:surfactant association, T2 = the cmc reached point. (Adapted 
from Lindman 2002b) 
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There are many factors which can influence the association between surfactants 
and polymers and these include (i) temperature (ii) addition of electrolyte (iii) 
surfactant chain length (iv) surfactant structure (v) surfactant classes (vi) polymer 
molecular weight (vii) amount of polymer (viii) polymer structure and 
hydrophobicity. 
Surfactant:polymer systems that exhibit this behaviour include ionic surfactants 
and uncharged polymers, and examples include SDS:poly(vinylpyrrolidone) (PVP), 
SDS:PEO, (anionic or cationic) surfactant: poly(vinyl alcohol), P E ~ , , PVP, or MC 
(Goddard 1990; Goddard 1993). 
There are also other types of surfactant:polymer interaction, for example, (i) 
surfactants and hydrophobically modified polymers which results in an 
association structure e.g. SDS:HM-HEC (or hydrophobically modified 
hydroxylethyl cellulose), (ii) surfactants and polyelectrolytes which are opposite-
charged polymers and results in an strong intermolecular association e.g 
SDS:catioinically modified cellulosic polymer (or Polymer JR, Union Carbide), 
cationic surfactants:anionic polyelectrolytes. 
1.6.3 Surfactants in Pharmaceutical applications 
Surfactants are widely used in pharmaceutical applications. They are used as 
solubilising agents for poor solubility drugs, as wetting agents, and as emulsifying 
agents. Common surfactants which are used in pharmaceutical applications are 
summarized in Table 1.4, and from this list we chose the alkyl sulphates as the 
most appropriate for our study. 
Surfactants 
Anionic 
Docusate sodium 
(Dioctyl sodium 
sulfosuccinate) 
Emulsifying wax BP 
(Cetostearyl 
alcohol and sodium 
lauryl sulphate) 
Lecithin 
(Phospholipids) 
Sodium lauryl 
sulfate 
(SLS or SOS) 
Cationic 
Benzalkonium 
chloride 
Benzethonium 
chloride 
Cetrimide 
Nonionic 
Glyceryl 
monostearate 
Chapter 1 
Principal Application Concentration 
used (%) 
Mainly used in capsule and 0.01-1.0 
tablet formulations as a 
wetting agent; also used in 
laxatives 
Emulsifying agent in 3-30 
cosmetics and topical 
pharmaceutical 
formulations 
Emulsifying agent; 0.25-10 
solubilising agent; 
emollient 
Emulsifying agent; 0.5-10 
detergent in medicated (external use, 
shampoos; skin cleanser in >0.0025,1-2 
topical application; (internal use) 
solubilising agent; 
tablet lubricant; 
wetting agent 
Antimicrobial preservative; 0.01-0.02 
antiseptic; disinfectant; 
solubilizing agent; 
wetting agent 
Form 
Solid 
Wax 
Viscous liquid to 
semisolid 
Solid 
Solid 
Antimicrobial preservative; Up to O.s%w Iv Solid 
wetting agent; 
solubilising agent; 
topical disinfectant 
Antimicrobial preservative; 0.005; 0.1-1.0 
topical antiseptic; 
cleanser and disinfectant 
Solid 
Emulsifying agent; 
solubilizing agent; 
stabilizing agent; 
emollient; sustained-
release ingredient; tablet 
and capsule lubricant 
HLB value: 3.8 Wax-like solid 
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Surfactants Principal Application Concentration Form 
used (%) 
Nonemulsifying Used in topical HLB value: 3.3 Oily liquid or 
glyceryl formulations as an paste 
monooleate emollient and emulsifier 
(water-in-oil emulsions); 
stabilizer (oil-in -water 
emulsions) 
Poloxamer Dispersing agent; 0.3-50 Depend Liquid or solid 
emulsifying and on the usage 
coemulsifying agent; 
solubilizing agent; 
tablet lubricant; 
wetting agent 
Polyethylene glycol Ointment, suppository >5% w/w of Liquid grades 
(PEG, Macrogol) base; suspending agent; high molecular (PEG 200-600), 
co-emulsifier; weight PEG for solid grades 
tablet binder; plasticizer; tablet binders; (PEG>1000) 
tablet and capsule 10-ls%w/w 
lubricant; used in film PEG 6000 for 
coating of tablets. thermoplastic 
granulations; 
30%v/vPEG 
300, PEG 400 
for parenteral 
dosage forms 
Polyoxyethylene Emulsifying agent; Depend on the Liquid, paste, or 
alkyl ethers solubilizing agent; usage e.g. 15- solid 
(Cetomacrogol, wetting agent; 20 (gelling 
Brij) gelling and foaming agents agents) 
Polyoxyethylene Emulsifying agent; HLB value: 12- Liquid or paste 
castor oil solubilizing agent; 17 (depend on 
derivatives wetting agent; grade); 
(Cremophor) used in oral, topical, and 1 mLofa2s% 
parenteral pharmaceutical v/vaqueous 
formulations Cremophor RH 
40 or 
Cremophor EL 
for solubilizing 
vitamins or 
certain drugs 
Polyoxyethylene Emulsifying agent; 0.5-10 Solid or paste 
stearate solubilizing agent; 
wetting agent 
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Surfactants 
Polysorbate 
(Tween) 
Sorbitan esters 
(Span) 
Principal Application 
Emulsifying agent; 
solubilising agent; 
wetting agent; 
dispersing/ suspending 
agent 
Emulsifying agent; 
solubilising agent; 
wetting agent; 
dispersing/suspending 
agent. 
Concentration 
used (%) 
1-15 
1-15 
Chapter 1 
Form 
Oily liquid, liquid 
or solid 
Liquid or solid 
Table 1.4 Surfactants commonly used in Pharmaceutical applications (as listed in the 
Handbook of Pharmaceutical Excipients 2000) 
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1.7. Aims and objectives of PhD 
1.7.1 Principal aims 
The overall aims of this thesis was to (i) investigate the influence of soluble 
organic acid salts on the properties of HPMC solutions and the release 
performance of HPMC matrices (ii) to identify (within the limited range 
investigated) any structure-activity relationships and (iii) if these effects were 
significant to propose a mechanism of interaction between these compounds and 
HPMC. These salts are often the forgotten components of matrix formulations 
because they are present simply as drug counter-ions. However, previous work on 
soluble amino acids had suggested they may have effects on HPMC solution and 
matrix behaviour. The understanding that these effects were related to alkyl chain 
length, lead to a further investigation involving a homologous series of alkyl 
sulphate surfactants, and a short study to investigate if sodium dodecyl sulphate 
might be used to recover failing HPMC formulations. The knowledge gained from 
this study might provide the basis for rational selection of salt forms for 
incorporation into HPMC formulations, and perhaps the use of organic salts to 
obtain a desired drug release rate. 
To accomplish these aims, the thesis is divided into the following experimental 
chapters: 
Chapter 3: The effect of organic drug counter-ion salts, on the properties of HPMC 
solutions, and the investigation of the mechanism of interaction between these 
organic salts and HPMC. 
Chapter 4: The effect of organic salts on the drug release performance of HPMC 
matrices, and the structure-activity relationships of their effects. 
Chapter 5: The effect of a homologous series of alkyl sulphate surfactants on the 
properties of HPMC solutions and drug release performance of HPMC matrices, 
and the mechanism of interaction between these surfactants and HPMC. 
Chapter 6: Can HPMC matrices be recovered using incorporated sodium dodecyl 
sulphate? 
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I hope that this work might provide a better understanding of the influence of the 
organic salts and surfactants which may be incorporated into HPMC matrix tablets, 
so that the appropriate consideration can be given to their effects when designing 
formulations to achieve a desired extended release rate. 
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Materials and General Methods 
2.1 Materials 
2.1.1 Hydroxypropyl methylcellulose (HPMC) 
Hydroxypropyl methy1cellulose (HPMC) USP Type 2910 (Methocel™ E4M CR 
Premium EP /USP) and USP Type 2208 (Methocel™ K4M CR Premium EP /USP) 
were a kind gift from Colorcon Ltd, Dartford, UK. The E4M batch (QF11012N03) 
contained 8.6% hydroxypropyl and 29.3% methoxyl substitution and was used as 
the principal HPMC throughout this thesis. The K4M batch (TD09012N11) 
contained 8.4% hydroxypropyl and 23.3% methoxyl substitution and was used in 
some studies. These batches were typical of USP 2910 and USP 2208 HPMCs. The 
detail of grades and batches are also shown in Appendix 1. The moisture content 
was monitored at intervals using a MB45 Moisture Analyser (Ohaus Corporation, 
New Jersey, USA) and remained steady at 3% w /w. Results are shown in Appendix 
2. This is within recommended working limits (Doelker 1993). 
2.1.2 Other materials 
Comprehensive details of all other materials, including the organic salts, organic 
acids, surfactants, tablet excipients, other reagents and the water used throughout 
this study can be found in Appendix 1. 
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2.2 Methods 
2.2.1 The preparation ofHPMC solutions 
2.2.1.1 10% w /w HPMC stock solutions 
Concentrated stock solutions containing 10% w/w HPMC were prepared using the 
hot/cold dispersion method for cellulose ethers (Dow Chemical Company 2002b). 
The required amount of HPMC was dispersed in water which had been pre-heated 
to >80°C using a bench-top magnetic-stirrer with a hot plate (RCT basic, IKA 
Labortechnik Staufen, Janke&Kunkel GMBH&CO.KG, Germany). The dispersion 
was then put into ice and cooled to room temperature while stirring was 
continued using a bench-top magnetic stirrer (KM02 basic, IKA® Labortechnik 
GMBH&CO.KG, Germany). The solution was then stored at 2-8°C for at least 24 
hours prior to use. 
2.2.1.2 1-2% w /w HPMC stock solutions 
Solutions containing 1-2% w/w HPMC were prepared by mixing the required 
weight of 10% w /w HPMC stock solution with water and making up to volume. 
Solutions were stoppered, stirred overnight and stored at 2-8°C for at least 24 
hours prior to use. 
2.2.2 The preparation of 0.1% and 1% w/w HPMC solutions containing 
additives 
HPMC stock solutions, and solutions of additives (e.g. drugs, salts and surfactants) 
were prepared separately to avoid any interactions prior to complete dissolution 
or hydration. The required amount of each additive was dissolved in water of 
about nine tenths of the final weight before being incorporated into a 1 %w /w 
HPMC stock solution one tenth of the final weight to obtain solutions containing 
additives in O.l%w/w HPMC. The mixtures were covered, stirred until 
homogeneous, and stored at 2-8°C for at least 24 hours prior to use. 
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2.2.3 Turbidimetric determination of HPMC cloud point temperature 
HPMC solutions undergo a thermoreversible sol:gel transition on heating and 
cooling (as described in Chapter 1 Section 1.3.1) and the temperature at which this 
occurs can be determined by turbidimetric, light scattering, rheological or 
calorimetric methods (Ford 1999). This temperature provides a sensitive measure 
with which to compare the molecular hydration of the polymer in solution in the 
presence of various additives. The significance of the sol:gel transition 
temperature (SGTT) is discussed in more detail in Chapter 1 Section 1.3.1. In this 
study the SGTT of HPMC solutions was measured by cloud point measurements 
using a multicell, temperature-ramped, white light turbidimeter (Cloud point 
apparatus, Medical Physics, Queen Medical Centre NHS trust, Nottingham, UK). 
This instrument detects the light transmission through sample solutions as a 
function of temperature, and detects the growth of aggregated polymer which 
behave as point scatterers of visible light (Kratochvil 1987; Chu 1991). 
2.2.3.1 Operational method 
A schematic diagram illustrating the operation of the cloud point apparatus is 
shown in Figure 2.1. The experimental method and the operation of the apparatus 
will be described together, as follows: 
• Sample solutions were filled into a cuvette (10 mm pathlength, quartz 
cuvette, Starna companies, U.K.) carefully avoiding bubbles which can affect 
the light scattering. 
• Sample cuvettes were placed in the temperature-controlled block as shown 
in Figure 2.1. 
• Before the test started, the baseline of each sample was investigated by 
running a light beam through the blank. 
• During the test, sample solutions were heated in the temperature 
controlled block by a water thermocirculator (the temperature-ramp was 
set at a rate of 1.5°C min·1), and stirred continuously using a custom made 
magnetic stirrer (Medical Physics, Queen Medical Centre NHS trust, 
Nottingham, UK) to ensure uniform temperature distribution and 
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homogeneity. The temperature of the sample was controlled by the 
surrounding heated block, and the temperature of the sample monitored by 
TC-08 silicone-coated thermocouples (Pico technology Ltd, Cambridge, UK). 
These were placed carefully in the sample cells as close as possible to the 
light beam but ensuring that the probe did not impede the path of the light 
beam or was in contact the side of the cuvette. 
• A beam of white light passes through the sample cell, and the intensity of 
transmitted light through the sample was detected by the photodiode. A PC 
interface converted the signals and graphs on the screen displayed how 
light transmission changed as a function of temperature. The temperatures 
at which light transmittance is reduced to 50% is termed the cloud point 
temperature (CPT) and this represented SGTT (Sarkar 1979). 
Tungsten 
light 
source 
Sample 
cell 
Temperature 
controlled 
block 
Magnetic 
stirrer 
) Photodiode 
detector 
SIgnal transfer 
Figure 2.1 Schematic diagram of the cloud point temperature apparatus. 
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2.2.4 Tensiometric determinations of HPMC surface tension 
HPMC possesses surface activity, as described in Chapter 1 Section 1.3.3. The 
surface activity of solutions can be determined by tensiometry and goniometry by 
various methods including the Du Noiiy Ring, Wilhelmy plate, spinning drop, 
pendant drop, sessile drop, bubble pressure, drop (weight) volume and capillary 
rise methods (Mulqueen & Huibers 2002; Goodwin 2004; Tadros 2005). The 
significance of surface tension in polymer-surfactant interactions are discussed in 
more detail in Chapter 1 Section 1.3.3 and 1.8.3. In this study, the surface tension 
was measured by using pendant drop method using a Profile Analysis Tensiometer 
(Sinterface tensiometer PAT1, Berlin, Germany). 
2.2.4.1 Measuring surface tension using a profile analysis tensiometer 
The Profile Analysis Tensiometer consists of a dosing system with a capillary 
(from which to generate a drop), a video camera with an objective, and a frame 
grabber to transfer the image into a PC. This tensiometer can measure both the 
surface and interfacial tensions of liquids based on the analysis of the shape of 
pendant and growing drops which hang from the end of the capillary (Figure 2.2a). 
The surface tension can be determined by fitting the Gauss-Laplace equation 
(Equation 2.1), which represents a relationship between the curvature of a liquid 
meniscus and the surface tension (y). The curve that fits best to the experimental 
points (red point obtained from the video image of a pendant drop as shown in 
Figure 2.2b) then corresponds to the optimum value of the surface tension. 
Equation 2.1 
Where l' is the surface tension, Rl and Rz are the main radii of curvature, liPo is 
the pressure difference in a reference plane, lip is the density difference, g is the 
acceleration due to gravity, and h is the vertical height of the drop measured from 
the reference plane. 
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(a) (b) 
Figure 2.2 (a) a pendant drop of liquid (b) the liquid meniscus used for the Gauss-
Laplace calculation 
2.2.4.2 Surface tension measurements ofHPMC solutions 
Surface tension measurements were conducted by pendant drop using the Profile 
Analysis Tensiometer (Sinterface tensiometer PAT1, Berlin, Germany) on 0.1 % 
w /w HPMC solutions containing surfactants or organic salts at 20 ± 1°C. Replicate 
measurements were automatically conducted 100 times on each sample. The 
relative standard deviations of the 100 measurements were smaller than 0.05%. 
Three separate aliquots of each solution were measured in this way. 
2.2.5 Density measurement 
Prior to conducting the surface tension measurements, the density of the sample 
solution was measured. Density values for 0.1 % w/w HPMC solutions containing 
surfactants or organic salts were obtained using a DMA 5000 oscillating U-tube 
Density Meter (Anton Paar, Graz, Austria). The measurement cell comprises a 
borosilicate glass U-shaped tube inside a thermostat jacket. The U-shaped tube 
sensor filled with -lmL of sample was electronically excited to Simultaneously 
oscillate at its fundamental resonant frequency and its harmonics. The oscillation 
characteristics are then measured with an integrated reference oscillator 
positioned in close thermal contact with the U-shaped tube. If the sample volume 
trapped between the oscillation nodes is assumed to be constant, the oscillation 
frequency is a function of sample density. The density determination is based on 
measuring the period of oscillation of a vibrating U-shaped tube filled with sample, 
and using a relationship between the period of oscillation and the density 
(Equation 2.2) which holds as long as the sample is not too viscous (Fitzgerald 
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2000). Mean density values (n=3) were obtained at 20±t °C and were used 
subsequently in the surface tension measurements. 
2 Jpv+m T= 1£ --
c 
Equation 2.2 
Where 't is oscillation period, p is sample density, v is cell volume, m is cell mass 
and c is spring constant. 
2.2.6 Rheological determinations 
2.2.6.1 Rheology, viscosimetry and viscoelasticity 
Viscosimetry, a branch of rheology, is an easy accessible but significant analytical 
method for the characterization of polymers in solution. Viscosimetry allows for a 
fast and low-priced determination of relevant parameters such as solution 
structure, volume fraction, coil dimensions, molar mass, viscOSity or 
thermodynamical properties ofa polymer in solution (Kulicke & Clasen 2004). 
Rheology is the science of deformation and flow which all forms of shear 
behaviour are described in terms of the behaviour of an ideal viscous liquid and an 
ideal elastic solid. A force applied to an ideal liquid causes a flow which is termed 
viscous behaviour whereas the same force applied to an ideal solid causes a 
deformation which is instantaneously reversed on the removal of the force and is 
termed elastic behaviour. The behaviour of many real materials is based on a 
combination of both the viscous and the elastic portion, and they are therefore 
called viscoelastic (or Maxwell) materials (Barnes et a11989; Mezger 2006). 
HPMC solutions are viscoelastic liquids whose behaviour can be illustrated using 
the Maxwell model. Figure 2.3 shows the Maxwell model which consists of a 
spring representing the solid/elastic component (E) and a dashpot representing 
the liquid/viscous component (Y). Initially, when a force (F) is applied (Figure 
2.3b), only the spring shows an immediate deformation until a constant deflection 
value is reached. When the constant force is continuously applied, the piston of 
the dashpot moves for as long as the force is applied (Figure 2.3c). After a certain 
period of time, both components show a certain extent of deformation which 
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corresponds to the degree of the force. When the force is removed, the spring 
relaxes immediately and completely to its original state whereas the dashpot does 
not (Figure 2.3d). The sample is now partly deformed and this deformation 
corresponds only to the viscous component. The time which a deformed material 
attempts to return to rest after applying a force strain is known as the relaxation 
time, and for viscoelastic materials, relaxation occurs at an exponential rate. The 
relaxation times of polymer solutions depend on the polymer structure and molar 
mass. Cross-linked polymers possess greater elastic behaviour and show the 
longer relaxation times whereas non-linked polymers, which may be less 
entangled (perhaps more hydrated) show more rapid and complete relaxation. 
The materials with a high molar mass generally show longer relaxation times 
(Clasen & Kulicke 2001; Mezger 2006). 
a v E d v E 
original state Force remo\'ed 
1 1 
b v E c v E F F 
Force applied continllolls force 
Figure 2.3 Schematic diagram of a single Maxwell model illustrating the 
deformation of a viscoelastic sample on application of a force. (a) The original state of 
the sample. (b) Force, F applied (see arrow) causes the spring to extend (deform). (c) The 
continued force is transferred to piston in the dashpot. (d) Force is removed and the 
spring returns to its original state while the dashpot does not (deformation is maintained). 
Adapted from Mezger (2006). 
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2.2.6.2 Dynamic oscillatory rheology 
The viscoelastic behaviour of materials can be evaluated by oscillatory (dynamic 
shear), creep and relaxation tests (Mezger 2006; Rao 2007) and the behaviour of 
HPMC solutions and HPMC solutions containing organic salts in this thesis is has 
been determined by oscillatory rheology. 
The basic principle of oscillatory rheology or dynamic mechanical analysis is to 
induce a sinusoidal shear deformation in the sample, using a parallel plate or cone 
and plate geometry, and then measure the sinusoidal stress response. The time 
scale is determined by the oscillatory or angular frequency (ro) of the shear 
deformation and the sinusoidal stress and strain relationship depends on the 
properties of a material. The stress of an ideal elastic solid is exactly in phase with 
the applied sinusoidal strain deformation as energy applied is stored and then 
completely returned on sample relaxation (Figure 2.4a). In contrast, the applied 
strain and the measured stress of a purely viscous liquid are out of phase by a 
phase angle 0 = !! (90°) because the energy is lost through heat as the liquid flows 
2 
(Figure 2.4b). In viscoelastic materials because they combine solid and liquid-like 
behaviour, the stress response contains both in phase and out of phase 
contributions, therefore the total stress response shows a phase shift with respect 
to the applied strain that lies between that of solids and that of liquids. The phase 
angle covers the range of 0 < 0 < ~ ~ (Figure 2.4c). This phase angle can be used 
to convert the amplitude of the stress response into a measure of elasticity and 
viscosity, but this is only accurate within the 'linear viscoelastic region' (LVR). 
This is a region where the deformation is small enough that stress is proportional 
to strain. The LVR can be identified by increasing the amplitude of oscillation and 
noting the magnitude of phase shift and the amplitude ratio. The limit of linearity 
can be detected when dynamic rheological properties change rapidly from their 
otherwise almost constant values (Mezger 2006; Rao 2007; Wyss et al 2007). 
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a) Elastic solid 
5-0 
-
b) Viscous liquid 
5 _ 90° 
-
c) Viscoelastic Juaterial 
Figure 2.4 Schematic stress response to oscillatory strain deformation for (a) a 
purely elastic solid, (b) a purely viscous liquid and (c) a viscoelastic material. 
Adapted from Mezger (2006)and Wyss et al (2007) 
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2.2.6.3 Descriptive factors used in oscillatory rheology 
The viscoelastic behaviour of a sample can be described by several parameters but 
the most usual are the elastic or storage modulus (G'), the viscous or loss modulus 
(G"), the complex viscosity (1"\*) and the loss tangent (tan B). G' expresses the 
magnitude of the energy stored in the material or recoverable per cycle of 
deformation whereas G" is a measure of the energy lost as viscous dissipation per 
cycle of deformation. The relationship between these viscoelastic moduli, and the 
sample stress and strain is described in Equation 2.3. 
CJ = G"y sin(wt) + G'y cos(wt) Equation 2.3 
where CJ is the sample stress, y is the strain, ro is the angular or oscillation 
frequency and t is the time. For an ideal elastic solid, all the energy is stored so 
that G" is zero and the stress and the strain are in phase (0°). In contrast, for an 
ideal viscous liquid, all the energy is dissipated as heat so that G' is zero and the 
stress and the strain are 90 0 out of phase. For a viscoelastic material which 
possesses both elastic and viscous portions, if G' is much greater than G", the 
material will exhibit more solid-like behaviour. However, if G" is much greater 
than G', the material behaviour is more liquid-like. Tan B is the ratio of the 
dissipated energy to the stored energy per cycle of deformation ( ~ ) ) and therefore 
if a sample exhibits predominantly liqUid characteristics (G">G'), tan B is greater 
than 1, or more gel-like behaviour (G'>G"), tan B is less than 1 (Ferry 1980; Rao 
2007). 
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2.2.6.4 Operational method 
In this thesis, the viscoelastic properties of HPMC solutions and HPMC solutions 
containing the selected organic salts were determined by using an MCR-301 
Rheometer equipped with Rheoplus software (Anton Paar, Graz, Austria). A 
parallel plate (PP) geometry (2°/50 mm) was used with a gap of 1000J,im (Figure 
2.5). A freshly prepared sample was applied carefully to the peltier temperature-
controlled plate using a plastic pipette to avoid air bubbles. When the geometry 
was lowered to the "trim position", the excess sample was removed from the edges 
of the plate using a spatula. The gap was then lowered to 1 0 0 0 ~ m m to start the test 
A plastic cover with a solvent trap was placed and the sample edge was coated 
with low-viscosity silicone oil (Fisher Scientific, Leicestershire, UK) to limit sample 
evaporation. 
a) Amplitude sweeps 
An amplitude test was undertaken to determine the dependence of G' and Gil on 
sample strain and to identify the "linear viscoelastic region" (LVR) of each sample 
Samples were subjected to increasing strain from 0.01% to 100% using 25 points 
on a logarithmic scale and at a constant frequency (O.5Hz). The sample 
temperature was kept constant at 20±0.1°C during each amplitude sweep. A 
strain of 1%, within the LVR, was selected for use throughout the study. Results 
are shown in Figure 2.6. 
b) Frequency sweeps 
Frequency sweeps were conducted over the range O.OlHz to 10 Hz using 22 points 
on a logarithmic scale at a constant strain of 1 %. The sample temperature was 
20±0.1°C. Measurements were made in triplicate. 
c) Temperature sweeps 
Temperature sweeps were performed over the range of 20 - 80°C at a heating rate 
of 1°C min·1. Prior experiments undertaken using different rates of heating had 
established this as an optimum heating rate. Tests were carried out at a constant 
strain (1%), and frequency (0.5Hz). Measurements were made in triplicate. 
61 
Sample--.... 
OSCILLATION 
o· 
::70.090• 
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Peltier temperattn'e-controlled plate 
Chapter 2 
Parallel plate 
geometry 
Figure 2.5 Schematic diagram illustrating the parallel plate (PP 2°/50mm) 
geometry used for rheological determinations of HPMC solutions. The gap between 
the sample and the pp geometry was 1000J1m. 
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Figure 2.6 DynamiC amplitude sweep on a 2%w/w HPMC solution with respect to 
storage modulus (G') and loss modulus (G"). The linear viscoelastic region (LVR) is 
identified. Frequency O.5Hz. Temperature 20±O.1°C. This test was conducted for all 
polymer solutions. 
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2.2.7 The manufacture of HPMC hydrophilic matrix tablets 
2.2.7.1 The preparation of formulation blends 
Formulation compositions are provided in the relevant experimental chapters. 
Powder blends for each formulation (batch size 50 or 100 tablets) were prepared 
by mixing the required amounts of each ingredient in a 50 (or 100mL) glass 
container using a Turbula2TF mixer (Glen Creston Ltd, Middlesex, UK) for 15 
minutes. After mixing, the blends were stored in airtight container prior to 
tabletting. 
2.2.7.2 The manufacture of matrix tablets 
Matrix tablets weighing 250 ± 5 mg were manufactured using a Manesty F3 single 
punch tablet press (Manesty, Liverpool, UK) at standardised compression pressure 
(160 MPa for the organic salts study and 280MPa for the surfactant study), using 8 
mm diameter flat-faced punches (I. Holland, Nottingham, UK). The tabletting 
machine was manually operated through the compression cycle. The upper punch 
compression pressure was recorded using a tablet compression monitor TCMl 
(Copley Instruments Ltd, Nottingham, UK). Matrix tablets were tested for weight 
uniformity (HR-120 balance, A&D company, Limited, Japan) and crushing strength 
using a CT40 hardness tester (Engineering Systems, Nottingham, UK). 
2.2.7.3 The labelling and storage of matrix tablets 
All batches of matrix tablets were assigned a date of manufacture and a batch 
number for reference and were stored in amber glass, air-tight jars at room 
temperature. A minimum storage time of 24 hours was allowed prior to further 
testing, to allow any post-compression relaxation to occur. 
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2.2.8 Dissolution testing of matrix tablets 
Drug release from HPMC matrices was determined in USP dissolution apparatus I 
(basket) (Dissolutest, Prolabo, France) at 100rpm, in 900ml of helium-sparged 
dissolution medium at 37±0.5°C. Sampling was undertaken by a closed-loop 
automated dissolution system (Hewlett Packard, Waldbronn, Germany) driven by 
a peristaltic pump (Bennett Scientific Ltd, Weston-super-Mare, Somerset, UK). This 
circulated dissolution samples through 10mm flow-through quartz cells and 
returned them to the dissolution vessel. Drug quantification was undertaken by 
UV spectrometry (Agilent 8453 spectrophotometer, Agilent Technologies, 
Stockport, UK) at 273nm, the Amax for caffeine, and with reference to a standard 
curve. The time taken to achieve 80% cumulative drug release (Tao%) was 
estimated from the dissolution profiles by linear interpolation between the two 
nearest time points. The principal dissolution media used in the experiments was 
distilled water, but sodium chloride (NaCI), potassium chloride (KCI) solutions, 
and simulated gastric fluid USP without enzymes (SGF) were also used in Chapter 
3. Sucrose solutions were used as dissolution media in Chapter 5. 
2.2.8.1 Mathematical models for determining the drug release mechanism 
ofHPMC matrices 
In the presence of a gel layer, drug release from a HPMC matrix will occur through 
diffusion, erosion or a combination of these processes (Colombo et al 2000). This 
release mechanism has been described mathematically using a variety of models 
as reviewed in Chapter 1 Section 1.4.3. The power law (Korsmeyer et al 1983; 
Equation 2.4) is perhaps the most widely used model for gel-forming matrices. 
The coupled diffusion/relaxation equation (Peppas & Sahlin 1989; Equation 2.5) 
which distinguishes the Fickian diffusion and relaxation contributions to the 
mechanism, and the modified power law (Ford et al 1987; Equation 2.6) which 
accounts for the lag time (I) are interesting and will be investigated. 
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Equation 2.4 
Mt 
-= Equation 2.5 
~ ~ = k(t -l)n 
Moo Equation 2.6 
In these equations, Mt is the amount of drug released at time t, Moo is the amount of 
drug released at infinite time, kt and k2 are kinetic constants, t is the release time 
and nand m are diffusional exponents which have been used to describe the 
release mechanism. In the case of Equation 2.5, the first term of the right side 
describes the Fickian contribution, and the second term of the right side being the 
Case II relaxation. 
Drug release data from the model HPMC matrix used in this thesis was fitted to 
Equation 2.4, 2.5 and 2.6, and the calculated parameters are shown in Table 2.1. 
From this table it can be seen that the coupled diffusion/relaxation equation from 
Peppas and Sahlin (1989) showed that, (i) up to 40% release, relaxation and 
swelling dominated the drug release mechanism (kt <k2) (ii) at about 60% drug 
release, diffusion and relaxation were contributing equally to the release 
mechanism (kt::k2) (iii) whereas at about 80-95% drug release, the release 
mechanism was mainly Fickian diffusion (kt>kz). 
The power law (Korsmeyer et al 1983) and modified power law (Ford et al 1987) 
also described the same trend: the higher the % drug release, the more dominant 
was Fickian diffusion (shown in the decrease of the diffusional exponent, n). 
However, the purpose of comparing dissolution profiles in this thesis is to 
compare the relative effects of different organic salts on matrix drug release. A 
simpler (and more easily understandable) parameter was therefore used: the time 
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taken to achieve 80% cumulative drug release (Tso%). At 80% all of the above 
mathematical models suggest the matrices have adopted a diffusion dominated 
release mechanism. Caffeine is a water soluble drug and the release mechanism is 
expected to be mainly by diffusion. The modified power law is the best model for 
describing Fickian release mechanism where n s 0.5 with an acceptable 
correlation coefficient (r2 ~ ~ 0.997) at 40-95% drug release. This equation was 
therefore selected to use as the mathematical model for describing drug release 
throughout this thesis. 
Power law Coupled diffusion/relaxation Modified power law 
Fitted data (Korsmeyer et al 1983) (Peppas and Sahlin 1989) (Ford et a11987) 
range· 
n r2 m k, k2 n r2 
Up to 400/0 0.707 0.9942 0.43 0.003 0.012 0.504 0.9997 
release 
Up to 60 0/0 0.686 0.9957 0.43 0.011 0.01 0.498 0.9992 
Up to 80 0/0 0.654 0.9913 0.43 0.024 0.007 0.484 0.9982 
Up to 95 0/0 0.607 0.9871 0.43 0.035 0.005 0.469 0.9976 
Table 2.1: The results of fitting drug release data to some mathematical models. 
• the initial datum point (15 minutes) was excluded for the modified power law. 
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2.2.9 Confocal laser scanning microscopy (CLSM) 
Confocal laser scanning microscopy (CLSM) imaging has been developed within 
our group to investigate the development of the early gel layer of HPMC matrices, 
and to explore for example, the influence of ionic salts and sugar media on gel 
layer formation (8ajwa et al 2006; Pygall et al 2008; Williams et al 2009). In the 
current study, this technique was used to investigate the effect of surfactants on 
gel morphology and the processes involved in early gel layer formation. 
2.2.9.1 Theory ofCLSM 
The CLSM is a fluorescence microscope in which the image is obtained by laser 
scanning, and confocal optics which prevent out-of-focus light contributions from 
the specimen and markedly improve image sharpness. The CLSM has a point laser 
light source which raster-scans the specimen and constructs a point-by-point 
image based on the fluorescent response of the sample. The advantages of this 
technique are high sensitivity and selectivity, good spatial resolution and the 
potential for non-invasive optical sectioning and 3-dimensional reconstructions 
(Sheppard & Shotton 1997; Holmes & Cheng 2006). 
The principal components and functioning of a confocal microscope is illustrated 
by Figure 2.7. A laser beam at the excitation wavelength passes through a high 
numerical illuminating aperture and then is reflected by a dichroic mirror to the 
objective lens. The laser beam is then focused, by the objective lens, at a specific 
point within a narrow focal plane within the specimen. The fluorescence emitted 
from the laser-specimen interaction is collected by the objective and filtered by the 
beam splitter. The emitted fluorescence wavelengths are directed through a 
pinhole aperture to the photo multiplier tube (PMT) in the detector. A narrow 
confocal aperture permits only fluorescent light in the focal plane to enter the 
detector, and therefore out-of-focus light from above and below the focal plane 
contributes very little to the final image. This increases the resolution of the 
acquired image. The final image is transferred from the PMT to a computer and 
the fluorescent intensities in the image are coded using colours or a greyscale. 
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Illuminating aperture 
PMT = Photomultiplier tube 
Confocal aperture 
Ocular lens 
Dichroic mirror / 
Beam splitter 
Objective lens 
'--_"&"_-"'-- Focal plane 
In-focus rays 
Out-of-focus rays 
Figure 2.7 Schematic diagram of the principal elements and light paths within a 
confocal laser scanning microscope. Adapted from Sheppard and Shotton (1997). 
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2.2.9.2 Congo red 
The fluorophore used throughout this thesis was Congo red (Figure 2.8), an 
anionic azo dye used as a histo-pathological and botanical stain for cellulose and in 
textile dyeing (Horobin 2002). 
In solutions, Congo red molecules are randomly orientated and when substrates 
such as amyloid and cellulose are stained by Congo red, in unpolarised light they 
appear various shades of red. This is because Congo red has maximal absorption 
wavelengths (Amax) in the blue/green range of the visible spectrum. The Amax of 
Congo red in alkaline or weakly acid solutions shifts to longer wavelengths in 
strongly acid conditions, and the Amax may also move to the longer wavelengths 
with increased binding to a substrate, termed a bathochromic shift (Howie & 
Brewer 2009). It has been noted that absorbance of Congo red can also decrease 
with increased ionic strength, or example in NaCl, KBr, KN03 and NaCI04 solutions, 
and this is probably this is probably due to salting out (Sladewski et al 2006). 
Congo red shows a high binding affinity for the polysaccharides with (1-+4)-P-D-
glucopyranosyl sequences which are native to cellulose (Wood 1980). Congo red 
binding to cellulose is thought to be a combination of electrostatic, hydrophobic 
interactions and H-bonding between dye azo and amino groups and the native 
cellulose fibres. The adsorption of Congo red on cellulose has been described as 
follows: Firstly, a monolayer of Congo red molecules is formed on the surface of 
native cellulose sequences, in which the initial rate of adsorption depends upon 
the availability of active sites. When the monolayer reaches saturation, there is a 
further increase due to multilayer adsorption (Yamaki et al 2005). 
Cellulose is a linear poly(glucose) in which there is a regular spacing of identical 
atoms along the chain. This is probably an important factor for the sorption of 
Congo red molecules. In the case of HPMC, the degree substitution varies along the 
chain to the extent that it is thought to contain significant regions of unsubstituted 
native cellulose, and this is probably why HPMC also responds to Congo Red 
staining. Binding also causes the dye to fluoresce, making Congo Red a useful 
fluorophore. In addition, both cellulose and HPMC swell on hydration, the polymer 
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is significantly expanded and more binding sites become accessible. As a result, 
Congo red can be used to highlight regions of hydrated HPMC when whilst 
fluorescence remains low in the surrounding solution (Mirza et al 1996; Pygall et 
aI2007). 
This effect has been exploited by Bajwa et al (2006) who used confocal microscopy 
with Congo red to selectively identify hydrating regions within a developing gel 
layer. He found that 0.008% w Iv Congo red in the hydration medium provided 
excellent resolution of individual particles within the emerging gel without 
significant effects on polymer swelling and hydration. 
Congo red 
Figure 2.8 The chemical structure of Congo red. 
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2.2.9.3 Operational method 
Confocal laser scanning microscopy (CLSM) was carried out using a Bio-Rad MRC-
600 confocal microscope (Hemel Hempstead, UK) equipped with a 15mW Krypton 
Argon laser, a Nikon Optiphot upright microscope and a 4x/0.13NA air objective. 
Early gel layer formation was observed up to 15 minutes, using the method 
developed by Bajwa et al (2006). Figure 2.9 shows the sample geometry. 
Matrices were positioned in a "Fixed Observational Geometry" (FOG) sample cell 
between two Perspex® discs and secured by three acrylic screws. The lower 
surface of the upper disc was coated with a water repellent (Sigmacote®) to 
prevent ingress of hydration medium between the tablet and the Perspex disc 
surface. The FOG apparatus was positioned within a temperature-controlled 
hydration vessel (37±1°C) to allow the gel layer formation to be observed from 
above for the first 15 minutes of tablet hydration. Measurements of radial swelling 
were quantified with respect to time using the method of Bajwa et al (2006) and 
Image Pro Plus v6.2 (Media Cybernetics, USA) software. A grid of ten evenly 
spaced horizontal lines was superimposed over the image, and measurements of 
length at each time interval, were made between the outer edge of the gel layer 
and the original dry matrix boundary at t=O minutes. This provided the mean 
thickness of the apparent gel layer with respect to time. Imaging experiments 
were performed in triplicate, using three separate tablets. 
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Figure 2.9 Schematic diagram of the experimental geometry used during confocal 
imaging, "Fixed Observational Geometry" (FOG). 
Matrices are hydrated in a hydration medium containing the fluorophore, maintained at 
37°C. Th is geometry permits the observation of gel layer development from above while 
the matrix undergoes radial hydration. Adapted from 8ajwa et al (2006) . 
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2.2.10 Routine monitoring ofHPMC powder moisture content 
It is well known that powdered HPMC absorbs and desorbs moisture depending on 
the external relative humidity. As a result HPMC can contain an equilibrium 
moisture content that varies between 2-10% w /w (Doelker 1993). Therefore 
throughout the thesis period, the moisture content of all HPMC batches were 
monitored periodically using a MB45 Moisture Analyser (Ohaus Corporation, 
Leicester, UK). This apparatus heats one gram of HPMC powder on disposable 
aluminium pans from ambient to 105°C using a linear temperature ramp over 3 
minutes and holds this temperature until there was less than 1 mg change over 2 
minutes. This end point is automatically determined by the apparatus. Results 
(see Appendix 2) showed that the moisture content was in the range 2.6-3.7% 
w /w throughout the the thesis work. 
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The Effect of Organic salts on HPMC Solutions 
3.1 Rationale 
Many organic species are used as drug counter-ions. Examples include maleate, 
propionate and tartrate and these salts are chosen above their inorganic 
counterparts, as they exhibit better stability, solubility, physical properties, or 
bioavailability. Drugs with organic counter-ions are often formulated as HPMC 
matrix tablets, but the influence of the counter-ion on the formulation has, to date, 
not been the focus of any systematic studies. It is hoped that the study of the effect 
of organic salts on HPMC will be useful in providing further formulation guidance 
for HPMC matrices. 
3.2 Introduction 
3.2.1 Previous studies of additives affecting the properties of HPMC 
solutions 
The effects of additives on the properties of HPMC have been widely studied. One 
of the most important characteristics of HPMC is the reversible thermal gelation 
that occurs on heating or cooling aqueous solutions. It has been found that the 
sol:gel transition temperature (SGTT) of HPMC can be changed by chaotropic or 
kosmotropic solutes. With organic species, there is evidence that their influence 
depend on the relative influence of different parts of their molecular structure. 
For examples, small hydrophilic L-amino acids decrease SGTT, while larger and 
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more hydrophobic or aromatic amino acids increase SGTT (Richardson et al 2006). 
This was postulated to be related to the balance of ionic to hydrophobic moieties 
in their molecular structure. Kosmotropic solutes such as ethanol, PEG 400, and 
propylene glycol raised SGTT, whereas glycerol, sorbitol, and most electrolytes 
decreased SGTT because they possess more affinity for water and dehydrated the 
polymer sheath (Alderman 1984; Doelker 1987; Li et al 2005). NSAID drugs such 
as diclofenac Na, meclofenamate Na, and mefenamate Na were found to depress 
SGTT (Banks 2003; Pygall et al 2011). The internal buffering agents such as 
tris(hydroxylmethyl) aminomethane (THAM, TRIS) and sodium citrate was found 
to accelerate release of the weak acid drug in both pH 1.2 and 7.5 media (Pygall et 
al 2009; Pygall et al 2010). Water-soluble drugs such as propranolol 
hydrochloride and tetracycline hydrochloride have been shown to play an active 
role in the swelling behaviour of HPMC and methylcellulose matrices. The 
mechanism for this was thought to be by 'salting in' the polymer leading to 
increased polymer solubility, and a more efficient diffusion barrier gel layer 
whereas poorly soluble drugs cannot contribute in this way (Ford et al 1993; 
Mitchell et a11993a; Mitchell et aI1993d). The model of salting out and salting in 
behaviour or Hofmeister effect on HPMC in solutions has also been proposed for 
ionic solute (Mitchell et al 1990a), electrolytes (Mitchell et al 1991), amino acids 
(Richardson et a12006) and inorganic salts (Alderman 1984; Bajwa 2006; Liu et al 
2008). However, the effects of organic salt commonly used as counter-ions on 
SGTT of HPMC have not yet been reported. 
3.2.2 The studies of organic acids and salts with HPMC 
There are few reports of organic acids and their salts being utilised in HPMC 
systems. However, sodium citrates have been used as internal buffers by Pygall et 
al (2009) and certain organic acids, such as malic acid, fumaric acid, tartaric acid, 
citric acid and glutaric acid have been used as microenvironmental pH modulators 
for basic drugs (Kranz et al 2005; Varma et al 2005; Siepe et al 2006a; Siepe et al 
2006b; Tatavatri & Hoag 2006). In each case the aim was to make pH-independent 
controlled release systems for drugs with pH dependent solubilities. 
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3.3 Chapter Aims and Objectives 
In this chapter, the effect of selected organic salts which are used as drug counter-
ions on HPMC solution properties are investigated with respect to (i) organic salt 
chain length and (ii) organic salt structure relationship. The solutions studies 
aimed to clarify the mechanism of interaction between these organic salts and 
HPMC. 
In particular, the experimental work in this chapter investigates the effect of 
organic species on: 
• The sol:gel transition temperature (SGTT) 
• The viscoelastic properties 
• The surface tension 
of HPMC solutions. 
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3.4 Materials and Methods 
3.4.1 Organic salts 
3.4.1.1 Homologous series 
In the initial investigations, the simplest form of organic counter-ions was chosen 
from Table 1.3 in order to study the relationship between aliphatic chain length 
and their effects on HPMC. A homologous series of aliphatic organic sodium salts 
containing a 1-carboxylic group are shown in Table 3.1. The source and batch 
numbers of these materials are documented in Appendix 1. 
3.4.1.2 Structure activity relationships 
The organic salts shown in Table 1.3 were selected and categorised according to 
their functional groups and structural relationships. In this chapter, the effect of 
these groups on HPMC were studied by comparing salts with (a) geometric 
isomerism (b) degree of ionisation (c) different acid functional groups (carboxylic 
and sulfonic acids) (d) the hydroxyl substituents and (e) the number of carboxyl 
groups. The selected organic salts are shown in Table 3.2. The source and batch 
numbers of these materials are documented in Appendix 1. 
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Organic salts Chemical structure of the anion Molecular Solubility pH of 
weight solution 
(gjmol) 
Formate, 0 68.01 -1.3 parts -7 HAO sodium water (aqueous solution) 
Acetate, 0 82.03 1 gin 0.8 ml -7.5 - 9.2 
sodium Ao (water); 1 g (3% in 0.6 ml anhydrous 
(boiling solution) 
water); 1 g 
in 19 ml 
(alcohol) 
Propionate, 0 96.06 1 gin 1 ml - 7.8 - 9.2 ~ o osodium (water); 1 g (2% in 0.65 ml solution) 
(boiling 
water); 1 g 
in 24ml 
(alcohol) 
Butyrate, 0 110.09 soluble in -7-8 ~ o osodium water (aqueous solution) 
Pentanoate, 0 124.12 soluble in -7 
sodium ~ o o water (aqueous solution) 
Caproate, 0 138.14 soluble in -7-10 ~ o osodium water (aqueous solution) 
Octanoate, 166.20 freely -8.0 -10.5 
sodium soluble in (10% 
- water and solution) 0 
acetic acid; 
sparingly 
soluble in 
alcohol 
Table 3.1 The homologous series of 1-carboxyl aliphatic salts used in this chapter. 
All ions were used as sodium salts. (references: USP 29; Handbook of pharmaceutical 
excipients. 2000, Martindale 2005, Merck Index 14, Handbook of Data on Organic Compounds 
1994) 
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Organic salts Chemical structure of 
the anion 
Molecular 
weight 
(g/mol) 
(a) The effect of counter-ion geometric isomerism 
Solubility 
Succinate, disodium 0 162.05 -5 parts (water) ~ o o·0 
0 
Fumarate disodium 0 160.04 soluble in water ~ ~ ~·0 ~ ~
0 
Maleate, disodium 
.o-(}=o 160.04 soluble in water 
o ·0 
(b) The effect of counter-ion ionisation 
Fumarate, 0 160.04 soluble in water ~ ~ ~ ~dis odium 
0 
Fumarate, sodium 0 138.06 8.5g in 100 ml H O ~ ~ ~hydrogen (water, 25°C) 
0 
(c) The effect of different acid functional groups: a comparison between 
carboxylic and sulfonic acid sodium salts 
Acetate sodium Jlo 
Mesilate, sodium I 
o=s=o I . 
o 
Benzoate, sodium 
82.03 See Table 3.1 
118.09 soluble in water 
144.11 19 in 1.8 ml 
(water), 1.4 ml 
(boiling water) 
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Besitate. sodium o _ 180.16 soluble in water ~ / o oU\ 
(d) The effect of hydroxyl group substituents 
Benzoate. sodium 0 144.11 19in 1.8 ml 
oA- (water). 1.4 ml (boiling water) 
Salicylate. sodium HO 160.11 -1000 gIl ) ( ) (water. 20°C) 
Malate. disodium 0 196.06 soluble in water Jyy' -0 
OH 0 
Tartrate. dis odium OH 0 230.08 - 3 parts (cold ~ r r r water); 1.5 parts • 0- (boiling water) 
0 OH 
(e) The effect of the number of carboxylic group 
Acetate. sodium 0 82.03 See Table 3.1 )lo 
Oxalate. dis odium o-{-o 134.00 27 parts (water); 16 parts (boiling 
water) 
0 
Table 3.2 OrganiC salts used in the study of structure activity relationships in this 
chapter. All ions were used as their sodium salts. (references: USP 29; Handbook of 
pharmaceutical excipients. 2000, Martindale 2005. Merck Index 14. Handbook of Data on Organic 
Compounds 1994) 
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3.4.2 HPMC 
HPMC USP Type 2910 (Methocel™ E4M CR Premium EP /USP) and HPMC USP 
Type 2208 (Methocel™ K4M CR Premium EP /USP) were used in this study. Full 
details of these materials are given in Appendix 1. The quality and source of 
deionised water used in solution manufacture is also described in Appendix 1. 
3.4.3 Manufacture of HPMC solutions 
10% stock solutions were prepared by dispersing the required amount of HPMC in 
hot water (> 80°C) using a bench-top magnetic-stirrer with hot plate (RCT basic, 
IKA Labortechnik Staufen, Janke&Kunkel GMBH&CO.KG, Germany). When 
thoroughly mixed, the dispersion was then put in an ice box to cool to room 
temperature while agitation was continued using a bench-top magnetic stirrer 
(KM02 basic, IKA® Labortechnik GMBH&CO.KG, Germany). Solutions were then 
stored in a refrigerator at 2-8°C for at least 24 hours prior to use in order to obtain 
a completely hydrated solution. Previous work in our group had shown that there 
was little viscosity increase after 24 hours using this method. 
To prepare solutions of 0.1 and 1 %w /w HPMC, the required amount of 10% w /w 
HPMC stock solution was made up to volume by adding water. Solutions were 
stirred overnight and stored at 2-8°C for a further 24 hours prior to use. 
To prepare 0.1% and 1%w/w HPMC solutions containing different concentrations 
of organic salts, the following method was used. HPMC and organic salt solutions 
were prepared separately to avoid any interactions prior to complete dissolution 
or hydration. The required amount of each organic salt was completely dissolved 
in water about nine tenth of the final weight before incorporated into a 1 %w /w 
HPMC stock solution about one tenth ofthe final weight to obtain 0.1 %w /w HPMC 
solution (or 10%w/w HPMC stock solution to obtain l%w/w HPMC solution). The 
mixed solution was then stirred until homogeneous, and stored at 2-8°C for at 
least 24 hours prior to use. 
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3.4.4 Turbidimetric determinations 
The sol:gel transition temperature (SGTT) of l%w/w HPMC solutions containing 
organic salts were determined by turbidimetry in Cloud Point Apparatus (Medical 
Physics, Queen Medical Centre NHS trust, Nottingham, UK). 1 %w /w HPMC 
solutions containing different concentration of organic salts or organic acids were 
used. Each sample was measured in triplicate. Full details of the method are 
described in Section 2.2.3. 
3.4.5 Surface tension measurements 
Surface tension measurements were conducted at 20 ± 1 °C by the pendant drop 
method using a Profile Analysis Tensiometer (Sinterface tensiometer PAT1, Berlin, 
Germany). Replicate measurements were automatically determined 100 times on 
each sample and this was repeated on three separate samples of each solution. 
The relative standard deviations of the 100 measurements were smaller than 
0.05%. Full details of the method are described in Section 2.2.4. 
3.4.6 Density measurements 
Density measurements on 0.1 %w /w HPMC solutions containing organic salts were 
conducted by using a DMA 5000 oscillating U-tube Density Meter (Anton Paar, 
Graz, Austria). The density determination is based on measuring the period of 
oscillation of a vibrating U-shaped tube filled with sample, and using the 
relationship between the period of oscillation and the density. This relation holds 
as long as the sample is not too viscous. The density was obtained at 20°C and 
mean values (n=3) were used subsequently in the surface tension measurements. 
Full details of the method are described in Section 2.2.5. 
3.4.7 Rheological determinations 
The viscoelastic properties of HPMC solutions and HPMC solutions containing 
organic salts were determined rheologically using a MCR-301 Rheometer with 
Rheoplus software (Anton Paar, Graz, Austria). The parallel plate (PP) geometry 
(2° /50 mm) was used, with a gap of 1 0 0 0 ~ m . . A freshly prepared sample was 
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applied carefully to the peltier temperature-controlled plate using a plastic pipette 
to avoid the air bubbles. When the geometry was lowered to the "trim position", 
the excess sample was removed from the edges of the plate using a spatula. The 
gap was then lowered to 1000llm to start the test. A plastic cover with a solvent 
trap was placed and the sample edge was coated with low-viscosity silicone oil 
(Fisher Scientific, Leicestershire, UK) to limit sample evaporation. Sample testing 
was performed in triplicate. Full details of the method are described in Section 
2.2.6. 
3.4.7.1 Amplitude sweeps 
Determinine the linear viscoelastic reeion (LVRl 
An amplitude test was undertaken to determine the dependence of G' and G" on 
sample strain and to identify the "linear viscoelastic region" (LVR) of each sample. 
Samples were subjected to increasing strain from 0.01 to 100% using 25 pOints on 
a logarithmic scale and at a constant frequency (0.5Hz). The sample temperature 
was kept constant at 20±0.loC during each amplitude sweep. The strain at 1% 
which was within LVR was selected to use throughout the study. 
Determinine the rheoloeical data at different temperatures 
The amplitude sweep test was conducted to determine the G', G" and tan 0 of each 
sample at 20, 50 and 80°C. Samples were subjected to increasing strain from 0.01 
to 100% using 25 points on a logarithmic scale and at a constant frequency 
(O.5Hz). The rheological data at 1% strain was brought to compare the effect of 
each salt on HPMC solutions. 
3.4.7.2 Frequency sweeps 
The frequency sweep tests were conducted from a range of 0.01 to 10 Hz using 22 
points on a logarithmic scale at a constant strain (1% which is within the LVR). 
The sample temperature was kept constant at 20±0.loC during each frequency 
sweep. Measurements were made in triplicate. 
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3.4.7.3 Temperature sweeps 
Temperature sweeps were performed over the range of 20 - 80°C at a heating rate 
of 1°C min-1. Prior experiments undertaken using different rates of heating had 
established this as an optimum heating rate. Tests were carried out at a constant 
strain of (1%, within the LVR) and a constant frequency (0.5Hz). Measurements 
were made in triplicate. 
3.4.8 Statistical analysis 
Statistical differences between rheological profiles were determined using a 
Student's t Test (JMP 7 software, SAS Institute Inc., Cary, NC). A p value o/Iess than 
o.05was considered statistically significant. 
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3.S Results and Discussion 
3.5.1 The effect of organic salts on the sol:gel transition temperature 
(SGTT) of HPMC solutions 
3.5.1.1 Homologous series of salts 
The sol:gel transition temperatures (SGTT) of 10/0w/w HPMC solutions containing 
various concentrations of different aliphatic acid sodium salts were determined 
turbidimetrically by measurement of cloud point temperatures. Figure 3.1 shows 
cloud point salt concentration relationships for HPMC E4M and Figure 3.2 for 
HPMC K4M. The cloud point values showed a linear dependency on salt 
concentration (Table 3.3) but the gradients of these lines (.1CPT) varied with the 
aliphatic chain length of the salt. Solutions pH was also measured and showed no 
correlation with CPT (no data shown). Figure 3.1(a) and 3.2(a) show that the 
effect on HPMC E4M and K4M showed a similar trend in which this homologous 
series of aliphatic acid sodium salts influenced the SGTT of HPMC solution in rank 
order of hydrocarbon chain length (Figure 3.1(b) and 3.2(b)). Short chain-length 
anions (C1-C4) were found to decrease the cloud point values, whereas the longer 
chain-length anions (C6-C8) increased cloud point. The crossover point was 
between C5 and C6 and pentanoate sodium (C5) had the least effect on HPMC 
solution. 
For the short chain anions containing 1-4 C-atoms, these salts may alter the cloud 
point of HPMC by depleting polymer hydration. Their behaviour appears to 
correlate with the Hofmeister series observed for simple inorganic salts in which 
anions restructure water in the polymer hydration sheath, inducing a "salting out" 
effect (Touitou & Donbrow 1982b). These results support previous studies of 
inorganic salts which can restructure water by structure-making properties 
through rearrangement of the clathrate-like water structures surrounding 
methoxyl rich regions of the HPMC polymer chain (Bajwa et aI2006). 
In the case of aliphatic salts containing 6-8 C-atoms, these salts appear to enhance 
HPMC hydration, possibly through interaction with hydrophobic regions. This 
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suggests behaviour analogous to previous solution studies of amino acids 
(Richardson et aI2006). These studies indicated that the ability of the charged ion 
to destabilise the polymer hydration sheath is opposed, with increasing chain 
length, by the ability of the hydrophobic chain to interact with and methoxyl-rich 
regions and polymer hydration is thereby improved by a process analogous to 
solubilisation. 
HPMC E4M solution HPMC K4M solution 
Aliphatic salts ACPT r ACPT r 
(OC/M) (OC/M) 
Formate sodium -25.90 0.995 -34.17 0.995 
Acetate sodium -27.70 0.996 -36.43 0.992 
Propionate sodium -22.76 0.996 -27.29 0.999 
Butyrate sodium -17.05 0.988 -16.85 0.982 
Pentanoate sodium -4.75 0.972 1.48 0.912 
Caproate sodium 5.95 0.945 24.30 0.999 
Octanoate sodium 15.59 0.988 65.99 0.994 
Table 3.3 Organic salts: The linear correlation (r) and slope (4CPT) of curve 
between aliphatic salts concentration and cloud point temperature (CPT). These 
values were obtained from Figures 3.1 and 3.2. r is the correlation coefficient 
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Figure 3.1 Effect of the homologous series of salts on SGTT of HPMC E4M. The effect 
of (a) concentration (b) chain length of dissolved organic sodium salts on the sol:gel 
transition temperature (SGTT) of 1 %w /w HPMC E4M solution. SGTT expressed as cloud 
point temperature (CPT. °C). Temperature ramp rate of loSoC/min. Mean (n=3). llCPT 
obtained from the gradient of curve in figure 3.1(a). 
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Figure 3.2 Effect of the homologous series of salts on SGTT of HPMC K4M. The effect 
of (a) molar concentration (b) chain length of dissolved organic sodium salts on the sol:gel 
transition temperature (SGTT) of 1 %w /w HPMC K4M solution. SGTT expressed as cloud 
point temperature (CPT, 0c). Temperature ramp rate of 1.50C/min. Mean (n=3). l1CPT 
obtained from the gradient of curve in figure 3.2(a). 
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3.5.1.2 Structure activity relationships 
Organic acid anions containing similar structures, had been chosen previously for 
the purpose of investigating the influence of different functional groups (Table 
3.2). The SGTT of 1 %w /w HPMC solutions containing these salts were determined 
turbidimetrically by cloud point as previously described. Cloud points showed a 
linear dependency on salt concentration and these results are shown in Figure 3.3 
and Table 3.4. The pH of these solutions were measured and showed no 
correlation with cloud point values (no data shown). 
Figure 3.3(b) show that hydrocarbon chain length, molecular valency and 
structure of organic salts influenced SGTT of HPMC solution. Monovalent salts 
containing 1 to 4 C-atoms had little effect to lower CPT comparing to divalent salts 
which were more potent. These valency effects are well-known in studies of 
'Hofmeister Series' (Alderman 1984; Cho et al 2006; Mitchell et al 1990a; Mitchell 
et al 1991; Bajwa et al 2006) and is related to the extent that soluble charged 
anions can restructure water in the polymer hydration sheath, as previously 
described. 
Some of these organic salts have been studied before with respect to their 
Hofmeister effects, for example, in the study of HSV-I protease activity (Hall & 
Darke 1995). In this study there was a rank order salting out effect of: 
1- < Br- < CI- < Acetate- < Glutamate2- < Succinate2- < Malate2- < F- < Citrate3-
(Least) - - - - - - - - - - - - - - - - - + ~ ~ (Most) 
In our study we found the same order of salting out potency: 
Acetate- < Succinate2- < Malate2-
Both succinate and malate contain 4 C-atoms, but malate also contains a hydroxyl 
group (-OH) and was more potent than succinate. This potency-structure 
relationship will be discussed in next section. 
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Aromatic organic salts, including benzoate, besilate and salicylate, were 
exceptional cases. These salts elevated CPT possibly by enhancing HPMC 
hydration by acting as hydrotropes. Hydrotropes are compounds that can change 
a turbid macromolecular dispersion into a transparent solution and hydrotropic 
action is attributed to a 'salting in' effect (Matero 2002). These aromatic organic 
salts could self-associate in water to form the stacking rings with n-n interactions 
(Balasubramanian et al 1989; Sindkhedkar et al 2000; Waters 2002; Sasaki et al 
2006; Desai & Parikh 2009; Hao et al 2012) which can enhance the solubility of 
organiC compounds such as polymer if present at a sufficient amount 
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Figure 3.3 Effect of the organic salts on SGTT of HPMC E4M. The effect of (a) 
concentration (b) chain length of dissolved organic sodium salts on the sol:gel transition 
temperature (SGTT) of 1 %w /w HPMC E4M solution. SGTT expressed as cloud point 
temperature (CPT, 0c). Temperature ramp rate of l.S oC/min. Mean (n=3) . .1CPT obtained 
from the gradient of curve in figure 3.4(a). 
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Organic salts ~ C P T T (OC/M) r 
Benzoate sodium 15.70 0.999 
Besilate sodium 17.55 0.993 
Fumarate disodium -53.25 0.994 
Fumarate sodium -23.43 0.997 
hydrogen 
Malate disodium -97.82 0.999 
Maleate disodium -71.93 0.993 
Mesilate sodium -23.68 0.996 
Oxalate disodium -95.09 0.999 
Salicylate sodium 42.23 0.999 
Succinate disodium -74.30 0.998 
Tartrate disodium -112.22 0.999 
Table 3.4 The linear correlation (r) and slope (4CPT) of curve between aliphatic 
salts concentration and cloud point temperature (CPT). These values were obtained 
from Figures 3.3. r is the correlation coefficient. 
92 
Chapter 3 
3.5.1.3 The effect of functional groups and anion structure 
Several comparisons can be made of the effects of different structures and 
functional groups on SGTI. Although we only have a few members of each group, 
we can compare the effects of (a) geometric isomerism, (b) a comparison between 
carboxylic and sulfonic groups, (c) the hydroxyl group substituents and (d) 
number of carboxyl groups in the weak acid anion. From the results in Figure 3.3 
we can devise some simple rules. 
Rule 1: Divalent salts are more potent than monovalent salts. 
Figure 3.4 compares different effect of monovalent and divalent salts on SGTI of 
HPMC solutions. Divalent salts (oxalate diNa, succinate diNa and fumarate diNa) 
exhibited a greater ability than monovalent salts (acetate Na, butyrate Na and 
fumarate NaH) to depress SGTI of HPMC solutions. This suggests they had a 
greater ability to potentiate phase separation because the divalent salts are more 
highly charged, and further up the Hofmeister series. This corresponds to the 
study of inorganic salts, phosphate and citrate buffers (Mitchell et al 1991; 
Kujawinski 2000; Liu et al 2008; Pygall et al 2009). 
Rule 2: Valencies, substitutions and geometric isomerism influence the 
ability of organic salts on altering HPMC thermogelation. 
Figure 3.S compares the ability of 4 C-atom organic salts which possess different 
valencies, substitutions and geometric isomerism to alter SGTI of HPMC solutions. 
These differences lead to the different physical properties of organic salts, and 
hence their ability to restructure polymer hydration sheath which may exert 
Hofmeister's series. The species with more affinity to water have more potential 
to dehydrate HPMC and thus depress its SGTT. 
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Rule 3: Carboxylic and sulfonic groups show little difference in their effects. 
Figure 3.6 compares the effect of salts containing carboxylic and sulfonic groups. 
There was no different effect between acetate (carboxylic) and mesilate ( sulfonic) 
or benzoate (carboxylic) and besilate (sulfonic). The strong similarity may be due 
to the monovalent character of both acid groups, however the sulfonic acid group 
(pKa = 1.9) is a stronger acid than carboxylic acid (pKa = -3.9) and may therefore 
exert monovalent ion-effects on SGTT in the solutions of lower pH. 
Rule 4: Adding more hydroxyl groups, increases potency of the ion. 
Figure 3.7 show how the different hydroxyl groups substituents (-OH) influence 
the effect on SGTT of HPMC solutions. Salicylate (1-0H) was more potent than 
benzoate (no -OH) in elevating the SGTT of HPMC solution. In contrast, the 
potency of kosmotropic ions in depressing the SGTT of HPMC solution were rank 
ordered as follows: 
Tartrate (2-0H) > Malate (l-OH) > Succinate (no -OH) 
These rank orders may simply have arisen as a result of the small number of 
anions investigated. However, increasing numbers of hydroxyl groups, provide 
more potential for interaction with the hydrogen bonded structure of water, and 
so it is not surprising that additional -OH groups enhance the effects of the parent 
molecule. However, studies of soluble hydroxyl-rich species such as sugars 
(Williams et al 2009) show that the orientation of the hydroxyl group is also an 
important factor. Sugars in which the -OH group disrupts water structure have an 
enhanced kosmotropic effect. 
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Figure 3.4 The effect of the number of carboxyl groups of the organic salts on the 
sol:gel transition temperature (SGTT) of 1 %w /w HPMC E4M solution. SGTT 
expressed as cloud point temperature (CPT, DC). Temperature ramp rate of 1.50 C/min. 
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from the gradient of curve in figure 3.4(a). 
95 
Chapter 3 
30 
0 0 d'0- Besilate ~ / o o20 Benzoate 0'\ 
10 
::E 0 (3 
~ ~
I-
-10 D-
u 
<I 
-20 
-30 Acetate Mejilate 
0 0 = 5 = 0 
-40 A o I . 0 
Figure 3.6 A comparision of carboxylate and sulphonate organic salts on the sol:gel 
transition temperature (SGTT) of 1 %w /w HPMC E4M solution. SGTT expressed as 
cloud point temperature (CPT, °C). Temperature ramp rate of l.SoC/min. Mean (n=3) . 
.1CPT obtained from the gradient of curve in figure 3.4(a). 
60 
40 
20 
cro-
Benzoate 
Salicylate :> ~ ( ( ) 
0 
-::E (3 -20 
~ ~
I-
-40 D-
u 
<I 
-60 
-80 
o 
-1 00 
-1 20 
o ~ " " 0 Malate 
o o..-l. . ~ ~ ~ o o Tartrate 0 Y Y l l~ ~ 0 ~ ~ T I( . 0 
OH 0 
o OH 
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3.5.2 The effect of organic salts on the surface tension of HPMC solutions 
The ability of organic salts to modulate the surface tension of water and 0.1 %w /w 
HPMC solutions were investigated by tensiometry at 20°C. From these results, the 
salts could be categorised into 3 groups; 
a) Low surface activity &fQUp (Salts with little or no surface activity) 
This group comprised organic salts containing 2-4 C-atoms (Figure 3.8). Sodium 
acetate (C2), sodium propionate (C3) and sodium butyrate (C4), showed no 
surface activity both in water and HPMC solution within the range 0-750mM, and 
only slightly reduced the surface tension at -lOOOmM. 
b) Surface-active &rOUp (Salts with clear surface activity in the range investigated) 
Sodium pentanoate (C5) and sodium caproate (C6) exhibited weak surface activity 
in water and HPMC solutions from Figure 3.9(a-b). The onset of aggregation 
started at the concentration of 100 mM. Octanoate (C8) exhibited obvious surface 
activity in reducing the surface tension of both water and HPMC solutions and 
exhibiting a critical micelle concentration (cmc) in water and a critical aggregation 
concentration (CAC) in HPMC solutions (Figure 3.9 (d)). 
Disodium tartrate (C4) also exhibited weak surface activity which started at 
concentration of 100mM. This salt raised the surface tension of water, but 
reduced that ofHPMC solutions (Figure 3.9(c)). 
Overall, these results showed that longer alkyl chain length salts have more 
potential to reduce the surface tension of water and HPMC solution, and exhibited 
the lower cmc and CAe. This is consequence of the increasing hydrophobicity of 
the anion with alkyl chain length, which has been well-documented in higher chain 
length surfactants (Smith & Tanford 1973; Tsao et a11991; Lim et aI2007). 
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c) Aromatic eroup 
Organic salts containing an aromatic ring showed weak surface activity in water, 
but little surface activity in HPMC solutions (Figure 3.10). However, sodium 
benzoate, sodium besilate and sodium salicylate are amphiphiles which they can 
self-associate in water if the concentration is high enough to form an-stacking 
aggregation (Balasubramanian et al 1989; Matero 2002). This type of system does 
not exhibit cmc (Florence & Attwood 2009). 
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3.5.3 The effect of organic salts on the viscoelastic properties of HPMC 
solutions 
Dynamic oscillatory rheology investigates the viscoelastic properties of a solution 
by applying small oscillations to a sample and determining the ability of the 
sample to recover. This can provide the information on the internal molecular 
structure. 
Prior to testing, the linear viscoelastic region (LVR) was determined for each 
sample in order to obtain the appropriate test conditions (Mezger 2006). This was 
determined at the same temperature as the subsequent frequency (20°C, 50°C and 
80°C). The optimisation of conditions for the oscillatory rheology studies in this 
chapter was conducted (data not shown). 
3.5.3.1 Homologous series 
(a) Temperature experiment 
Storage modulus (G'), loss modulus (G") and tan B values for 2%w/w HPMC 
solutions containing acetate Na (C2), pentanoate Na (C5) and Octanoate Na (C8) 
were determined at different temperatures. Table 3.5 shows that at 200 C, there 
were only small differences between these samples, and all values were low 
compared with the divalent organic salts which will be discussed in the next 
section. At this temperature, G" of all samples dominated which means they were 
liquid-like in their properties. 
At 500C, there were large differences in G' because this temperature is 
approaching SGTI (The SGTT of a l%w/w HPMC solution, and HPMC solutions 
containing 0.5M acetate Na, 0.5M pentanoate Na and O.25M octanoate Na are -55, 
40, 52, 59°C, respectively). At this temperature, HPMC solutions containing 
aceatate Na and pentanoate Na showed a clear G' domination which means their 
characteristics are more solid-like (elastic) than liquid-like. In contrast, the HPMC 
solutions containing octanoate Na still exhibited G" domination. These results 
correlate with their SGTI as previously mentioned. 
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At 80°C, all samples were G' dominated which means they were more solid in this 
state. The G' values were in a rank order of chain length as follows: 
Acetate (C2) > Pentanoate (C5) > Octanoate (C8) 
and all values were higher than HPMC solution alone. This suggests that at 
temperatures above the SGTT, the elastic property of HPMC solutions are 
enhanced by adding these salts. This effect could be due to increased competition 
for water of hydration, resulting in more pronounced phase separation in 
hydrophobic region of the gel. 
(b) FreQuency sweep experiment 
Frequency sweep experiments were conducted at 20°C. The results are shown in 
Figure 3.11. Figure 3.11(a) shows the frequency dependence of the complex 
viscosity which can indicate the overall viscoelastic response of polymer-salt 
mixtures. The complex viscosity of HPMC solutions containing acetate Na and 
Pentanoate Na were not different from HPMC solution alone, while those of HPMC 
solution containing octanoate Na was manifestly lower. This suggests that HPMC 
solutions containing octanoate Na exhibit more liquid-like behavior. All these salts 
showed a weak interaction with the polymer. 
Figure 3.11(b) and (c) show the frequency dependence ofthe storage modulus (G') 
and loss modulus (Gil) for HPMC solutions containing acetate Na, pentanoate Na 
and octanoate Na. In the presence of acetate Na and pentanoate Na, there was 
very small increase in both G' and Gil. However, with octanoate Na, there was 
decrease in these mechanical moduli, suggesting that both elastic and viscous 
properties ofthese HPMC solutions were being suppressed by the octanoate Na. 
The magnitude of G' is related to the gel strength of the sample. If the sample is a 
strongly cross-linked gel, G' would be much higher than Gil and not affected by the 
oscillatory frequency. In contrast, Gil would be larger than G' at some point in the 
frequency range if the sample is a physically entangled gel network. This is 
because freely entangled polymer chains can move past each other at low 
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frequencies so that the sample behaves like a viscous liquid, whereas there is not 
enough time for this network rearrangement to occur within an oscillation cycle at 
the higher frequencies, resulting in a predominately elastic deformation. 
From these experiments, at the temperature below the SGTT, HPMC solutions 
containing octanoate Na appear to be behaving as a physically entangled gel with a 
free movement of polymer chains at 20°C. At the temperatures above the SGTT, 
octanoate Na appears enhance the gel structure in both elastic and viscous 
properties relative to HPMC alone. 
Tan 0 values represent the ratio of Gil to G' and provide further evidence of the 
changes in viscoelasticity, if tan 8 <1, indicating the potential of the sample to 
move towards gel-like behaviour. These salts show no apparent potential to 
induce gel-like behaviour in HPMC solutions (Figure 3.11 (d)). 
(c) Continuous ranKe temperature sweep experiment 
The temperature sweep experiment of 2%w /w HPMC solutions containing acetate 
Na, pentanoate Na and octanoate Na are shown in Figure 3.12. Acetate Na 
exhibited a very sharp crossover (gel point), with incomplete recovered on the 
cooling cycle. Pentanoate Na exhibited the same behavior as an HPMC solution but 
recovered more completely. Octanoate Na samples showed a sharp drop in Gil and 
G' before a rise and crossover at the gel point. It also was not fully recovered in the 
cooling cycle. These gel points from crossover corresponded to their SGTT 
determined earlier (see CPT studies in Section 3.5.1). The different slopes ofthese 
viscosity profiles suggest that HPMC solutions containing these organic salts may 
exhibit different mechanism of phase separation when going through the sol:gel 
transition. 
104 
Samples 
2% w /w HPMC 
2% w/w HPMC + 
O.SOM Acetate Na 
2% w /w HPMC + 
O.SOM Pentanoate Na 
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Rheological data at different temperatures 
20°C 50°C BO°C 
G' G" tana G' G" tana G' G" tana 
2.02 8.43 4.18 4.38 3.92 0.90 27.1 3.01 0.11 
3.87 12.2 3.14 41.0 4.16 0.10 112 8.37 0.07 
3.82 12.7 3.33 11.6 2.10 0.18 44.4 3.99 0.09 
2% w/w HPMC + 2.03 9.41 4.64 0.47 3.25 6.93 34.7 10.5 0.30 
0.2SM Octanoate Na 
Table 3.5 Rheological data of HPMC solutions (2%w /w) containing the initial 
homologous series of organic salts. The data obtained from amplitude sweep test at 
different temperatures. These are the values at 1% strain. 
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(c) Loss modulus or viscous modulus, G" 
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Figure 3.11 Frequency dependence of (a) complex viscosity (b) elastic modulus, G' 
(c) viscous modulus, G" and (d) tan S for 2% w/w "PMC solutions containing the 
initial homologous series of organic salts. 
Geometry = PPSOmm. Temperature = 20°C. Strain = 1% 
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3.5.3.2 Structure activity relationships 
Storage modulus (G'), loss modulus (G") and tan 0 of 2%w /w HPMC solutions 
containing the different organic salts used to investigate structure activity 
relationships were determined at different temperatures (Tables 3.6-3.10) and in 
frequency sweep experiments at 20°C shown in Figure 3.13-3.17. 
(a) The effect of counter-ion geometric isomerism 
These experiments compared the effect of succinate, maleate and fumarate as 
disodium salts. The sol:gel transition temperature (SGTT) of l0/0w/w HPMC 
solutions containing 0.5M succinate diNa, 0.5M maleate diNa and 0.5M fumarate 
diNa had been determined as 14, 15 and 24°C respectively (without salts, the SGTT 
was 55°C). The rheological data in Table 3.6 shows that 20/0w/w HPMC solutions 
containing fumarate diNa (trans) exhibited far higher G' and G" values than 
maleate diNa (cis) and succinate diNa (single bond) at all temperatures. The much 
greater strength of gel formed in the presence of fumarate diNa, is remarkable and 
suggests this ion either (i) promotes much greater molecular aggregation of HPMC 
or perhaps (ii) is directly involved in molecular cross-linking. The mechanism of 
this is unclear and merits further investigation. 
At 20°C, HPMC solutions containing succinate and maleate exhibited low G' and G" 
values compared to HPMC alone, suggesting these ions promoted liquid-like 
behaviour even though they reached their SGTT around this temperature. At 50°C 
and 80°C, their G' dominated gels were higher than HPMC alone at 50°C, but not 
80°C, unlike fumarate-containing HPMC gels. 
The frequency dependence of the complex viscosity was determined at 20°C and is 
shown in Figure 3.13(a). HPMC solutions containing Maleate diNa (cis) were not 
different to HPMC alone, whereas succinate diNa and fumarate diNa (trans) salts 
manifestly significantly increased the complex viscosity of HPMC solutions 
(Student's t Test, p<0.05). These results suggest that HPMC solutions containing 
maleate exhibit a liquid-like behaviour, indicating only a weak interaction or effect 
on polymer solution properties. In the other hand, those containing fumarate 
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(trans) and succinate predominated with solid-like (elastic) behaviour. This 
strong elastic response is typical for systems with well-developed association 
networks (Larson 2005). In this case, the trans form could have more ability than 
the cis form to be more involved in the network, or to condense the polymer to a 
denser gel, perhaps by removing water. 
Figure 3.13(b) and (c) show the frequency dependencies of the storage modulus 
(G') and loss modulus (Gil). The presence of maleate diNa caused no change in 
both G' and Gil. However fumarate diNa and succinate diNa, both increased these 
mechanical moduli (Student's t Test, p<O.OS), suggesting that both elastic and 
viscous properties of HPMC solution were enhanced in the presence of fumarate 
diNa and succinate diNa. 
Tan 0 values is the ratio of Gil to G' and indicates the potential of the sample to 
move towards gel-like behaviour (tan 0 <1). Figure 3.13 (d) exhibits the expected 
trend toward G' domination with increasing frequency normally seen for HPMC 
solutions, and this behaviour is paralleled by solutions containing maleate. Gel 
containing succinate and fumarate showed lower tan 0 values, a consequence of 
their greater G' dominance, and they were also more independent of frequency 
than HPMC solutions. This suggests these gels are physically different, and may 
have a higher degree of intermolecular linkages, perhaps a greater degree of 
structural development, or a greater number or stronger intermolecular bonds. 
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Rheological data at different temperatures 
Samples 20°C 50°C 80°C 
G' Gil tanS G' Gil tanS G' Gil tanS 
2%w/wHPMC 2.02 8.43 4.18 4.38 3.92 0.90 27.1 3.01 0.11 
2%w/wHPMC+ 0.33 0.27 0.83 12.3 3.65 0.30 14.5 3.60 0.25 
0.50M Succinate diNa 
2%w/wHPMC + 11.8 14.0 1.19 163 10.4 0.06 196 16.5 0.08 
0.50M Fumarate diNa 
2%w/wHPMC + 2.64 0.85 0.32 16.9 2.74 0.16 13.8 2.24 0.16 
0.50M Maleate diNa 
Table 3.6 Rheological data of HPMC solutions (2%w /w) containing organic salts: the 
effect of geometric isomerism. The data obtained from amplitude sweeps at different 
temperatures. These are the value at 1 % strain 
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(c) Loss modulus, G" 
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Figure 3.13 The effect of geometric isomerism of the organic salts on the frequency 
dependence of the (a) complex viscosity (b) G' (c) G" and (d) tan ~ ~ for 2% wjw 
HPMC solutions. Geometry = PPSOmm. Temperature = 20°C. Strain = 1%. All salts were 
presented at O.SM concentration. 
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(b) The effect of counter-ion ionisation 
These experiments compared the effect of monovalent and divalent fumarate Na 
on the rheological properties of HPMC solutions. Table 3.7 shows how HPMC 
solutions containing fumarate diNa exhibited much greater G' and Gil values than 
monovalent fumarate NaH. This was evident at all temperatures, examined, 
whether above or below their SGTT. The SGTT of 1 %w /w HPMC solutions 
containing 0.1SM fumarate NaH and O.SM fumarate diNa were -49 and 24°C 
respectively. 
Figure 3.14 shows the effect of ionization on the viscoelastic properties. The 
complex viscosity of HPMC solutions containing fumarate diNa was markedly 
higher than fumarate NaH (Student's t Test, p<O.OS). 
Figure 3.14(b) and (c) show the frequency dependence of storage modulus (G') 
and loss modulus (Gil). Fumarate diNa increased both G' and Gil of HPMC solutions 
at all frequencies, whereas fumarate NaH increased only G' at medium to low 
frequencies. This shows that fumarate diNa could enhance both elastic and 
viscous properties of HPMC while fumarate NaH could enhance only elastic 
properties at low frequencies. Figure 3.14(d) shows Tan 0 values which show that 
fumarate diNa had more potential to become gel-like than fumarate NaH. 
There is, however, an important caveat to these experiments. The comparison in 
this section was not ideal because of the different concentration used in the 
experiments. This was a consequence of the different solubility of these salts. It 
has been often shown that increasing the valency of ions (e.g. phosphate, citrate) 
increases their potency to reduce SGTT (Mitchell et al 1990a; Mitchell et al 1991; 
Kujawinski 2000; Pygall et al 2009). This is a consequence of the ionic ability to 
reduce polymer hydration, and it is therefore also a possibility that gels formed 
above the SGTT, could also be dehydrated more effectively by higher valency ions. 
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Rheological data at different temperatures 
Samples 20°C sooe 80°C 
G' G" tanS G' G" tanS G' G" tanS 
2% w /w HPMC 2.02 8.43 4.18 4.38 3.92 0.90 27.1 3.01 0.11 
2%w/wHPMC+ 2.91 10.1 3.48 11.1 4.01 0.36 30.6 3.53 0.12 
0.15M Fumarate Na H 
2%w/wHPMC+ 11.8 14.0 1.19 163 10.4 0.06 196 16.5 0.08 
0.50M Fumarate diNa 
Table 3.7 Rheological data of HPMC solutions (2%w/w) containing fumarate salts: 
the effect of ionization. The data obtained from amplitude sweeps at different 
temperatures. These are the value at 1% strain 
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(c) Loss modulus, G" 
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Figure 3.14 The effect of ionisation of fumarate salts on the frequency dependence 
of the (a) complex viscosity (b) G' (c) G" and (d) tan Sin 2% wjw HPMC solutions. 
Geometry = PPSOmm. Temperature = 20°C. Strain = 1%. Fumarate NaH and diNa were presented 
at O.1SM and 0.50M concentration respectively. 
117 
Chapter 3 
(c) The effect of counter-ion functional groups a comparison between 
carboxylic and sulfonic acid sodium salts 
The rheological properties of HPMC solutions incorporating carboxylic and 
sulfonic acid sodium salts were compared. Table 3.8 shows the rheology of HPMC 
solutions containing acetate Na, mesilate Na, benzoate Na and besilate Na. Overall, 
HPMC solutions containing carboxylic acid salts (acetate and benzoate) appeared 
to exhibit slightly higher values than those containing sulfonic acid salts (mesilate 
and besilate). These differences did not correlate with their SGTT, as the SGTT of 
1 %w Iw HPMC solution containing O.SM acetate Na, O.SM mesilate Na and O.SM 
benzoate Na and besilate Na are -40, 40, 64, 64°C respectively. As mentioned 
earlier, at temperatures higher than their SGTT, G' became dominant, indicating an 
increase in solid characteristics as the solution gelled. 
Figure 3.15 shows the frequency dependence of the rheological values. Figure 
3.1S(a) shows that the complex viscosity of HPMC solutions containing actatate Na 
and mesilate Na were higher than HPMC alone, but were not themselves different 
(Student's t Test, p<O.OS). Benzoate Na significantly enhanced viscosity of HPMC 
solutions, but besilate Na was not (Student's t Test, p<O.OS). This might because of 
the relative strengths of C-C (346kJ/mol) and C-S (272 kl/mol) bonds. Carboxyl 
groups have a stronger bond, may exhibit more elastic behaviour if they directly 
interact with the polymer. Alternatively, this may reflect differences between 
carboxylate and sulfonate group to disrupt water structure and dehydrate the gel. 
Figure 3.1S(b) and (c) show the frequency dependence ofthe storage modulus (G') 
and the loss modulus (G"). These mechanical moduli were slightly increased by 
adding actatate Na and mesilate Na. G' was increased at low frequencies by 
besilate Na, but G' and G" of HPMC solutions were increased at all frequencies by 
benzoate Na. This suggests that aromatic organic salts had more potential to 
enhance the elastic properties of HPMC solutions. The aromatic compounds are 
known to form stacking ring structures in solution (Sindkhedkar et al 2000; 
Waters 2002). This might underly their ability to enhance the viscoelastic 
property of HPMC solutions. 
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Tan 0 values (figure 3.15(d)) showed a corresponding tendency to move towards 
gel-like behaviour (tano = 1) but only HPMC solutions containing besilate Na 
showed a substantive effect, and only at low frequencies. 
Rheological data at different temperatures 
Samples 20°C 50°C 80°C 
G' Gil tano G' Gil tano G' Gil tano 
2% w/wHPMC 2.02 8.43 4.18 4.38 3.92 0.90 27.1 3.01 0.11 
2% w/wHPMC+ 3.87 12.2 3.14 41.0 4.16 0.10 112 8.37 0.07 
O.SOM Acetate Na 
2%w/wHPMC+ 3.14 10.1 3.22 23.6 2.74 0.12 133 12.7 0.10 
O.SOM Mesilate Na 
2% w/wHPMC+ S.39 16.6 3.07 1.61 S.68 3.52 33.1 3.20 0.10 
O.SOM Benzoate Na 
2% w/wHPMC+ 2.4S 9.30 3.80 0.42 3.07 7.23 19.4 1.76 0.09 
O.SOM Besilate Na 
Table 3.8 Rheological data of HPMC solutions (20/0w /w) containing organic salts: A 
comparison of carboxylate and sulfonate organic salts. The data obtained from 
amplitude sweeps at different temperatures. These are the value at 1 % strain. 
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(e) Loss modulus, Gil 
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Figure 3.15 A comparison of carboxylate and sulfonate organic salts on the 
frequency dependence ofthe (a) complex viscosity (b) G' (c) Gil and (d) tan 0 for 2% 
w /w HPMC solutions. Geometry = PPSOmm. Temperature = 20°C. Strain = 1 %. All salts were 
presented at O.SM concentration. 
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(d) The effect of hydroxyl group substituents 
The effect of the presence of hydroxyl group(s) within the organic counter-ion salt 
was investigated by comparing the effect of succinate diNa (no -OH), malate diNa 
(1-0H), tartrate diNa (2-0H), benzoate Na (no -OH) and salicylate Na (1-0H). 
Table 3.9 shows that HPMC solutions containing these salts, at temperatures above 
the SGIT, exhibited a G' dominant (solid-like) behaviour, characteristic of HPMC 
solutions above their SGIT. At 20°C the rheological data showed few differences 
between the salts. At 50°C, G' values for HPMC solutions containing succinate diNa 
and malate diNa were raised but then decreased again at 80°C. Those containing 
tartrate diNa were raised at SOoC and 80°C. For HPMC solutions containing 
aromatic organic salts, G' was depressed at SOoC but was raised at 80°C. 
The frequency dependence of these rheological values determined at 20°C is 
shown in Figure 3.17. Figure 3.16(a) shows that the complex viscosity of HPMC 
solutions was manifestly increased by all these salts (Student's t Test, p<0.05). 
Figures 3.16(b) and (c) show the frequency dependence of the storage moduli (G') 
and loss moduli (Gil). All salts elevated G' at all frequencies and slightly increased 
Gil, showing that the elastic and viscous properties of HPMC solution were 
enhanced by all these salts. This strong elastic response is typical for systems with 
well-developed association network (Larson 2005). Moreover, divalent salts, 
including succinate diNa, malate diNa and tartrate diNa showed more potential to 
enhance elastic behaviour of HPMC solutions than aromatic, monovalent salts, 
(benzoate Na and salicylate Na) even though the latter were present in solution at 
twice the concentration. Tan B in Figure 3.16(d) also shows the potential of these 
divalent salts to maintain a more gel-like behaviour at low frequencies (tan B <1). 
In summary, in this study succinate diNa, malate diNa, tartrate diNa, benzoate diNa 
and salicylate diNa significantly enhanced viscoelastic properties of HPMC, 
suggesting their potential to induce polymer association. However, the different 
hydroxyl group substituents did not affect their potential to modulate HPMC 
viscoelasticity. 
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Although the aromatic organic salts show higher degree of the effect than aliphatic 
organic salts as mentioned in the last section, the divalent salts still exhibited the 
greater effect. These results supported the hypothesis that divalent salts have 
more potential to enhance both elastic and viscous properties of HPMC, and 
greater potential to move towards gel-like behaviour at low frequencies. 
Rheological data at different temperatures 
Samples 20°C 50°C 80°C 
G' Gil tanB G' Gil tanB G' Gil tanB 
2%w/wHPMC 2.02 8.43 4.18 4.38 3.92 0.90 27.1 3.01 0.11 
2%w/wHPMC+ 4.10 12.0 2.92 149 8.07 0.05 16.8 2.84 0.17 
0.25M Succinate diNa 
(no-OH) 
2% w/w HPMC + 6.43 13.1 2.03 183 9.20 0.05 31.2 3.87 0.12 
0.25M Malate diNa 
(1-0H) 
2% w/w HPMC + 5.50 13.6 2.47 22.0 2.91 0.13 23.1 2.98 0.13 
0.25M Tartrate diNa 
(2 -OH) 
2%w/w HPMC + 5.39 16.6 3.07 1.61 5.68 3.52 33.1 3.20 0.10 
O.sOM Benzoate Na 
(no-OH) 
2% w/w HPMC + 5.11 15.4 3.01 0.89 5.22 5.86 6.77 2.69 0.40 
0.50M Salicylate Na 
(1-0H) 
Table 3.9 Rheological data of HPMC solutions (2%w /w) containing organic salts: the 
effect of hydroxyl group substituents. The data obtained from amplitude sweeps at 
different temperatures. These are the value at 1% strain 
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Figure 3.16 The effect of hydroxyl group substituents on the organic salts on the 
frequency dependence of the (a) complex viscosity (b) G' (c) Gil and (d) tan 0 for 2% 
w jw HPMC solutions. Geometry = PP50mm. Temperature = 20°C. Strain = 1%. Disodium 
salts (succinate, malate and tartrate) were presented at 0.25M concentration. Monosodium salts 
(benzoate and salicylate) were presented at O.5M concentration. 
125 
Chapter 3 
(e) The number of carboxylic groups within counter-ion 
The effect of the number of carboxylic groups within the organic salts were 
investigated by comparing acetate Na (1 COO·), and oxalate diNa (2 COO'). Table 
3.10 shows the rheological data for HPMC solutions containing acetate Na and 
oxalate diNa. At the temperatures higher than SGTT of each salts, G' became 
dominant, as a result of thermogelation. SGTT of 1 %w /w HPMC solution 
containing O.SM acetate Na and O.lSM oxalate diNa were -40 and 35°C 
respectively. 
The frequency dependence of the rheological parameters at 20°C is shown in 
Figure 3.17. The complex viscosity, storage modulus (G') and loss modulus (Gil) of 
HPMC solutions were not affected by acetate Na (1 COO·) and oxalate (2 COO"). 
Tan 0 values also indicated that these salts had no potential to induce greater gel-
like behaviour over the whole frequency range. 
The comparison in this section was not ideal because of the different 
concentration used in the experiment, a consequence of the limiting solubility of 
these salts. 
Samples 
2%w/wHPMC 
2%w/wHPMC+ 
O.SOM Acetate Na 
(1 carboxyl group) 
2%w/wHPMC+ 
O.lSM Oxalate diNa 
(2 carboxyl groups) 
Rheological data at different temperatures 
20°C SO°C SO°C 
G' Gil tano G' Gil tano G' Gil tano 
2.02 8.43 4.18 4.38 3.92 0.90 27.1 3.01 0.11 
3.87 12.2 3.14 41.0 4.16 0.10 112 8.37 0.07 
2.72 9.99 3.67 48.5 4.97 0.10 128 11.7 0.09 
Table 3.10 Rheological data of HPMC solutions (20/0w/w) containing organic salts: 
the effect of number of carboxyl groups. The data obtained from an amplitude sweeps 
at different temperatures. These are at 1 % strain. 
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Figure 3.17 The effect of number of carboxyl groups within the organic salts on the 
frequency dependence ofthe (a) complex viscosity (b) G' (c) G" and (d) tan 0 for 2% 
wjw HPMC solutions. Geometry = PPSOmm. Temperature = 20°C. Strain = 1%. Acetate Na 
and oxalate diNa were presented at O.5M and O.lsM concentration respectively. 
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3.S.4 The interaction between organic salts and HPMC 
Figure 3.18 shows a potential mechanism of interaction between HPMC and 
organic salts. For aliphatic organic salts containing 1-4 C-atoms, these small 
hydrophilic molecules would exert Hofmeister effects. Because their water affinity 
is higher than HPMC, these salts will act as kosmotropes which alter the solubility 
of HPMC by competing for available water and dehydrating the polymer hydration 
sheath. This would result in enhanced association of methoxyl-rich regions of the 
HPMC chain, in accordance with the model of Haque and Morris (1993). The result 
is movement of the SGTT to lower temperatures and precipitation of HPMC by 
"salting out", This scheme is shown in Figure 3.18(a). The divalent salts exhibited 
a greater ability to depress SGTT and enhanced the solid-like properties and gel-
like behaviour of HPMC solutions. This suggests they had a greater ability to 
potentiate phase separation because the divalent salts are more highly charged, 
and further up the Hofmeister series. 
Meanwhile, aliphatiC organic salts containing over 6 C-atoms which increased 
SGTT (and reduced the surface tension of HPMC solutions) reflecting their ability 
to increase the solubility of HPMC through micellar solubilisation of hydrophobic 
region (methoxyl-rich area) of HPMC as shown in Figure 3.18(b). These salts are 
considered as chaotropes or 'salting in' salts in the Hofmeister series. This model 
of 'salting out' and 'salting in' behaviour on HPMC in solution has been proposed 
for amino acids (Richardson et al 2006), halide salts (Alderman 1984; Bajwa et al 
2006). 
Figure 3.18(c) shows a postulated mechanism for the interaction between HPMC 
and aromatic organic salts. In polar solvents such as water, aromatic compounds 
will commonly self-associate in the form of stacking rings with x-x interactions, 
which is a hydrophobic interaction (Sindkhedkar et al 2000; Waters 2002; Sasaki 
et al 2006; Hao et al 2012). The properties of these aromatic stacks depend on the 
ring substituents. In this study, the aromatic salts are amphiphiles in which their 
aromatic stacking rings are the hydrophobic part, and the carboxylic and sulfonic 
groups are the hydrophilic part. The aromatic compounds consist of an anionic 
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group and a hydrophobic aromatic ring or ring system can induce a n-stack-type 
aggregation are (also categorised as hydrotropes) a configuration which can 
considerably enhance the aqueous solubility of organic substances if present at a 
sufficient concentration (Balasubramanian et al 1989; Sindkhedkar et al 2000; 
Matero 2002; Waters 2002; Sasaki et al 2006; Desai & Parikh 2009; Hao et al 
2012). In this study, these aromatic salts which elevated SGIT and enhanced 
elastic behaviour of HPMC solutions might interact directly with HPMC by 
solubilising the hydrophobic regions of the HPMC polymer, by their stacking 
aggregation and amphipathic characteristics. Richardson et al (2006) also found 
the same effects occurred with aromatic amino acids. In addition the hydrophobic 
regions may become negatively charged as a result of solubilisation and 
absorption of the aromatic salts. These regions of negative charge would repel 
each other, straightening and extending the polymer chain, making the solution 
more viscous and gel-like entanglements more frequent. This might result in a rise 
of G' and Gil. In the case of the small aliphatic molecules, those higher up the 
Hofmeister series may give rise to denser gels (with higher G' and Gil as shown by 
succinate and fumarate) as a result of a greater ability to dehydrate the theme-
gelled polymer. 
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Figure 3.18 Illustration of the postulated mechanisms between HPMC and organic 
salts containing (a) 1-4 C-atoms (b) over 6 C-atoms and (c) containing an aromatic 
ring. 
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3.6 Conclusions 
In this chapter, organic salts were found to influence HPMC solution properties 
such as sol:gel transition temperature (SGTT), viscoelastic behaviour and surface 
tension. These effects depend on the structure of organic salts which can conclude 
as following: 
(i) Or&anic salts with 1-4 C-atoms 
These salts depressed of HPMC solutions, but did not change the surface activity of 
HPMC. Their action corresponds to Hofmeister effects by acting as kosmotropes. 
These small hydrophilic molecules are thought to compete for the available water 
and remove water from the polymer hydration sheath of HPMC, and hence cause 
HPMC precipitation ("salting out"). The rheological studies also prOvided the 
evidence that divalent salts had potential to enhance the solid-like properties of 
HPMC solution both below and above the SGTT. 
(ii) Or&anic salts with oyer 6 C-atoms 
These salts elevated SGTT and reduced the surface tension of HPMC solutions. 
These results provide a hypothesis that these salts might act as chaotropes of the 
Hofemeister series, and possibly solubilise the hydrophobic regions of HPMC 
through micellar solubilisation. 
(iii) Or&anic salts containin& an aromatic &roup 
These salts elevated SGTT of HPMC solutions, but showed no effect on the surface 
activity of HPMC. The rheological studies provided the evidence that they had 
potential to enhance the viscoelastic behaviour of HPMC solutions. These support 
a hypothesis that the aromatic organic salts might act as hydrotropes and 
solubilise the hydrophobic regions of HPMC by stack-type aggregation and 
amphiphilicity. 
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All the investigations in this chapter suggest that the organic salts used as counter-
ions might affect the gel layer formation of HPMC matrices, so that these salts 
might be one factor that we should consider in HPMC matrices formulation. In 
next chapter, the effect of these organic salts on HPMC matrices will be 
investigated. 
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The Effect of Organic salts on HPMC Matrices 
4.1 Rationale 
Previous chapters have shown that some organic salts used as drug counter-ions, 
can affect the properties of HPMC in solution. This suggests that they may also 
have an influence on the gel layer of HPMC matrices. In this chapter, the effect of 
these organic salts on matrices will be investigated, with the intention that this 
understanding may be useful in the future formulation of HPMC matrices. 
4.2 Introduction 
The effect of many additives on the extended release performance of HPMC has 
been studied. Soluble or insoluble diluents, and anionic surfactants for example 
may influence drug release rates (Lapidus & Lordi 1968; Daly et a11984) whereas 
magnesium stearate did not affect the release rates of promethazine (Ford et al 
1985b). The solubility and particle size of drug may also alter the release rate of 
HPMC matrices (Ford et al 1985a; Ford et al 1985b; Ford et al 1987). It has been 
postulated that highly soluble drugs and exciepients can act as pore formers, with 
micro-cavities making the gel structure more porous and physically weaker, 
leading to increased drug release rates (Yang & Fassihi 1997). Sheu et al (1992) 
found that the release rate of dicIofenac sodium can be retarded by the use of 
sodium chloride, which salted out diclofenac sodium, and resulted in a lower 
dissolution rate. Diclofenac sodium matrices using HPMC and carboxypolymer 
mixtures as the controlled release polymer, studied by Bravo et al (2004), showed 
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how more rapid release occurred as the carboxypolymer ratio within the matrices 
increased. This could be a hydration or a molecular weight induced change, but 
these matrices were also pH dependent because the carboxypolymer needed to be 
ionized to be able to interact with HPMC to control the drug release. 
Tablet diluents can have significant effects. It has been reported that 
microcrystalline cellulose (MCC) can change the dissolution profile by 
accentuating the initial burst effect, whilst non-swellable insoluble fillers, for 
example, dicalcium phosphate, completely destroy sustained release properties of 
HPMC matrix tablets with a low polymer formulation (Alderman 1984). The use of 
partially gelatinized maize starch, Starch 1500®, in chlorpheniramine maleate and 
theophylline matrices has been found to retard drug release rate because of a 
potential synergistic interaction between Starch 1500 and HPMC, whilst, MCC and 
spray-dried lactose were found in the same formulations to accelerate drug 
release (Levina & Rajabi-Siahboomi 2004). 
The effect of internal buffering agents such as tris(hydroxylmethyl) aminomethane 
(THAM, TRIS) and sodium citrate on HPMC matrices has been shown to accelerate 
release of the weak acid drug in both pH 1.2 and 7.5 media (pygall et al 2009; 
Pygall et aI2010). 
High levels of ionic salts, particularly multivalent ions, can cause precipitation of 
HPMC leading to premature drug release (Alderman 1984). The ionic strength of 
electrolytes in a dissolution media can affect the drug release rate of HPMC 
matrices and an ionic strength of approximately 0.5moIjL or greater in the 
dissolution media can cause the burst release of the matrices (Xu et aI2006). 
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4.3 Chapter Aims and Objectives 
In this chapter, the effect of selected organic salts, which are used as drug counter-
ions, on HPMC matrix properties are investigated with respect to (i) organic salt 
chain length and (ii) organic salt structure activity relationship. The study in 
matrices aimed to explore the influence of these organic salts on the drug release 
from HPMC matrices both with and without diluents incorporating into the tablet. 
In particular, the experimental work in this chapter, investigates the effect of 
organic species on the extended release performance of HPMC matrices. 
In the end, the correlation between the effect of these organic salts on the drug 
release performance of HPMC matrices (from this Chapter) and on the sol:gel 
transition temperature (from Chapter 3 Section 3.5.1) of HPMC solutions was 
determined. 
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4.4 Materials and Methods 
4.4.1 Organic salts 
4.4.1.1 A homologous series 
The simplest series of organic counter-ions was chosen from Table 1.3 in order to 
study the relationship between aliphatic chain length and ion effects on HPMC. 
The homologous series of aliphatic organic sodium salts containing a 1-carboxylic 
group are shown in Table 3.1 and the source and batch numbers of these materials 
are documented in Appendix 1. 
4.4.1.2 The relative groups 
The organic salts shown·in Table 1.3 were selected and categorised according to 
their functional groups and structural relationships. In this chapter, the effect of 
these groups on HPMC were studied by comparing salts with (a) geometric 
isomerism (b) degree of ionisation (c) different acid functional groups (carboxyl 
and sulfonic acids) (d) the presence of hydroxyl group(s) and (e) the number of 
carboxyl groups. These organic salts are listed in Chapter 3 (Table 3.2) and the 
source and batch numbers of these materials are documented in Appendix 1. 
4.4.2 HPMC 
HPMC USP Type 2910 (MethoceITM E4M CR Premium EP /USP) and HPMC USP 
Type 2208 (Methocel™ K4M CR Premium EP /USP) were used in this study. Full 
details of these materials are given in Appendix 1. 
4.4.3 Manufacture of matrix tablets 
Matrix tablets weighing 250 ± 5 mg were manufactured using a Manesty F3 single 
punch tablet press (Manesty, Liverpool, UK) at a compression pressure of 160MPa 
(within the linear range of compression pressure-hardness profile), using 8 mm 
flat-faced punches (I Holland, Nottingham, UK) as described in section 2.2.7. The 
formulations of HPMC matrices used in this chapter are shown in Table 4.1, 4.2 
and 4.3. For the study of the effect of amount of organic salts, tablets were 
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prepared containing by weight, a high amount of organic salts (60%w/w) without 
diluents and a low amount (10%w/w) of organic salts with diluents (Table 4.1). In 
the study of the effects of different diluents, tablets were prepared with a diluent 
of high solubility (dextrose), an insoluble diluent (microcrystalline cellulose), a 
diluent of intermediate solubility (partially pre-gelatinized starch) and the 50:50 
mixtures of each (Table 4.2). The effect of diluents in the presence of an organic 
salt, succinate diNa, was also studied (Table 4.3(a)) which Table 4.3(b) shows the 
control formulations for table 4.3(a) with CH, CI, CI, CK and CL being the controls for 
H, I, J, K and L respectively. Different types of HPMC, including HPMC E4M, HPMC 
E4M ( 6 3 - 9 0 ~ m m fraction) and HPMC K4M were used in the study for the effect of 
diluents. 
Note: Compression pressure-hardness profiles for matrix tablets containing each 
organic salt were obtained, in order to determine the appropriate compression 
pressure. A compression pressure of 160 MPa was chosen because it was within 
the linear compression range for all organic salt formulations (Data not shown). 
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Weight Composition (%w /w) 
Ingredients 
A B Control 
Caffeine anhydrousa 10.0 10.0 10.0 
HPMC 30.0 30.0 30.0 
Organic saltb 60.0 10.0 
Dextrose 50.0 60.0 
Table 4.1 The formulation of HPMC matrix tablets containing (A) high amounts 
of salts without diluents (8) low amounts of the salts with diluents used in this 
chapter. 
a <12S#lm sieve fraction. bselected organic salts as described in section 4.4.1. Full details 
of all materials are provided in Appendix 1. 
Grade/ Weight Composition (%w /w) Ingredients Type C D E F G 
Caffeine Analytical 10.0 10.0 10.0 10.0 10.0 
anhydrousa grade 
HPMC Methocel™ 30.0 30.0 30.0 30.0 30.0 
E4M CR/ 
Methocel™ 
E4M CR 
( 6 3 - 9 0 ~ m m
fraction)/ 
Methocel™ 
K4MCR 
Dextrose M e r i t a b ~ ~ 60.0 30.0 30.0 
Pre-gelatinised Starch 60.0 30.0 
Starch 1500® 
Microcrystalline Avicel 60.0 30.0 
Cellulose (MCC) PHI02 
Table 4.Z The formulation of HPMC matrix tablets used in the study of the effect of 
diluents on HPMC matrices. 
a <12S#lm sieve fraction. Full details of all materials are provided in Appendix 1. 
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(a) Formulation of matrices containing an organic salt 
Gradel Weight Composition (%w Iw) Ingredients Type H I J K L 
Caffeine Analytical 10.0 10.0 10.0 10.0 10.0 
anhydrousa grade 
HPMC Methocel™ 30.0 30.0 30.0 30.0 30.0 
E4MCR 
Succinate 10.0 10.0 10.0 10.0 10.0 
disodium 
Dextrose Meritab® 50.0 25.0 25.0 
Pre-gelatinised Starch 50.0 25.0 
Starch 1500® 
Microcrystalline Avicel 50.0 25.0 
Cellulose (MCC) PHI02 
(b) Control formulations 
Gradel Weight Composition (%w Iw) Ingredients Type CH C, CJ CK CL 
Caffeine Analytical 10.0 10.0 10.0 10.0 10.0 
anhydrousa grade 
HPMC Methocel™ 30.0 30.0 30.0 30.0 30.0 
E4MCR 
Dextrose Meritab® 60.0 10.0 35.0 10.0 35.0 
Pre-gelatinized Starch 50.0 25.0 
Starch 1500® 
Microcrystalline Avicel 50.0 25.0 
Cellulose (MCC) PHI02 
Table 4.3 The formulation of HPMC matrix tablets used in the study of the effect of 
diluents on HPMC matrices containing dlsodium succinate. 
a <125Jlm sieve fraction. Full details of all materials are provided in Appendix 1. 
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4.4.4 Dissolution determination 
Drug release profiles of HPMC matrices were determined at 37±0.SoC in 900ml of 
degassed media using USP dissolution apparatus I (basket) at 100rpm 
(Dissolutest, Prolabo, France). The main dissolution media used was deionized 
water but sodium chloride (NaCI), Potassium chloride (KCI), and simulated gastric 
fluid USP without enzymes (SGF) were also used in this chapter. Full details of the 
dissolution method are provided in Section 2.2.8. 
4.4.4.1 The preparation of dissolution media 
To prepare 0.1S4M NaCI solution, S4.00g of NaCI was weighed and completely 
dissolved in a small amount of water, and then made up to 6L with deionised 
water. To prepare a 0.1S4M KCI, 68.89g of KCI was weighed and completely 
dissolved in a small amount of water, and then made up to 6L with water. 
Simulated gastric fluid (SGF) without enzymes was prepared according to the USP 
29. 1L of SGF was prepared by dissolving 2g of sodium chloride in a small amount 
of water, and then adding the appropriated amount of hydrochloric acid to achieve 
pH 1.2, and finally made up to 1L with water. All media were degassed by helium 
sparging for at least 20 minutes prior to use. The reagents and the quality and 
source of the deionised water are described in Appendix 1. 
4.4.S Statistical analysis 
Statistical differences between drug release profiles were determined using a one-
way ANOVA (JMP 7 software, SAS Institute Inc., Cary, NC). A P value o/Iess than 
a05was considered statistically significant. 
The drug release profiles were also compared by using the difference factor (f1) 
and similarity factor (f2). The difference factor (f1) calculates the percent (%) 
difference between the two curves at each time point and is a measurement of the 
relative error as shown in equation 4.1. The similarity factor (f2) is a logarithmic 
reciprocal square root transformation of the sum of squared error and is a 
measurement of the similarity in the percent (%) dissolution between the two 
curves. 
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Equation 4.1 
Equation 4.2 
where n is the number of time points, Rt is the dissolution value of the reference 
batch at time t, and Tt is the dissolution value of the test batch at time t 
If fl values are close to 0 (generally 0-15) and f2 values are close to 100 (generally 
50-100), the two curves are considered similar or equivalent On the other hand if 
fl values are more than 15 and f2 values are less than 50, the two curves are 
considered different (US FDA; Shah 1998; Pillay & Fassihi 1998; Gohel et al 2005, 
Wadher et aI2011). 
4.4.6 Photography of hydrating HPMC matrices 
Hydrated matrix tablets taken from the dissolution determination were collected 
to image at Omin, 10 min, lhour, and 8hours using a Celestron handheld digital 
microscope (Celestron@, Torrance, CA, USA) and a digital camera (canon@ixus55, 
Japan) 
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4.5 Results and Discussion 
4.5.1 The selection ofthe dissolution media 
Four dissolution media (deionised water, O.lSM NaCI, O.lSM KCI and simulated 
gastric fluid USP without enzymes (SGF)) were used in this study. To isolate the 
effect of the organic salt on the HPMC matrix tablet, these tablets contained only 
an organic salt, HPMC and a model drug (formulation A in Table 4.1). Dissolution 
tests of HPMC matrices containing acetate Na, pentanoate Na, or octanoate Na 
were conducted in these four dissolution media using apparatus I at 100 rpm and 
37°C. The release profiles are shown in Figure 4.1. Matrices incorporating each 
salt exhibited significantly different drug release profiles in every dissolution 
media (p<O.OS, one-way ANOVA) and the rank order of drug release was always: 
acetate (C2) > pentanoate (C5) > octanoate (C8) 
highest •• ---- dissolution rate ----- lowest 
However, the difference (f1) and similarity factors (fz) also highlighted differences 
in different media (Table 4.4). Water showed the greatest difference between the 
salts. 
As the aim of this thesis is to investigate the influence of the organic salts on drug 
release from HPMC matrices, it was decided that ionic strength should be 
controlled as least as possible. A simple two component test medium (water and 
salts component) would best facilitate the identification of potential interactions 
between the salts and the model HPMC matrix. Therefore water was chosen as the 
main dissolution medium to be used throughout this thesis. Further details of the 
effect of these organic salts on HPMC matrices will be discussed in section 4.5.4. 
Dissolution media fl f2 
Water 26.23 31.46 
O.15M NaCl 16.15 41.34 
O.15M KCl 21.17 34.22 
SGF (without enzyme) 13.26 45.87 
Table 4.4 The difference factor (ftl and the similarity factor (fd between HPMC 
matrices containing acetate Na and pentanoate Na. 
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Figure 4.1 The effect of dissolution media on the drug release profile of HPMC 
matrices containing sodium acetate, sodium pentanoate or sodium oetanoate. 
Dissolution media are (a) water (b) O.lSM NaCI (e) O.lSM KCl and (d) SGF without 
enzyme. Smm, 2S0mg matrices contain 30%HPMC E4M, 10%eaffeine anhydrous, 60% 
organic salt. USP I, 100rpm, 37°C in dissolution medium. Mean(n=3)± IS.0. 
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4.5.2 The effect of 60% organic salts on drug release from HPMC matrices 
Table 4.5 shows the effect of incorporated organic salts, on matrix drug release 
times (Tao%) and an analysis using the modified power law (Ford et al 1987). Salts 
were present at 60%w /w so that they could exert their maximum effect. The 
influence of the salts varied widely, from modifying extended release behaviour to 
inducing immediate release behaviour in the matrix. 
According to the study of the effect of these organic salts on HPMC solutions, 
pentanoate Na has the least effect on the sol:gel transition temperature (SGTT) of 
HPMC solutions (Chapter 3), and therefore it exhibited the least potential to alter 
the release profile of HPMC matrices comparing with control (without salt). 
The organic salts which retained the controlled release characteristics of HPMC 
matrices were: pentanoate Na, caproate Na, octanoate Na, benzoate Na, besilate 
Na, salicylate Na and tartrate diNa. In all cases, their release profiles showed a 
good fit with the modified power law model up to 80% cumulative release 
(r2>0.99), and the exponent (n) was within the range of 0.386-0.632, close enough 
to 0.5 to suggest the drug release mechanism was diffusion-dominated. 
The salts acetate Na, propionate Na, fumarate NaH, fumarate diNa, maleate diNa, 
succinate diNa, malate diNa, mesilate Na and oxalate diNa had as greater impact on 
the release mechanism. Matrices containing these salts lost their extended release 
capability and exhibited burst release. When the release profiles were fitted to the 
modified power law up to 99% cumulative release, the very small diffusional 
exponent (n <0.1) and very high release rate constant (k>54) were found which 
may be used to compare the release rate modulated by organic salts incorporated 
into HPMC matrices. Linear regression was also used to compare the early release 
of these organic salts, and this will be discussed in the next section. Although the 
power law and its numerous adaptations have been used many times in the 
literature to understand changes in release mechanism from gel-forming matrices 
(Siepmann & Peppas 2001), this immediate release behaviour is probably outside 
the scope of this model as it only describes drug release mechanisms in terms of 
gel layer diffusion and erosion. 
In the following sections, the effect of these organic salts on drug release is 
discussed in terms of structure-activity relationships. 
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Organic salts Tao'll> k n r2 
UlJ:lUJll. 
No salt ( dextrose used as a diluent) 178 9.58 0.419 0.9992 
Homologous series 
Acetate Na 13 96.84(a) 0.005(a) 0.9378(1) 
Propionate Na 14 93.19(a) 0.015(a) 0.8948(a) 
Pentanoate Na 150 10.03 0.386 0.9994 
Caproate Na 240 3.82 0.564 0.9990 
Octanoate Na 264 2.49 0.632 0.9907 
Geometric isomerism 
Fumarate diNa 14 90.33(a) 0.022(a) 0.9492(a) 
Maleate diNa 56 54.25(e) 0.106(e) 0.9742(e) 
Ionisation 
Fumarate Na H 14 86.91(a) 0.032(a) 0.9585(1) 
Fumarate diNa 14 90.33(a) 0.022(a) 0.9492(a) 
Functional groups 
Acetate Na 13 96.84(a) 0.005(a) 0.9378(0) 
Mesilate Na 37 61.57(e) 0.088(e) 0.9940(e) 
Benzoate Na 170 7.56 0.475 0.9989 
Besilate Na 206 4.87 0.542 0.9985 
r l z ~ ~ IZcmag: Q . [ b . v d r Q l o ~ ~ u,CQUIZls.l 
Succinate diNa 23 78.79(b) 0.062(b) 0.9034(b) 
Malate diNa 27 64.46(b) 0.114 (b) 0.9292(b) 
Tartrate diNa 89 27.13 0.251 0.9985 
Benzoate Na 170 7.56 0.475 0.9989 
Salicylate Na 113 9.36 0.472 0.9977 
'liz' a u m l l ~ c c Q . [ C l l . d z c a . ~ l i ' ' graups 
Acetate Na 13 96.84(a) 0.005(0) 0.9378(a) 
Oxalate diNa 12 92.77(a) 0.017(0) 0.9630(a) 
Table 4.S The effect of 60% organic salts on drug release kinetics using the modified power 
law. Modified power law is described by Ford et al (1987) and was fitted up to 80% cumulative 
release. 8mm, 250mg matrices, 160MPa containing 30% HPMC E4M, 10% caffeine anhydrous, 60% 
organiC salt Tao'll> is the time to 80% cumulative drug release. k is the kinetic constant n is the 
diffusional exponent r2 is determination coefficient (a) Drug release >80% within 15 min. (b) Drug 
release >80% within 30 min. (c) Drug release >80% within lh. These fast release matrices were 
calculated up to 99% cumulative release and also evaluated by linear regression for the early 
release. 
148 
Chapter 4 
4.5.2.1 The effect of the C-chain length of organic salts on drug release from 
HPMC matrices (homologous series) 
Release profiles for HPMC matrices containing a homologous series of aliphatic 
organic salts are shown in Figure 4.2. The release data and kinetics (extracted 
from Table 4.5) are shown in Table 4.6. 
The release rate constant (k) and the time to 80% cumulative drug release (Tao%) 
were in a rank order of C-chain length as follows: 
acetate (C2) > propionate (C3) > p e n t a n o ~ t e e (C5) > caproate (C6) > octanoate (C8) 
.. release rate 
acetate (C2) = propionate (C3) < pentanoate (C5) < caproate (C6) < octanoate (C8) 
Tao% 
These salts show the same rank order as their effects on the sol:gel transition 
temperature of HPMC solutions (Chapter 3). Their correlation will be discussed in 
section 4.5.4. 
With respect to control the longer C-chain salts retarded the release from the 
matrix, whereas the shorter C-chain lengths accelerated drug release. If we use 
the same arguments derived by Richardson et al (2006) to explain the effects of 
amino acids on the sol:gel transition temperature, then these salts may modulate 
the release profiles ofHPMC matrices by virtue of their hydrophobicity. The more 
hydrophilic salts, acetate (C2) and propionate (C3) would accelerate drug release 
by competing for water, in the hydration sheath of the polymer as do common 
anionic salts such as sulphate and phosphate. In the hydrating matrix this would 
result in inhibition of polymer swelling, interfering with gel layer formation, 
compromising the gel diffusion barrier and leading to greater liquid penetration of 
the matrix core. The more hydrophobic salts, caproate (C6) and octanoate (C8) 
would increase polymer hydration through micellar solubilisation of HPMC, 
making gel layer formation more rapid, and it seems, more effective as a drug 
retarding barrier. 
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Figure 4.2 The effect of C-chain length of the organic salts on the drug release profile 
of "PMC matrices. 8mm, 250mg matrices contain 30%HPMC E4M, 10%caffeine 
anhydrous, 60% organic salt. USP I , 100rpm, 37°C in water. Mean (n=3) ± 1S.D. 
Modified power law Linear 
Organic salts Tso% Tao% (Ford et al 1987) regression 
k n r2 k r 
Control 
No salt (dextrose 66 178 9.58 0.419 0.9992 1.32 0.9963 
used as a diluent) 
liQl1J.QlQ{J.QUs. s . e . d ~ ~
Acetate Na 8 13 96.84(a) 0.005(a) 0.9378(a) 6.19 0.9999 
Propionate Na 10 14 93.19(a) 0.015(a) 0.8948(a) 5.91 0.9958 
Pentanoate Na 54 150 10.03 0.386 0.9994 1.17 0.9974 
Caproate Na 109 240 3.82 0.564 0.9990 0.55 0.9984 
Octanoate Na 130 264 2.44 0.638 0.9880 0.52 0.9948 
Table 4.6 The effect of an aliphatic homologous series of organic salts on drug 
release kinetics using the modified power law and linear regression. Modified power 
law is fitted up to 80% cumulative release, but the fast release matrices were calculated up to 99% 
cumulative release. Linear regression is fitted for the early release. 8mm. 250mg matrices contain 
30%HPMC E4M. 10%caffeine anhydrous, 60% organic salt. Tso% and Tao% are the time to 50% and 
80% cumulative drug release respectively. k is the kinetic constant. n is the diffusional exponent. r2 
is determination coefficient. (a) Drug release >80% within 15 min. 
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4.5.2.2 The effect of the structure relationship of organic salts on drug 
release from HPMC matrices 
(a) The effect of counter-ion geometric isomerism 
Release profiles for HPMC matrices containing the geometric isomers fumarate 
diNa and maleate diNa are compared in Figure 4.3. Dissolution test kinetic 
parameters, extracted from Table 4.5, are shown in Table 4.7. 
Both salts markedly accelerated drug release from HPMC matrices in comparison 
with the control tablet (Section 4.5.2) and this behaviour can be described through 
their water affinity, which is higher than HPMC. Fumarate and maleate both act as 
kosmotropic salts in the Hofmeister series, altering the solubility of HPMC by 
competing for and removing water from the polymer hydration sheath. In the 
hydrating matrix tablet this leads to suppression of polymer swelling and gel layer 
formation. 
The release rate constant (k) and the time to 80% cumulative drug release (Tao%) 
(Table 4.7) showed drug release from HPMC matrices containing fumarate (trans 
form) was significantly more quickly than those containing maleate (cis form) 
(p<0.05, one-way ANOVA; f1= 28.66, f2= 33.25). This corresponds with results 
from the study of these salts on HPMC solutions which suggested fumarate 
exhibited a stronger potential to promote the molecular aggregation of HPMC (or 
perhaps be involved in molecular cross-linking through stronger intermolecular 
bonds) than maleate which indicated it had only a weak interaction with the 
polymer (Chapter 3). These molecular differences would influence polymer 
solvation and therefore the trans form would have more ability than the cis form 
to destroy the controlled release properties of HPMC matrix tablets. 
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Figure 4.3 The effect of fumarate/maleate geometric isomerism on the drug release 
profile of HPMC matrices. 8mm, 250mg matrices containing 30%HPMC E4M, 
10%caffeine anhydrous, 60% organic salt. USP I , 100rpm, 37°C in water. Mean (n=3) ± 
1S.D. 
Modified power law Linear 
Organic salts Tso% Tao% (Ford et al 1987) regression 
k n r2 k r 
Control 
No salt (dextrose 66 178 9.58 0.419 0.9992 1.32 0.9963 
used as a diluent) 
G . ~ Q Q11l e.trj (; 
is.Q 11l e.t:is.cn 
9 14 90.33(a) 0.022(a) 0.9492(a) 5.91 1.0000 
Fumarate diNa 
Maleate diNa 12 56 54.25 (c) 0.106(c) 0.9742(c) 4.06 1.0000 
Table 4.7 The effect of fumarate/maleate geometric isomerism of the organic salts 
on drug release kinetics using the modified power law and linear regression. 
Modified power law is fitted up to 80% cumulative release, but the fast release matrices 
were calculated up to 99% cumulative release. Linear regression is fitted for the early 
release. 8mm, 250mg matrices contain 30%HPMC E4M, 10%caffeine anhydrous, 60% 
organic salt. Tso% and TBO% are the time to 50% and 80% cumulative drug release 
respectively. k is the kinetic constant. n is the diffusional exponent. r2 is determination 
coefficient. (a) Drug release >80% within 15 min. (b) Drug release >80% within 1h. 
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(b) The effect of counter-ion ionisation 
Fumarate has two ionisable carboxyl groups and previous solution studies had 
shown fumarate diNa (divalent) to be twice as potent as fumarate NaH 
(monovalent) in depressing the sol:gel transition temperature (SGTT) (Chapter 3). 
However, in the matrix the degree of ionisation, had little effect on the potency of 
this salt to accelerate drug release (Figure 4.4) (f1 = 1.37, f2 = 92.08). Matrices 
containing either salt lost their extended release characteristics, and released over 
80% of drug within 15 min with the same release r ~ t e e constant (k)(Table 4.8). 
This suggests the high amount salts present was too extreme to differentiate them. 
The effect of lower amounts of salts is further investigated in section 4.5.3.3. 
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Figure 4.4 The effect of ionisation of fumarate salts on the drug release profile of 
HPMC matrices. 8mm, 2S0mg matrices contain 30%HPMC E4M, 10%caffeine anhydrous, 
60% organic salt. USP I, 100rpm, 37°C in water. Mean (n=3) ± 15.0. 
Modified power law Linear regression 
Organic salts Tso% Tao% (Ford et a11987) 
k n r2 k r 
Control 
No salt ( dextrose 66 178 9.58 0.419 0.9992 1.32 0.9963 
used as a diluent) 
l Q l 1 i z . C J . . i Q l 1 1
Fumarate Na H 8 14 86.91(0) 0.032(3) 0.9585(3) 5.91 0.9983 
Fumarate diNa 9 14 90.33(3) 0.022(a) 0.9492(a) 5.91 1.0000 
Table 4.8 The effect of ionisation of fumarate salts on drug release kinetics using 
the modified power law and linear regression. Modified power law is fitted up to 80% 
cumulative release, but the fast release matrices were calculated up to 99% cumulative release. 
Linear regression is fitted for the early release. 8mm, 250mg matrices contain 30%HPMC E4M, 
10%caffeine anhydrous, 60% organic salt Tso% and Tao% are the time to 50% and 80% cumulative 
drug release respectively. k is the kinetic constant. n is the diffusional exponent. r2 is 
determination coefficient. 
(a) Drug release >80% withm 15 min. 
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(e) The effect of counter-ion functional groups: a comparison between 
carboxylic and sulfonic acid sodium salts 
In this section, release profiles from HPMC matrices containing organic salts with 
carboxylic groups (acetate Na and benzoate Na) and their corresponding sulfonic 
acid counterparts (mesilate Na and besilate Na) are shown in Figure 4.6. The 
release data and kinetics (extracted from Table 4.5) are shown in Table 4.9. 
The aliphatic organic salts, acetate and mesilate both accelerated drug release 
(Table 4.5) suggesting they act as kosmotropic salts in the Hofmeister series. The 
release profiles of HPMC matrices containing acetate Na and mesilate Na were 
significantly different (p<0.05, one-way ANOVA; f1 = 15.64, f2 = 33.77). The release 
rate constant (k) and the time to 80% cumulative drug release (Tao%) in Table 4.9 
show drug release from matrices containing acetate salt was more rapid. 
Surprisingly, however, no difference was detected in their effect on the SGTT of 
HPMC solutions (Chapter 3). This suggests another mechanism may be 
responsible for differences, perhaps differences in osmotic transport into the 
matrix core. 
In contrast however, the aromatic organic salts, benzoate and besilate both 
retarded drug release, and besilate matrices were significantly slower than 
benzoate (p<0.05, one-way ANOVA; f1 = 19.06, f2 = 49.26). This corresponds to 
their ability to raise SGTT of HPMC solutions which assumed to prolong drug 
release from HPMC matrices by solubilising HPMC (Chapter 3). Pygall et al (2011) 
have provided evidence that a benzoic acid derivative, sodium meclofenamate, a 
self associating drug, exhibits drug:HPMC association which can be detected 
rheologically, and by small-angle neutron scattering. Benzoate and besilate might 
solubilise HPMC through a similar mechanism, forming x-stacking aggregates 
around the hydrophobic domain of HPMC. Besilate, with a sulphur atom within its 
structure may be able to form the self-assembled structure better than benzoate 
through intermolecular x-x and sulphur-sulphur interactions (Van der Waals) 
between adjacent molecules (Sasaki et al 2006; Hao et al 2012) as shown in Figure 
4.5. The stacking of these polar molecules around the hydrophobic domains of 
HPMC will make these areas of the polymer chain more attractive to water and 
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stabilise the hydration sheath. The consequences of this could be more rapid 
hydration, swelling and gel layer formation in the matrix tablet. 
s-s interaction 
t[- t[ interaction 
Figure 4.5 The intermolecular 'Ir- 'Ir and sulphur-sulphur (S-S) interactions between 
adjacent molecules of a stacking aromatic species such as besilate (Taken from Hao 
et aI2011) . 
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Figure 4.6 A comparison of carboxylate and sulfonate organic salts on the drug 
release profile of "PMC matrices. 8mm, 250mg matrices contain 30%HPMC E4M, 
10%caffeine anhydrous, 60% organic salt. USP I , 100rpm, 37°C in water. Mean (n=3) ± 
1S.D. 
Modified power law Linear regression 
Organic salts Tso% Tao% (Ford et a11987) 
k n r2 k r 
Control 
No salt ( dextrose 66 178 9.58 0.419 0.9992 1.32 0.9963 
used as a diluent) 
Eunc.tiQI1JJ.I a r Q I J . 1 2 ~ ~
Acetate Na 8 13 96.84(a) 0.005(a) 0.9378(a) 6.19 0.9999 
Mesilate Na 10 37 61.57(e) 0.088(e) 0.9940(e) 4.78 0.9994 
." B e ~ ; ~ o ~ " t e eN a""·""""""""" 69"""""""i 7"0"""""" 7."f,(;"""""" 0.-47"5"""""" "0.-9cisci"··""" i. is""""" "0:9992""" 
Besilate Na 86 206 4.87 0.542 0.9985 0.67 0.9982 
Table 4.9 A comparison of carboxylate and sulfonate organic salts on drug release 
kinetics using the modified power law and linear regression. Modified power law is 
fitted up to 80% cumulative release, but the fast release matrices were calculated up to 99% 
cumulative release. Linear regression is fitted for the early release. 8mm, 250mg matrices contain 
30%HPMC E4M, 10%caffeine anhydrous, 60% organic salt. Tso% and Teo% are the time to 50% and 
80% cumulative drug release respectively. k is the kinetic constant. n is the diffusional exponent. r2 
is determination coefficient. 
(a) Drug release >80% within 15 min. (b) Drug release >80% within 1h. 
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(d) The effect of hydroxyl group substituents 
Hydroxyl groups substituents in aliphatic and aromatic counter ions had different 
effects on drug release from HPMC matrices (Figure 4.8). 
The aliphatic organic salts, succinate (no -OH), malate (1-0H) and tartrate (2-0H) 
all accelerated drug release compared with the control (no salt) (Table 4.5). This 
may be described by their kosmotropic action in the Hofmeister series ions. The 
release profiles of HPMC matrices containing succinate and malate were 
equivalent by the f1/f2 test (f1 = 6.16, f2 = 60.53) whereas succinate and tartrate (f1 
= 61.34, f2 = 23.84) and malate and tartrate (f1 = 51.40, f2 = 27.05) showed 
significant difference. The release rate constant (k) and the time to 80% 
cumulative drug release (Tso%) in Table 4.10 suggest that the potency of these 
kosmotropic ions in accelerating the drug release from HPMC matrices were rank 
ordered as follows: 
Succinate (no -OH) ~ ~ Malate (1-0H) > Tartrate (2-0H) 
This rank order is reversed with respect to the effect of these salts on HPMC 
solutions (Chapter 3) in which we postulated that the increasing numbers of 
hydroxyl groups, provide more potential for interaction with the hydrogen bonded 
structure of water, and would enhance the effects of the parent molecule in 
dehydrating the polymer hydration sheath. 
A reason why tartrate exhibited the lowest potential to accelerate drug release 
may be because of the difference in molecular orientation in solution and as a 
solid. In the solution studies, HPMC and tartrate were separately hydrated before 
mixing. In this case, the orientation of tartrate is a hydrated free anion (Figure 
4.7a) which has higher affinity to water than succinate and malate. In contrast, in 
the solid state, the orientation of tartrate is more rigid because of the 
intramolecular bond between carboxylate and alcoholic hydroxyl groups of the 
ligand (Rodrigues et al 2009). In this case, energy is needed to break this 
crystalline structure before salt hydration can occur, leading to slower dissolution 
and less ability to compete for available water with HPMC (Figure 4.7b) 
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In the case of aromatic salts, both benzoate (no -OH) and salicylate (1-0H) 
retarded drug release (Table 4.5), but benzoate was significantly slower (p<O.05, 
one-way ANOVA; f1 = 15.94, f2 = 43.23). This was the opposite rank order to their 
solution behaviour, in which salicylate was more potent in elevating SGTT. This 
might because salicylate with its -OH, although able to form stacking structure, 
also interacts with the hydrogen bonded structure of water and therefore better 
compete for polymer water of hydration. This would lead to slower gel layer 
formation. Benzoate however is able to solubilise HPMC by better molecular 
stacking, and without the extra competing effects. 
(a) (b) 
OH 0 ~ " " O O
·0 
·0 
O· O· 
0 OH 0" /0 
-'H 
Figure 4.7 The orientation of tartrate structure in (a) solution (b) solid. 
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Figure 4.8 The effect of hydroxyl group substituents on the release profile of 
HPMC matrices. 8mm, 250mg matrices contain 30%HPMC E4M, 10%caffeine anhydrous, 
60% organic salt. USP I , 100rpm, 37°C in water. Mean (n=3) ± 1S.0. 
Modified power law Linear 
Organic salts T50% T80% (Ford et al 1987) regression 
k n r2 k r 
Control 
No salt ( dextrose 66 178 9.5S 0.419 0.9992 1.32 0.9963 
used as a diluent) 
rbe. 1 2 r e . . s . ~ m ; : ~ ~Qt 
I n ~ d . [ Q Q . ' i 1 1 [ J . r : J l U l 1 . { ~ J J
Succinate diNa 12 23 7S.79(b) 0.062(b) 0.9034(b) 4.40 0.9926 
Malate diNa 13 27 64.46(b) 0.114 (b) 0.9292(b) 3.S3 0.9930 
Tartrate diNa 25 89 27.13 0.251 0.9985 2.84 0.9954 
-B e ~ ~ o - a t e - r : - i a a --- ----- -------69---- -- --i 70---- -- -7 ~ 5 6 6 ------ - O ~ 4 47S- ---- -- O : 9 ~ ) 8 9 9 ----i-iii -"" --6.-99"92""-
Salicylate Na 50 113 9.36 0.472 0.9977 0.95 0.9935 
Table 4.10 The effect of the presence of hydroxyl group(s) within the organic salts 
on drug release kinetics using the modified power law and linear regression. 
Modified power law is fitted up to 80% cumulative release, but the fast release matrices were 
calculated up to 99% cumulative release. Linear regression is fitted for the early release. 8mm, 
250mg matrices contain 30%HPMC E4M, 10% caffeine anhydrous, 60% organic salt. T50% and Tao% 
are the time to 50% and 80% cumulative drug release respectively. k is the kinetic constant. n is 
the diffusional exponent. r2 is determination coefficient. 
(a) Drug release >80% within 30 min. 
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(e) The effect of the number of carboxylic groups 
Release profiles for HPMC matrices containing acetate Na (1 COO-) and oxalate 
diNa (2 COO-) were shown in figure 4.8. Both of them markedly accelerated the 
drug release profile compared with the control matrix (no salt), and their release 
profiles were almost superimposable and equivalent (fl= 5.43, f2= 67.44). Matrices 
containing both compounds lost their extended release characteristics and 
released over 80% of drug within 15 min, with the same release rate constant (k) 
(Table 4.11). 
In HPMC solutions the divalent oxalate diNa was far more potent than the 
monovalent acetate Na in reducing the SGTT of HPMC (Chapter 3). Their release 
profiles were so similar in this case because of their effects were so extreme that 
they could not be differentiated. Both were present in high amounts in the matrix. 
The effect of lower salt contents was investigated and will be discussed in section 
4.5.3.3. 
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Figure 4.9 The effect of the number of carboxyl groups on the release profile of 
HPMC matrices. 8mm, 2S0mg matrices contain 30%HPMC E4M, 10%caffeine anhydrous, 
60% organic salt. USP I , 100rpm, 37°C in water. Mean (n=3) ± 15.0. 
Modified power law Linear regression 
Organic salts Tso% Tso% (Ford et al 1987) 
k n r2 k r 
Control 
No salt ( dextrose 66 178 9.58 0.419 0.9992 1.32 0.9963 
used as a diluent) 
r h ~ ~ a u . m l 2 ~ r Q , [ [
c.a.rhQ8.!d.ic. o . [ Q u 1 2 ~ ~
Acetate Na 8 13 96.84(0) 0.005(0) 0.9378(3) 6.19 0.9999 
Oxalate diNa 7 12 92.77(3) 0.017(0) 0.9630(0) 6.25 0.9930 
Table 4.11 The effect of the number of carboxyl groups on drug release kinetics 
using the modified power law and linear regression. Modified power law is fitted up to 
80% cumulative release, but the fast release matrices were calculated up to 99% cumulative 
release. Linear regression is fitted for the early release. 8mm, 2S0mg matrices contain 30%HPMC 
E4M, 10%caffeine anhydrous, 60% organic salt. Tso% and Tso% are the time to 50% and 80% 
cumulative drug release respectively. k is the kinetic constant n is the diffusional exponent. r2 is 
determination coefficient. (a) Drug release >80% within 15 min. 
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4.5.3 The influence of diluents on the effect of organic salts on drug release 
In the previous section, the effects of high amounts (60%w/w) of incorporated 
organic salts on HPMC matrix release were investigated. This high content is an 
extreme case and allowed us to see the worst effects which in lower amounts may 
be innocuous. However, some salts showed such potent effects that they induced 
burst release of up to 80% within 15 minutes. In these cases, it was almost 
impossible to differentiate them. The effect of the lower amount of salts will need 
to be investigated, but this means that appropriate diluents will need to be added 
in the matrix formulation. 
In this section, the suitability of different diluents was investigated through their 
effect on matrix drug release in the presence of a potent salt. The selected diluents 
were then used in formulations to investigate the effect of salts, in matrices 
containing a low salt content (10%w/w). 
4.5.3.1 The effect of diluents on drug release from HPMC matrices 
Dextrose (as a fully soluble diluent), microcrystalline cellulose (MCC, an insoluble 
diluent), or partially pregelatinised starch (Starch 1500®, as an intermediate 
solubility diluent) were investigated alone or in combination, to find the most 
suitable diluents for this study. The composition of these matrices is shown in 
Table 4.2. 
Compression pressure - hardness profiles of HPMC matrix tablets containing these 
are shown in Figure 4.10 and drug release data and kinetics in Table 4.12. 
The effect of these diluents on the release profiles of the matrices were also 
investigated with different types of HPMC, (HPMC E4M, HPMC E4M ( 6 3 - 9 0 ~ ~
fraction) and HPMC K4M). Matrices containing fractionated HPMC E4M with MCC 
and its mixture with dextrose were exceptional as their exponent (n) was <0.4 and 
they showed the potential for burst release. The diffusional exponent (n) of all 
other formulations was -0.5 suggesting a normal diffusion-controlled release 
mechanism. The effect of each diluent on the HPMC matrix is discussed separately: 
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Partially pregelatinised starch (Starch 15001: 
Figure 4.11 shows the effect of partially pregelatinised starch on the drug release 
profiles of HPMC matrices. Partially pregelatinised starch caused a markedly 
lower release rate (k) compared with the other diluents (Table 4.12, Formulation 
0). All matrices containing partially pregelatinised starch showed good extended 
release characteristics and release profiles were statistically equivalent (f1 = 4.47, 
f2 = 75.50 for E4M and K4M; f1 = 2.96, f2 = 80.62 for E4M and fractionated E4M). 
Faster profiles were obtained by adding dextrose 50:50. The release profiles of 
matrices containing these mixtures (Formulation E) were eqUivalent (f1 = 7.51, f2 = 
61.09 for E4M and K4M; f1 = 11.33, f2 = 52.58 for E4M and fractionated E4M). The 
lack of differences between different formulations might be because of the 
synergistic effects between partially pregelatinised starch and HPMC. Both 
polymers hydrate, swell, and contribute to the gel layer barrier leading overall to a 
more concentrated gel and therefore more delayed water penetration (Michailova 
et al 2001; Levina & Rajabi-Siahboomi 2004). Although the matrices containing 
partially pregelatinised starch exhibited the longest extended release compared 
with dextrose and MCC, tablet hardness values were low (Figure 4.10). 
MjcrocQ'stalline cellulose (Mec): 
Figure 4.12 shows the effect of MCC on the drug release profiles. MCC exhibited 
widely different effects between HPMC types from delayed release (for K4M) to 
fast release (for fractionated E4M). Release profiles for all matrices containing 
MCC (Formulation F) were significantly different (p<0.05, one-way ANOYA; f1 = 
33.34, f2 = 24.45 for E4M and K4M; f1 = 53.19, f2 = 13.22 for E4M and fractionated 
E4M). The mixture of MCC and dextrose (Formulation G) lessened this effect but 
their release profiles were still different (fl = 26.42, f2 = 25.45 for E4M and K4M; f1 
= 20.67, f2 = 38.67 for E4M and fractionated E4M). Table 4.12 shows the rank 
order of the release rate constant (k) and the time to 80% cumulative drug release 
(Tso%) were as follows: 
Fractionated E4M > E4M > K4M 
Release rate 
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Fractionated E4M < E4M < K4M 
Tao% 
This rank order corresponds to the likely hydration of the polymer in which HPMC 
K4M is the most rapidly hydrated. The argument is that faster hydrating 
derivatives will form gels more quickly and prevent rapid initial dissolution of 
surface particles (Doelker 1987), however this has been disputed (Li et al 2005). 
In this case, the most hydrophilic grade is HPMC K4M. Fractionated HPMC E4M 
(63-90llm) in which the hydration rate is even slower than E4M (which containing 
particle sizes < 631lm) exhibited the burst release of the tablet. This might because 
of the ability of MCC to alter the water penetration into the matrix system. Levina 
& Rajabi-Siahboomi (2004) found that matrices containing MCC rapidly absorbed 
water into the tablets which these quick water uptake and water front movement 
into the matrix tablet can lead to a higher release rate. 
MCC, has some advantages: tablets were harder than with dextrose and partially 
pregelatinised starch (Figure 4.10) but the high variability of release profiles with 
respect to HPMC substitution and particle size differences, is a worrying 
disadvantage. 
Dextrose: 
Figure 4.13 shows the effect of Dextrose on drug release profiles of HPMC 
matrices. Release profiles for HPMC matrices of E4M and K4M were slightly 
different (f1 = 14.17, f2 = 43.52) whereas those of E4M and fractionated E4M were 
similar (f1 = 8.24, f2 = 54.51). The profiles were much less variable than MCC. The 
release rate constant (k) and the time to 80% cumulative drug release (Tao%) 
suggest a rate midway between partially pregelatinised starch and MCC (Table 
4.12, Formulation C). Dextrose is a soluble diluent which may act as a pore former 
to make the gel structure more porous and weaker, leading to an increased drug 
release rate (Li 2005, Yang & Fassihi 1997). With dextrose, matrix tablets were 
harder than those with partially pregelatinised starch but softer than those with 
MCC, and the drug release rate was not unduly sensitive to HPMC type. 
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HPMCE4M HPMC E4M fractionated HPMCK4M 
Formulation 
Tao% k n r2 TaO% k n r2 Tao% k n r2 
C 206 6.65 0.477 0.9982 178 9.58 0.419 0.9992 265 3.88 0.552 0.9973 (dextrose) 
D 
(partially pregelatinised 465 4.16 0.487 0.9976 470 3.83 0.497 0.9994 480 3.38 0.520 0.9996 
starch) 
H 
(Dextrose+ partially 313 4.74 0.498 0.9982 270 7.26 0.434 0.9994 331 2.93 0.581 0.9953 
pregelatinised starch) 
F 
230 11.61 0.366 0.9989 40 30.33 0.305 1.0000 434 3.42 0.523 0.9990 
(NeC) 
G 
134 12.24 0.401 0.9985 90 23.63 0.281 0.9996 278 4.88 0.504 0.9986 
(Dextrose+ NeC) 
Table 4.12 The effect of diluents on drug release kinetics using the modified power law. Fitted up to 80% cumulative release. Modified power 
law is described by Ford et al (1987). The detail of formulation C, D, H, F and G is in section 4.4.3 table 4.2. T 80% is the time to 80% drug release. k is 
the kinetic constant. n is the diffusional exponent r2 is coefficient of determination. 
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Figure 4.10 Compression pressure - hardness profile for "PMC matrix tablets 
containing different diIuents. Smm, 250mg matrices contain 300/0HPMC, 100/0caffeine 
anhydrous, qs diluents. 
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Figure 4.11 The effect of partially pregelatinised starch (Starch1500) on the 
dissolution profile of "PMC matrices (E4M, E4M (63-90J.l.m fraction), and K4M). 
Smm, 250mg matrices contain 300/0HPMC, 100/0caffeine anhydrous, qs diluents. USP I , 
100rpm, 37°C in water. Mean (n=3) ± lS.0. 
167 
cu 
c 
.; 
:t 
IV 
u 
.... 
0 
cu 
VI 
IV 
cu 
'ii 
... 
"I-
100 
80 
60 
40 
_60% MCC + HPMC E4M 
-0-60% MCC + HPMC E4M (fractionated) 
20 
-60% MCC + HPMC K4M 
_ 30% Dextrose+ 30% MCC + HPMC E4M 
-0-30% Dextrose+ 30% MCC + HPMC E4M (fractionated) 
- 30% Dextrose+ 30% MCC + HPMC K4M o l l - - - - ~ ~ = = = = = = = = ~ = = = = = = ~ = = = = = = ~ ~
o 200 400 
Time (min) 
600 800 
Chapter 4 
Figure 4.12 The effect ofMCC on the dissolution profile ofHPMC matrices (E4M, E4M 
( 6 3 - 9 0 ~ m m fraction), and K4M). 8mm, 2S0mg matrices contain 300/0HPMC, 100/0caffeine 
anhydrous, qs diluents. USP I , 100rpm, 37°C in water. Mean (n=3) ± lS.D. 
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Figure 4.13 The effect of Dextrose on the dissolution profile of HPMC matrices (E4M, 
E4M ( 6 3 - 9 0 ~ m m fraction), and K4M). 8mm, 2S0mg matrices contain 300/0HPMC, 
10%caffeine anhydrous, qs diluents. USP I , 100rpm, 37°C in water. Mean (n=3) ± lS.D. 
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4.5.3.2 The effect of diluents on drug release from HPMC matrices containing 
disodium succinate 
The studies above were repeated with 10%w/w succinate diNa, a potent organic 
salt, included in the formulation H, I, J, K and L (Table 4.3a) and their controls, 
formulation CH, CI, CI, CK and C[" were shown in Table 4.3(b). The release data and 
kinetics are shown in Table 4.13. The diffusional exponent (n) of most 
formulations was -0.5 suggesting a diffusion-control release mechanism. Drug 
release was rapid in the same formulations as reported above (Section 4.5.3.1) and 
additionally, in succinate matrices containing fractionated HPMC E4M and 
dextrose. Dextrose was chosen in these studies as it has been shown to have the 
least influence on the SGTT of HPMC solutions, and on drug release profiles in 
comparison with other sugars such as lactose (Williams et al 2009). 
The effect of the each diluent in the presence of succinate diNa is discussed 
separately, and the graphs show a comparison between matrices containing 
100/0w/w succinate diNa, and control formulations containing 10% dextrose 
instead of the succinate. 
Partially pre.gelatjn;sed starch (Starch 1500); 
In the presence of succinate diNa (Formulation I and J), matrices with a diluent of 
partially pregelatinised starch exhibited extended release and the release profiles 
were not different from control (Formulation C, and Cd in all types of HPMC 
(Figure 4.14; f1 & f2 were shown in the figure). This suggests that the synergistic 
effect between HPMC and partially pregelatinised starch was still effective in 
maintaining the controlled release performance of these matrices 
M;CCQCCJlstaWne cellulose (MCC); 
Figure 4.15 shows the effect of succinate diNa on on the drug release profiles of 
MCC HPMC matrices. Release profiles for succinate-containing matrices were 
significantly different from control (f1 & f2 values are shown in the figure) and 
release rates were widely different among HPMC types, and were either higher or 
lower than the controls. A mixture of MCC and dextrose (Formulation L) lessened 
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the difference between matrices with and without succinate. Replacing MCC by 
dextrose or succinate diNa replaces 10% MCC with a more soluble diluents which 
may also osmotically attract water into the system, leading to more rapid 
hydration of HPMC. This may be the reason why the release rate of matrices with 
succinate diNa was slower than the control for HPMC E4M. On the other hand, the 
release rate of HPMC K4M matrices with succinate diNa was higher than control. 
This might because succinate diNa competed for the available water, leading to the 
slower gel formation than control. 
Dextrose: 
Figure 4.16 shows the effect of succinate diNa on drug release profiles of HPMC 
matrices containing dextrose as a diluent. In the presence of succinate diNa, the 
release profiles for E4M and K4M matrix were equivalent to control whereas those 
for fractionated E4M were significantly higher than control (f1 & f2 values are 
shown in the figure). Matrices of fractionated HPMC E4M, succinate diNa appear 
to be more sensitive that others (see previous section) and succinate diNa which is 
kosmotropic salt in a Hofmeister series, was perhaps potent enough to compete 
for the available water suppress polymer hydration and gel layer formation. The 
more tolerant polymer grades E4M and K4M produced gel layers and extended 
release. 
Figure 4.17 and 4.18 replots the previous graphs to compare the different diluents 
and polymer grades directly, both with and without the succinate salt. Without 
salt, there was no difference between matrices of HPMC E4M and fractionated E4M 
when using dextrose or partially pregelatinised starch as a dileunt. Using an MCC 
diluent matrices were different, as discussed in section 4.5.3.1. With succinate salt, 
the differences were seen using dextrose (f1=97.45, f2=6.11), MCC (f1=18.81, 
f2=42.71) and partially pregelatinised starch (f1=23.21, f2=38.40). Dextrose was 
the most sensitive diluent. 
In conclusion, partially pregelatinised starch appeared to mask the differences of 
HPMC particle size and substitution and 10% of this organic salt. This may be 
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advantageous to a formulator, but is a disadvantage in this study, as it may not 
allow us to differentiate the effects of different organic salts. MCC is also not 
appropriate, as its influence on HPMC matrices is highly variable. Moreover, this 
insoluble diluent may have a direct influence on HPMC gel formation by itself and 
so the obtained results might be the combination of both MCC and salts. Dextrose 
appears to be the most suitable diluent to be used in this study because it 
exhibited small differences among HPMC types, but the effect of salt can be 
differentiated form the control. These all results suggest that using dextrose with 
fractionated HPMC E4M is the most suitable to differentiate the effects of organic 
salts used in this study. 
~ : : Although Ford et al (1985a, b) stated that the compression pressure rarely 
influences drug release from HPMC matrices, Levina & Rajabi-Siahboomi (2004) 
found that the applied compression force affected drug release rate depended on 
the type of diluent. In this study, the effect of compression force on drug release 
from HPMC using dextrose as a diluent was investigated. The results are shown in 
Appendix 4 and suggested that the different compression force do not influence 
drug release. The compression pressure at 160MPa was used in the study of the 
effect of organic salts on HPMC matrices because it was within the linear range of 
compression pressure-hardness profile for all organic salts used in this study (data 
not be shown). 
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HPMCE4M HPMC E4M fractionated HPMCK4M 
Formulation 
Tao'll> k n r2 Tao'll> K n r2 Tao'll> k n r2 
H 225 5.91 0.487 0.9993 18 68.16 0.083 0.9982 251 3.30 0.588 0.9991 (dextrose) 
I 
(partially 385 4.38 0.493 0.9995 476 1.34 0.675 0.9593 440 2.81 0.555 0.9982 
pregelatinised starch) 
J 
(Dextrose+ partially 285 4.47 0.518 0.9988 259 6.66 0.453 0.9998 315 3.40 0.559 0.9979 
pregelatinised starch) 
K 
160 11.53 0.396 0.9988 115 19.83 0.304 0.9989 316 4.41 0.508 0.9986 
(MCC) 
L 
233 5.37 0.505 0.9982 60 40.08 0.182 0.9993 267 3.35 0.578 0.9976 
(Dextrose+ MCC) 
Table 4.13 The effect of diluents on drug release kinetics of HPMC matrices containing disodium succinate using the modified power law. 
Fitted up to 80% cumulative release. Modified power law is described by Ford et al (1987). The detail of formulation H, I, J, K and L and their controls 
is in section 4.4.3 table 4.3. Tao'll> is the time to 80% drug release. k is the kinetic constant n is the diffusional exponent r2 is coefficient of 
determination. 
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Figure 4.14 The effect of partially pregelatinised starch (Starch1500) on the 
dissolution profile of HPMC matrices containing disodium succinate which (a) E4M 
(b) E4M (63-90J1m fraction) and (c) K4M. 8mm, 250mg matrices contain 30%HPMC, 
10%caffeine anhydrous, 10% succinate diNa qs diluents. The detail of these formulations 
is section 4.4.3 table 4.3. USP I , 100rpm, 37°C in water. Mean (n=3) + lS.D. 
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Figure 4.15 The effect of MCC on the dissolution profile of HPMC matrices 
containing disodium succinate which (a) E4M (b) E4M (63-90J,lm fraction) and (c) 
K4M. 8mm, 250mg matrices contain 30%HPMC, 10%caffeine anhydrous, 10% succinate 
diNa qs diluents. The detail of these formulations is section 4.4.3 table 4.3. USP I , 100rpm, 
37°C in water. Mean (n=3) ± 15.0. 
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Figure 4.16 The effect of Dextrose on the dissolution profile of "PMC matrices 
containing disodium succinate which (a) E4M (b) E4M (63-90Jlm fraction) and (c) 
K4M. 8mm, 250mg matrices contain 30%HPMC, 10%caffeine anhydrous, 10% succinate 
diNa qs diluents. The detail of these formulations is section 4.4.3 table 4.3. USP I , 100rpm, 
37°C in water. Mean (n=3) ± 1S.0. 
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Figure 4.17 The difference of using native and sieved fraction HPMC E4M on the 
drug release profile of HPMC matrices. 8mm, 250mg matrices contain 30%HPMC E4M, 
10%caffeine anhydrous, 60% diluents. USP [ , 100rpm, 37°C in water. Mean (n=3) ± lS.D. 
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Figure 4.18 The difference of using native and sieved fraction HPMC E4M on the 
drug release profile of HPMC matrices containing disodium succinate. 8mm, 250mg 
matrices contain 30%HPMC E4M, 10%caffeine anhydrous, 10%succinate diNa, qs 
diluents. USP I, 100rpm, 37°C in water. Mean (n=3) ± lS.D. 
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4.5.3.3 The effect of 10% organic salt on drug release from HPMC matrices 
containing diluents 
In section 4.5.2, the highest amount of organic salts (60%w/w) was used in the 
matrix to elicit the maximum possible effect. However, at this level it was almost 
impossible to differentiate the more potent salts. Therefore in this section, the 
effect of a lower content of organic salt (10%w/w) was investigated in matrices 
containing HPMC E4M (63-90IJ.ll1 fraction) with dextrose were the 
polymer/diluent selection from the previous section. 
Table 4.14 shows the time to 80% cumulative drug release (Tao%) and the 
parameters from fitting the modified power law (Ford 1987). Matrices containing 
10%w /w salts exhibited the same overall trends as those containing 60%w /w 
salts but showed less extreme changes in their drug release profiles. For example, 
salts with lower potencies, such as the monovalent and hydroxylated salts, showed 
less burst release in their accelerated profiles. 
Organic salts which maintained the controlled release characteristics of HPMC 
matrices were pentanoate Na, caproate Na, octanoate Na and besilate Na. Their 
release profiles showed a good fit with the modified power law model up to 80% 
cumulative release (r2>0.99), and the exponent (n) was close to 0.5, suggesting a 
diffusion-controlled release mechanism. Release rates (k) for matrices containing 
10%w/w pentanoate Na were similar to control matrices, whereas those 
containing caproate Na, octanoate Na and besilate Na were slower than control 
(but faster than matrices containing 60%w /w salts). Matrices containing 
benzoate Na, salicylate Na, acetate Ha, propionate Na. fumarate NaH, malate diNa 
and tartrate diNa still exhibited controlled release behaviour, but with accelerated 
drug release rates (k) were higher than control and low exponent values (n= 
0.166-0.395). 
Matrices containing 10% fumarate diNa, maleate diNa, mesilate Na, succinate diNa 
and oxalate diNa lost their extended release properties and exhibited a tendency 
to release drug immediately although less rapidly than those containing 60% salt. 
If fitted to the modified power law they had very high release rate constants 
(k>46) and low diffusional exponents (n <0.15). 
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Organic salts Too'll> k n r2 
!JJJttCDl. 
No salt (dextrose used as a diluent) 178 9.58 0.419 0.9992 
HomoIqgQUS series 
Acetate Na 76 36.46 0.190 0.9991 
Propionate Na lOS 27.99 0.234 0.9996 
Pentanoate Na 173 9.58 0.422 0.9990 
Caproate Na 179 8.66 0.454 0.9995 
Octanoate Na 184 8.38 0.449 0.9994 
Geometric isomerism 
Fumarate diNa 54 46.73(b) 0.147(b) 0.9987(b) 
Maleate diNa 54 49.2t(b) 0.134(b) 0.9975(b) 
Ionisation 
Fumarate Na H 60 39.43 0.185 0.9991 
Fumarate diNa 54 46.73(b) 0.147(b) 0.9987(b) 
Functionql groUps 
Acetate Na 76 36.46 0.190 0.9991 
Mesilate Na 44 48.48(b) 0.149(b) 0.9999(b) 
Benzoate Na 119 12.92 0.394 0.9988 
Besilate Na 180 7.92 0.458 0.9979 
r b ~ ~ /2D:mJg: a.fb.Il.dc.fJ¥.ll.l QCou/2(.d 
Succinate diNa 18 68.83(1) 0.086(0) 0.9998(a) 
Malate diNa 61 42.25 0.166 0.9980 
Tartrate diNa 91 34.75 0.192 0.9978 
Benzoate Na 119 12.92 0.394 0.9988 
Salicylate Na 128 12.55 0.395 0.9989 
r b . ~ ~ l J u . m b ~ c cQ,[CQcI2D11d.i, g C o L l I l ~ ~
Acetate Na 76 36.46 0.190 0.9991 
Oxalate diNa 39 57.19(b) 0.108(b) 0.9983(b) 
Table 4.14 The effect of 10% organic salts on drug release kinetics In the presence of 
dlluents usl ... the modified power law. Modified power law is described by Ford et al (1987) 
and was fitted up to 80% cumulative release. 8mm, 250mg matrices, 160MPa containing 
30%HPMC E4M (63-90Ilm fraction), 10%caffeine anhydrous, 10% organic salt, qs dextrose. Too%is 
the time to 80% cumulative drug release. k is the kinetic constant n is the diffusional exponent r2 
is determination coefficient (a) Drug release >80% within 30 min. (b) Drug release >80% within 
Ih. These fast release matrices were calculated up to 99% cumulative release. 
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The effect of the C-chain len&th of or.oic salts 00 drull release from HPMC 
matrices (bomolollous series) 
Table 4.14 shows that release rate (k) and time to 80% cumulative drug release 
(Tao%) values for matrices containing 10%w/w aliphatic organic salts, were in a 
rank order of (-chain length, as previously seen in matrices containing 60% salts 
(Section 4.5.2.1). However, only acetate (f1=52.03, f2=22.19) and propionate 
(f1=40.13, f2=27.93) significantly accelerated drug release compared with the 
control (Figure 4.19). This suggests that acetate and propionate might cause more 
osmotically driven water penetration of the matrix because osmotic pressure 
depends on the number of molecules available. The low molecular weight salts 
contain more molecules in 10% w/w than higher molecular weight salts (caproate 
and octanoate). Moreover, caproate and octanoate which are low potency 
surfactants require high amount to exhibit micellar solubilisation so that 10% may 
be not high enough. However, matrices containing 10%w/w octanoate sodium 
still formed gel layer within 10 minutes as shown in Figure 4.20(a) and (b). 
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Figure 4.19 The effect of C-chain length of 10% w/w organic salts on the drug 
release profile of HPMC matrices. 8mm, 2S0mg matrices contain 30%HPMC E4M (63-
90llm fraction), 10%caffeine anhydrous, 10% organic salt, qs dextrose. USP I , 100rpm, 
37°C in water. Mean (n=3) ± 1S.0. 
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Figure 4.20(a) Microscopic photographs of HPMC matrix tablets containing 10% 
sodium octanoate taken from USP dissolution baskets at different times during the 
dissolution test Matrices hydrated in deionised water. 
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Figure 4.20(b) The photograph of HPMC matrix tablets containing 10% sodium 
octanoate taken from USP dissolution baskets at different times during the 
dissolution test Matrices hydrated in deionised water. 
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The effect of the structure relationship of orpnic salts on dme release 
(a) The effect of counter-ion geometric isomerism 
Figure 4.21 compares release profiles of matrices containing 10%w/w fumarate 
and 10%w/w maleate with the control (no salt). Both fumarate (f1=87.51, 
f2=16.60) and maleate (f1=61.70, f2=18.25) markedly accelerated drug release 
from HPMC matrices, and release profiles for matrices containing them were 
similar (f1=0.84, f2=91.38). This suggests that even at 10% content, both salts still 
show kosmotropic properties. 1 O%w /w fumarate was less potent to than 
60%w/w fumarate if the release profiles are compared (f1=41.84, f2=32.63) 
whereas 10% and 60% maleate exhibited similar release profiles (f1=1.35, 
f2=84.84) as shown in Figure 4.3 and 4.21. 
(b) The effect of counter-ion ionisation 
In matrices containing 10%w/w salt, the degree of fumarate ionisation had little 
effect on the salt ability to accelerate drug release (Figure 4.22) (f1 =4.35, f2=64.72). 
Both fumarate diNa and fumarate NaH markedly accelerated drug release (Figure 
4.22 and 4.4). However, in both cases, 10%w/w salt loading caused less 
acceleration of drug release than 600/0w/w (f1=41.84, f2=32.63 for fumarate diNa; 
f1=34.43, f2=29.55 for fumarate NaH). 
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Figure 4.21 The effect offumarate/maleate geometric isomerism (10%w/w) on the 
drug release profile of HPMC matrices. 8mm, 250mg matrices containing 30%HPMC 
E4M ( 6 3 - 9 0 ~ m m fraction), 10%caffeine anhydrous, 10% organic salt, qs dextrose. USP I , 
100rpm, 37°C in water. Mean (n=3) ± lS.D. 
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Figure 4.22 The effect of ionisation of fumarate salts (10%w /w) on the drug release 
profile of HPMC matrices. 8mm, 250mg matrices containing 30%HPMC E4M ( 6 3 - 9 0 ~ m m
fraction), 10%caffeine anhydrous, 10% organic salt, qs dextrose. USP I , 100rpm, 37°C in 
water. Mean (n=3) ± 1S.D. 
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(c) The effect of counter-ion functional groups: a comparison between 
carboxylic and sulfonic acid sodium salts 
10%w/w acetate Na and 10%w/w mesilate Na both accelerated drug release 
compared with control (Figure 4.23) but surprisingly the release profiles for 
HPMC matrices containing acetate were now significantly slower than those 
containing mesilate (f1=14.83, f2=43.85). This was different from their solution 
effects (SGTT values were similar (Chapter 3), and opposite to the effect of these 
salts at 60%w/w (section 4.5.2.2). This result is difficult to explain, and suggests 
osmotic transport into the matrix core may have greater influence at low salt 
contents. 
10%w/w aromatic organic salts, however, showed similar effects to 60%w/w. 
Benzoate accelerated drug release whilst besilate retarded drug release with 
respect to the control (Figure 4.23). Besilate matrices were significantly slower 
than benzoate (f1=25.14, f2=39.33) which correlates with their effect in elevating 
SGTT (Chapter 3) .10%w/w benzoate may be less effective in solubilising HPMC 
through 7I'-stacking aggregation. 
Figure 4.24 compares directly the release profiles for matrices containing 
10%w/w and 60%w/w salts. For the carboxylate salts (acetate and benzoate), 
10%w/w was less potent in altering drug release than 600/0w/w (f1=80.82, 
f2=22.66 for acetate; f1=18.46, f2=41.12 for benzoate). In the case of sulfonate salts 
(mesilate and besitate) 10%w/w and 60%w/w exhibited similar release profiles 
(f1=6.35, f2=51.07 for mesilate; f1=10.30, f2=52.76 for besilate). Hence the amount 
of salt in the matrix had an impact on matrix release for the carboxylic acid salts 
but not for their corresponding sulfonic acid counterparts. Moreover, sulfonate 
salts only at 1 O%w /w may reach the maximum effect so that there was no 
difference between 10% and 60% salts. 
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Figure 4.23 A comparison of carboxylate and sulfonate organic salts (10%wjw) on 
the drug release profile of HPMC matrices. 8mm, 250mg matrices containing 
30%HPMC E4M (63-90Ilm fraction), 10%caffeine anhydrous, 10% organic salt, qs 
dextrose. USP I , 100rpm, 37°C in water. Mean (n=3) ± lS.0. 
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Figure 4.24 A comparison of 10%w jw and 60%w jw carboxylate and sulfonate 
organic salts on the drug release profile of HPMC matrices. 8mm, 250mg matrices 
containing 30%HPMC E4M (63-90Ilm fraction), 10%caffeine anhydrous, 10% organic salt, 
qs dextrose. USP I , 100rpm, 37°C in water. Mean (n=3) ± lS.0. 
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(d) The effect of hydroxyl group substituents 
The aliphatic organic salts, succinate (no -OH), malate (1-0H) and tartrate (2-0H) 
all accelerated drug release compared with the control (no salt) (Figure 4.25). 
This may be ascribed to their kosmotropic action in the Hofmeister series of ions. 
The release rate (k) and the time to 80% cumulative drug release (Tao%) values in 
Table 4.14 suggest that their potency in accelerating drug release HPMC matrices 
was: 
Succinate (no -OH) > Malate (1-0H) = Tartrate (2-0H) 
This rank order is almost the same as that of 60%w jw salts. Matrices containing 
10%w jw malate were significantly slower than those containing 60%w jw malate 
(f1=23.19, f2=37.36). Matrices containing malate were dissimilar from succinate 
(f1=23.42, f2=34.79), but were equivalent to tartrate (f1=8.99, f2=51.33). This 
might arise because succinate and tartrate may have already reached their 
maximum effect at 10%wjw, whereas the effect of malate was affected by the 
amount of salts which the higher amount of malate attracted more water into the 
matrix core by osmotic difference. The effect of hydroxyl group substituents was 
discussed in Section 4.5.2.2 (d). 
In the case of aromatic salts, release profiles for matrices containing 10%w jw 
benzoate and 10%wjw salicylate were similar (f1=2.21, f2=83.95), and their 
release rate (k) was higher than control (Table 4.14). Surprisingly this was an 
opposite effect to that seen with high amount of salts (60%wjw) in which their 
release rate was lower than control (Table 4.10). This might arise because 
10%wjw of benzoate and salicylate may not enough to solubilise HPMC through 
ll-stacking aggregation so that these salts became drug release accelerators. 
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(e) The effect of the number of carboxylic groups 
Figure 4.26 shows release profiles for HPMC matrices containing 10%w/w acetate 
Na (1 COO-) and 10%w /w oxalate diNa (2 COO-). Both accelerated drug release 
compared with the control matrix, however, the effect of 10% salt was less potent 
than that of 60% salt (fl=80.82, f2=22.66 for acetate; fl=23.19, f2=37.26 for 
oxalate). Interestingly, when using low amount of salts, the effect of acetate and 
oxalate on HPMC matrices could be differentiated: drug release from oxalate 
matrices was statistically more quickly than acetate (fl=20.40, f2=35.52), and the 
release rate (k) of oxalate matrices was higher than acetate (Table 4.14). This 
corresponds to their effects on HPMC solutions in which the divalent oxalate diNa 
was shown to be far more potent than the monovalent acetate Na in reducing the 
SGTT of HPMC (Chapter 3). In matrices, the divalent oxalate will provide the more 
potent competitor for water, dehydrating the polymer hydration sheath, and 
inhibiting gel layer formation. 
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Figure 4.25 The effect of hydroxyl group substituents on the release profile of 
HPMC matrices (10%w jw salt). 8mm, 2S0mg matrices containing 30%HPMC E4M (63-
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Figure 4.26 The effect of the number of carboxyl groups on the release profile of 
HPMC matrices (10%w/w salt). 8mm, 2S0mg matrices containing 30%HPMC E4M (63-
90llm fraction) , 10%caffeine anhydrous, 10% organic salt, qs dextrose. USP I , 100rpm, 
37°C in water. Mean (n=3) ± 1S.D. 
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4.5.4 A correlation between the effects of organic salts on HPMC matrix 
drug release, and their effect on the thermogelation temperature (SGTT) 
ofHPMC solutions 
Graphs which correlate salt effects on sol:gel transition temperature (SGTT) of 
HPMC solutions, and the drug release performance of HPMC matrices is shown in 
Figure 4.27 and 4.28. Salt effects on SGTT are expressed ~ C P T , , the gradient of the 
CPT:concentration relationship for that particular salt (Chapter 3, Figure 3.4). 
Drug release performance is expressed as (i) L1T80, the difference between Tao% 
values for the salt-containing and the control matrix formulations and (ii) ~ k , , the 
difference in release rate constant between the salt and control matrix. The TaO% 
and k values from which have been derived are shown in Table 4.5 (for 60%w/w 
salt) and Table 4.14 (for 10%w/w salt). 
In the case of monovalent salts, L1T80 showed a significant linear correlation with 
L1CPT at 60%w/w salt (r=0.9440, p<0.01) and 10%w/w salt incorporation 
(r=0.8269, p<0.01) (Figure 4.27). The release rate difference ( ~ k ) ) also exhibited a 
significant linear correlation with ~ C P T T (r=0.9254, p<0.01 for 60%w/w salt and 
r=0.8885, p<0.01 for 10%w/w salt) (Figure 4.28). The homologous series of 
aliphatic organic salts also showed a good linear correlation between both L1T80 
and ~ C P T T (r=0.9884, p<0.01 for 60%w/w salt and r=O.9346, p<O.OS for 10%w/w 
salt) and between ~ k k and ~ C P T T (r=0.9288, p<0.05 for 60%w/w salt and r=0.9156, 
p<O.05 for 10%w/w salt). 
L1CPT reflects the ability of the anion to disrupt or enhance polymer hydration and 
is a function of ionisation and hydrophobicity, which oppositely affect the stability 
of the polymer hydration sheath (Richardson et al 2006). Drug release results 
suggest these anions may also have significant impact on the gel layer, in which 
water:polymer interactions play an important role. Pentanoate (C5) had the least 
effect on both HPMC solutions and matrices whereas the more hydrophobic salts 
(above C5) extended the retardation of drug release. Using the arguments 
presented in the Richardson paper (2006), these salts may associate with 
hydrophobically substituted regions of HPMC, inducing a higher water affinity in 
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the polymer molecule, enhancing swelling rates leading to rapid gel layer 
formation, and a more quickly established gel barrier, resulting in longer extended 
release. In contrast, the more hydrophilic salts (below C5), would reduce water 
affinity of the polymer by competing for water, leading to slower gel layer 
formation, more extensive medium penetration of the matrix, and therefore more 
accelerated release properties. 
Divalent anions (circled) were more potent in depressing SGrr than single valency 
anions, and all caused accelerated drug release, reflecting the similar effects of 
multivalent inorganic salts (Alderman 1984; Mitchell et a11991; Bajwa 2006; 
pygall et al 2009). 
This correlation suggests that organic salts incorporated in HPMC matrices have 
the potential to influence drug release, in a rank order that reflects their 
modulation ofthe HPMC polymer hydration sheath in solution. 
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Figure 4.27 Correlation between the effect of (a) 10%w jw (b) 60%w jw organic salts on 
the sol:gel transition temperature (SGTT) of HPMC solutions and on the time to 80% 
cumulative drug release (Too",,) of HPMC matrices. The effect on SGIT expressed as delta 
cloud point temperature (l1CPT, °CjM) which obtained from the gradient of CPT-salt 
concentration curve (Figure 3.4(a)). The effect on TBo% is expressed as l1T80 (min) obtained 
from the difference between Too'll. values for the salt-containing and the control matrix 
fomulations (Table 4.5 and 4.14). 
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Figure 4.28 Correlation between the effect of (a) 10%w/w (b) 60%w/w organic salts on 
the sol:gel transition temperature (SGTT) ofHPMC solutions and on the release rate (k) 
of HPMC matrices. The effect on SGTT expressed as delta cloud point temperature ( ~ C P T , ,
DCjM) which obtained from the gradient of CPT-salt concentration curve (Figure 3.4(a)). The 
effect on k is expressed as ~ k k obtained from the difference in release rate constant between 
the salt and control matrix (Table 4.5 and 4.14)' 
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4.6 Conclusions 
A homologous series of aliphatic organic salts influenced matrix properties in rank 
order of hydrocarbon chain length, in which pentanoate (C5) exhibited the least 
effect with respect to the control. The hydrophilic salts (C1-C4) accelerated drug 
release whereas the hydrophobic salts (C6-C8) retarded drug release. The 
structural relationships of the organic salts also influenced their apparent effect on 
drug release, as follows: 
(i) The effect of counter-ion ieometric isomerism 
The trans form (fumarate) had a greater ability than the cis form (maleate) to 
destroy the controlled release properties of HPMC matrices. This is probably 
because the trans form exhibits more potential to promote molecular aggregation 
of HPMC. At lower loadings of fumarate (10% w/w with a dextrose diluent) this 
salt was overall less potent in accelerating drug release, and there was no 
significant difference between trans and cis forms. 
(ii) The effect of counter-jon jonjsatjon 
The degree of ionisation had little effect on the potency of fumarate to accelerate 
drug release either with or without the diluent. 
(iii) A comparison between carboxyIic and sulfonjc acid sodjum salts 
Carboxylate salts (acetate and benzoate) were more potent than sulfonate salts 
(benzoate and besilate) in either accelerating or retarding drug release. At 
10%w/w with the dextrose diluent present, carboxylate salts were less potent 
Sulfonate salts exhibited no difference in their effects with or without the diluent. 
(iv) The effect of hydroxyl iroyP sybstjtyents 
Within the aliphatic series succinate (no OH), malate (1-0H), tartrate (2-0H), the 
salts with hydroxyl group substituents, were less potent in accelerating drug 
release. This was different from their effect on HPMC solutions, in which the 
greater number of hydroxyl groups, the more potent in depressing the SGTT. This 
192 
Chapter 4 
may be because of differences in their molecular orientation between solutions 
and solids. The effects of salts on the matrix were in the same rank order with or 
without a diluent. 
In the case of the aromatic salts. 10%w/w of benzoate and salicylate may not be 
enough to solubilise HPMC through n-stacking aggregation so that these salts 
became drug release accelerators. whereas at 60%w /w they retarded drug 
release. 
(v) The effect ofthe number of carboxylic (:roups 
Both acetate (1 COO·) and oxalate (2 COO·) accelerated drug release from HPMC 
matrices at 60 and 10%w/w. However. at the 10% loading oxalate was more 
potent in accelerating drug release. which corresponds with its greater effect on 
the SGTT of HPMC solutions. 
The effect of matrix diluent with respect to HPMC type and the effects of or(:anjc 
The diluents examined in this study were partially pregelatinised starch. MCC and 
dextrose. The latter was chosen as a soluble diluent with for minimal effect on 
HPMC solution SGTT. 
When different diluents were incorporated into matrices containing different 
HPMC grades a range of effects were observed. Partially pregelatinised starch 
masked the effect of a potent salt (succinate Na) in all types of HPMC whereas MCC 
exhibited variable effects among HPMC types. Dextrose with fractionated HPMC 
E4M was found to be the most suitable combination to differentiate the effect of 
organiC salts on drug release performance. With dextrose as a diluent. the effect of 
most organic salts was less potent either in accelerating or retarding drug release. 
This might because the higher amount of salts attracted more water into the 
matrix core by osmotic difference. 
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The effect of these organic salts on the drug release performance of HPMC 
matrices showed a significant linear correlation with their effect on the SGTT of 
HPMC solutions investigated in Chapter 3. Hence the effect of organic salts 
incorporated in HPMC matrices, reflects their modulation of the HPMC polymer 
hydration sheath. 
Monovalent salts containing 1 to 4 C-atoms and divalent salts lowered the SGTT of 
HPMC solutions, and accelerated matrix drug release (in comparison with a salt-
free dextrose control). These observations are consistent with Hofmeister effects 
in which hydrophilic anions restructure water in the polymer hydration sheath, 
induce 'salting out' and suppress particle swelling and matrix gel layer formation. 
Monovalent salts containing 5 to 8 C-atoms elevated SGTT and retarded matrix 
drug release. This suggests these salts enhance HPMC hydration possibly by 
interaction with polymer hydrophobic regions, by mechanisms such as micellar 
solubilisation and n-stacking aggregation as was described in previous studies of 
amino acids solution interactions with HPMC (Richardson et al 2006). It suggests 
that the ability of the charged ion to destabilise the polymer hydration sheath is 
opposed, with increasing chain length, by the ability of the hydrophobic chain to 
interact with and enhance polymer molecular hydration. The effects on matrix 
drug release also suggests that the presence of these ions impacts on 
water:polymer interactions which are important to the formation and diffusion 
barrier properties of the gel layer. 
These findings provide new insights when formulating HPMC matrix tablets from 
caffeine and organic salts and may provide guidance for other formulations in 
which drug is associated with organiC counterions. For example, high dose drugs 
with a strongly hydrophilic organic counter-ion should perhaps be avoided, 
whereas hydrophobic or amphipathic salts might be better candidates for 
incorporation into HPMC matrices, and may even improve their extended release 
properties. 
194 
Chapter 5 
The Effect of Alkyl Sulphate Surfactants on 
HPMC Solutions and HPMC Matrices 
5.1 Rationale 
In the previous studies of the effect of organic salts on HPMC (Chapter 3 and 4), 
aliphatic carboxylate salts containing over 6 C-atoms were found to raise the 
sol:gel transition temperature and to also prolong drug release from HPMC 
matrices. The length of the aliphatic chain was found to be important, but the 
study was limited by the poor solubility of the higher chain-length salts. This 
suggested a further study using alkyl sulphate surfactants which have higher 
solubility, and which are available in a range of chain lengths. A typical example is 
sodium dodecyl sulphate (SOS), an alkyl sulphate surfactant containing 12 C-atoms 
which is widely used in pharmaceutical formulations. This chapter investigates 
the effects of a homologous series of alkyl sulphate surfactants on HPMC solution 
and matrix behaviour. 
5.2 Introduction 
5.2.1 Alkyl Sulphate Surfactants 
Alkyl sulphate surfactants are fatty alcohol sulphates, with the general structure 
shown in Figure 5.1. Their surface-activity is dominated by their alkyl chain-
length and counter-ion. The homologous series most commonly investigated are 
the sodium salts of n-alkyl sulfuric acid mono esters with an even number of 
carbon atoms. Alkyl sulphates with 2-8 C-atoms show typical characteristics of 
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organic salts, and those with 10 or more C-atoms exhibit surface active behaviour 
(Stache 1996). However, this surface active behaviour is changed in the presence 
of substances with strong hydrophobicity (Schmalstieg & Wasow 2002). 
Figure 5.1 General structure of an alkyl sulphate surfactant. (R = alkyl chain) 
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5.2.2 Surfactants and Cellulose Ethers 
The interactions between cellulose ethers and surfactants, particularly sodium 
dodecyl sulphate (SOS) have been widely studied. SOS is known to form micelles 
in water by self-assembly at concentrations above its cmc (Powney & Addison 
1937; Kiraly & Oekany 2001), and addition of surfactants to a polymer solution 
may lead to adsorption of surfactant molecules on the polymer chain, and alter 
polymer solution properties. The interaction between surfactant and cellulose 
ethers is one of interest and there have been many attempts to clarify the 
interaction between them. In the early studies, SOS:EHEC (ethyl hydroxyethyl 
cellulose) mixture in aqueous solutions were widely investigated by a wide range 
of physicochemical methods including viscosity, equilibrium dialysis, steady-state 
fluorescence quenching, cloud point, conductometry, and H-NMR. In dilute 
polymer solution, an intramolecular clustering occurred with multiple mixing of 
the hydrophobic parts of the polymer in the same surfactant cluster. At higher 
polymer concentrations, surfactant clusters were shared intermolecularly, acting 
as 'tie points' in a 30 polymer network. Because of the adsorption of the negative-
charged moiety to EHEC, uncharged polymer, the low aggregation numbers will 
probably create a structure similar to a polyelectrolyte (Holmberg et al 1992; 
Evertsson et al 1996; Holmberg & Sundelof 1996; Holmberg et al 1997; Evertsson 
& Nilsson 1998; Evertsson et a11998, Singh & Nilsson 1999). 
Interactions with other surfactants have been studied, for example, the dynamic 
surface tension of sodium deoxycholate and HPMC in aqueous solution exhibited 
cluster formation above CAC (Avranas & Tasopoulos 2000). The influence of 
counterions on the interaction between dodecyl sulfates (KOS, NaOS, LiDS) and 
cellulose ethers (HPMC, EHEC) has been investigated by Ridell et al (2002) who 
found that when Li+ is the counterion to dodecyl sulphate, polymer-surfactant 
aggregates are less rigid, less densely packed and are formed at higher 
concentrations than with Na+ and K+. The interaction between SOS and other 
nonionic cellulose derivatives such as hydroxyethyl cellulose (HEC), 
hydroxypropyl cellulose (HPC), and methyl cellulose (MC) has been studied 
(Wittgren et al 2005; Bosco et al 2006; Wang et al 2006). Whilst the interaction 
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between SOS and other anionic surfactants with HPMC have widely investigated 
by a wide range of techniques including viscometry. equilibrium dialysis. dye 
solubilsation. fluorescence. conductivity. tensiometry and cloud point. The studies 
all suggest that there is SOS:HPMC aggregation above the CAC. The solubilisation 
capacity of SOS:HPMC system is less than found for SOS:EHEC systems. and the 
average adsorption capacity of SOS on HPMC is found to be the order of one 
adsorbed amphiphile molecule per monomer unit (Hammarstrom & Sundelof 
1993; Nilsson 1995; Persson et a11996; Kulicke et a11998; Avranas & Iliou 2003; 
Sovilj & Petrovic 2005; Sovilj & Petrovic 2006). A HPMC/NaCMC/SOS system was 
investigated by Sovilj and Petrovic (2007) and it found that SOS increased the 
synergistic effect between two polymers. 
The effect of surfactants on drug release from HPMC matrix tablets has also been 
studied. Oaly et al (1984) found that anionic surfactants were able to retard the 
release rate of chlorpheniramine maleate from HPMC matrices. while non-ionic 
and cationic surfactants showed no change in the release rate. Nokhodchi et al 
(1999; 2002) found that the theophylline release rate from HPMC matrices was 
accelerated by incorporated SOS whilst release of propanolol HCI from HPMC 
matrices decreased as the concentration of SOS was increased. which they 
suggested, was because SOS can form a complex with propanolol. 
Cao et al (2005) found that acetaminophen release characteristics from a HPMC 
matrix tablet were critically controlled by the types and amounts of excipients 
such as surfactants, disintegrants and solubilisers incorporated. SOS can also be 
used in the dissolution medium for HPMC matrix tablets (Maggi et al 1996). Zeng 
et al (2009) found that increased SOS concentration in the dissolution medium, 
accelerated the nimodipine release rate from a HPMC matrix, because of both the 
increased solubility of nimodipine, and the increasing rate of gel erosion by SOS. 
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5.3 Chapter Alms and Objectives 
In this chapter, the effect of SDS and its homologues on HPMC solution and matrix 
properties are investigated with respect to surfactant chain length. The solution 
studies aimed to clarify the mechanism of interaction between these alkyl sulphate 
surfactants and HPMC, and the matrix studies explored the influence of these 
surfactants on the drug release in HPMC matrices incorporating different tablet 
diluents. 
In particular, the experimental work in this chapter, investigates the effect of alkyl 
sulphate surfactants on: 
• The sol:gel transition temperature (SGTT), surface tension and viscoelastic 
properties of HPMC solutions. 
• The extended release performance of HPMC matrices. 
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5.4 Materials and Methods 
5.4.1 Surfactants 
In chapter 3, organic carboxylate salts with over 6 C-atoms were found to prolong 
drug release from HPMC matrices, but the study was limited by the poor solubility 
of the longer chain organic salts. Sodium hexyl sulphate (SHS). sodium octyl 
sulphate (SOS), sodium decyl sulpahte (SOeS), and sodium dodecyl sulphate (SOS) 
were selected for use in this chapter as they have higher solubility and are 
available on a range of interesting chain lengths. The chemical structure and cmc 
values of these surfactants are shown in Table 5.1. The source and batch numbers 
of these materials are documented in Appendix 1. 
Surfactants No.ofC cmca(mM) Structure 
SHS 6 517b q,J' ~ / s ' o - N . + +
SOS 8 133 c ~ ~ 9 9~ O / ' o - N a + +
SOeS 10 33 d ~ ~ 9 9~ / ' o - N a + +
SOS 12 8.3 e ~ ~ 9 9~ O " ' o - N a + +
Table 5.1 The homologous series of alkyl sulphate surfactants used in this chapter . 
• critical micelle concentration In water at 25°C, b Suarez et al 1999, c JohaI2011, d Kiraly & 
Dekany 2001, e Nilsson 1995 
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5.4.2 HPMC 
HPMC USP Type 2910 (Methocel™ E4M CR Premium EP /USP) was used in this 
study. Full details of this material are given in Appendix 1. 
5.4.3 Manufacture of HPMC solutions 
The quality and source of deionized water used in solution manufacture is 
described in Appendix 1. 
10% stock solutions were prepared by dispersing a required amount of HPMC in 
the hot water (>80°C) using a bench-top magnetic-stirrer with a hot plate (RCT 
basic, IKA Labortechnik Staufen, Janke&Kunkel GMBH&CO.KG, Germany). The 
dispersion was then put in an ice box to cool down to the room temperature while 
agitation was continued using a bench-top magnetic stirrer (KM02 basic, IKA® 
Labortechnik GMBH&CO.KG, Germany). Solutions were then stored in a 
refrigerator at 2-8°C for at least 24 hours prior to use in order to obtain a 
completely hydrated solution. 
To prepare solutions of 0.1 and 1% w/w HPMC, the required amount of 10%w/w 
HPMC stock solution was made up to volume by adding water. Solutions were 
stirred overnight and stored at 2-8°C for at least 24 hours prior to use. 
To prepare 0.1 % and 1 % w /w HPMC solutions containing different concentrations 
of surfactants, the following method was used. HPMC and surfactant solutions 
were prepared separately to avoid any interactions prior to complete dissolution 
or hydration. The required amount of surfactants was dissolved in the remaining 
part of water (nine tenth of the final amount) before being incorporated into the 
required amount of a 10% HPMC stock solution (one tenth of the final amount). 
The mixed solution was stirred until homogeneous, and stored at 2-8°C for at least 
24 hours prior to use. 
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5.4.4 Turbidimetric determination 
The sol-gel transition temperature (SGTT) of HPMC solutions was determined by 
turbidimetry in a Cloud Point Apparatus (Medical Physics, Queen Medical Centre 
NHS trust, Nottingham, UK). 1 %w/w HPMC solutions containing different 
concentrations of surfactants were used. Each sample was measured in triplicate. 
Full details of the method are described in Section 2.2.3. 
5.4.5 Surface tension measurement 
Surface tension measurements were conducted at 20 ± 1°C in a Profile Analysis 
Tensiometer (Sinterface tensiometer PAT1, Berlin, Germany) using the pendant 
drop method. Replicate measurements were automatically determined 100 times 
on each sample, and this was repeated on three separate samples of each solution. 
The relative standard deviations of the 100 measurements were smaller than 
0.05%. 
5.4.6 Density measurement 
Density measurements on 0.1 %w /w HPMC solutions containing surfactants were 
conducted by using a DMA 5000 oscillating U-tube Density Meter (Anton Paar, 
Graz, Austria). The density determination is based on measuring the period of 
oscillation of a vibrating U-shaped tube that is filled with sample and using the 
relationship between the period of oscillation and the denSity. This relation holds 
as long as the sample is not too viscous. The density was obtained at 20°C and 
mean values (n=3) were used subsequently in the surface tension measurements. 
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5.4.7 Manufacture of matrix tablets 
Matrix tablets weighing 250 ± 5 mg were manufactured using a Manesty F3 single 
punch tablet press (Manesty, Liverpool, UK) at a compression pressure of 280MPa 
(within the linear range of compression pressure-hardness profile), using 8 mm 
flat-faced punches (I Holland, Nottingham, UK) as described in Section 2.2.7. The 
formulations of HPMC matrices used in this chapter are shown in Table 5.2. 
Tablets were prepared containing a diluent of high solubility (dextrose), an 
insoluble diluent (microcrystalline cellulose), a diluent of intermediate solubility 
(partially pre-gelatinized starch) and the 50:50 mixtures of these diluents as 
shown in Table 5.2 (a). Table 5.2 (b) shows the control formulations of those in 
Table 5.2 (a). CA. CR, Ce, Co and CE are the controls of A, B, C, D and E respectively. 
5.4.8 Compression force-hardness profiles 
The upper punch compression pressure was detected by a tablet compression 
monitor TCMl (Copley Instruments Ltd, Nottingham, UK). Matrix tablets were 
sampled and tested for weight uniformity (HR-120 balance, A&D company, 
Limited, Japan) and crushing strength using a CT40 hardness tester (Engineering 
Systems, Nottingham, UK). The compression pressure was plotted against the 
crushing strength. 
5.4.9 DlssolutJon determlnatJon 
Drug release profiles of HPMC matrices were determined at 37±0.5°C in 900ml of 
degassed deionized water using USP dissolution apparatus I (basket) at 100rpm 
(Dissolutest, Prolabo, France). Full details of the method are provided in Section 
2.2.7. 
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(a) Matrices containing a surfactant 
Ingredients Gradel 
Weight Composition (%w Iw) 
Type A B C D E 
Caffeine Analytical 10.0 10.0 10.0 10.0 10.0 
anhydrous· grade 
HPMC Methocel™ 30.0 30.0 30.0 30.0 30.0 
E4MCR 
Surfactant SHS, SOS, 10.0 10.0 10.0 10.0 10.0 
SDeS, SOS 
Dextrose Meritabe 50.0 25.0 25.0 
Pre-gelatinized Starch 50.0 25.0 
Starch 1500· 
Microcrystalline Avicel 50.0 25.0 
Cellulose (MCC) PHI02 
(b) Control matrices 
Gradel Weight Composition (%w/w) 
Ingredients Type CA CB Cc CD CE 
Caffeine Analytical 10.0 10.0 10.0 10.0 10.0 
anhydrous· grade 
HPMC Methocel™ 30.0 30.0 30.0 30.0 30.0 
E4MCR 
Dextrose Meritabe 60.0 10.0 35.0 10.0 35.0 
Pre-gelatinized Starch 50.0 25.0 
Starch 1500· 
Microcrystalline Avicel 50.0 25.0 
Cellulose (MCC) PHI02 
Table S.2 The fonnulatlon of HPNe matrix tablets used in this chapter. 
• <12Sllm sieve fraction. Full details ofall materials are provided in Appendix 1. 
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5.4.10 Investigation of the early gel layer formation by confocal laser 
scanning microscopy 
Early gel layer formation of HPMC matrices containing SDS in water was imaged 
using a confocal laser scanning microscopy. Full details of the confocal 
microscope, cell chamber and method are described in Section 2.2.8. 0.008%w /w 
Congo red solution was selected as the fluorophore based on a previous study 
which found that at this concentration can provide excellent microscopic detail of 
the gel layer (8ajwa et al 2006). Images were processed by using Image Pro Plus 
v6.2 software (Media Cybernetic, USA). 
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s.s Results and Discussion 
5.5.1 The effect of surfactants on HPMC solutions 
5.5.1.1 The effect of surfactants on the surface tension of HPMC solutions 
The effect of increasing HPMC concentration on the surface tension of water at 
20°C is shown in Figure 5.2. This grade of HPMC reduced the surface tension of 
water from -72mN/m to -SOmN/m, illustrating the known surface activity of 
HPMC. Figure 5.3 shows how the surface tension of water and O.l%w/w HPMC 
solutions changed in the presence of the alkyl sulphate surfactants at 20°C. All 
surfactants in the homologous series reduced the surface tension of water and 
HPMC solutions and exhibited the critical micelle concentrations (emc) and critical 
aggregation concentrations (CAC). The cme and CAC values determined from this 
homologous series are shown in Table 5.3. 
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FilUre 5.2 The effect of HPMC concentration on the surface tension of water at 20°C. 
Surface tension was measured by the pendant drop method. Mean (n=3). SO bars are 
smaller than the symbols. 
Surfactants 
SHS 
SOS 
SDeS 
SDS 
cme (mM) 
500 
130 
40 
8 
CAe (mM) 
500 
100 
30 
4 
Table 5.3 emc and CAC values for a homologous series of alkyl sulphate surfactants 
In O.lCM.w/w HPMC solution. Values were determined from the graph in Figure 5.3. 
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FilUre 5.3 The effect of alkyl sulphate surfactant concentration on the surface 
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SDeS (d) SDS. Surface tension was measured by the pendant drop method. Mean (n=3). 
SD bars are smaller than the symbols. 
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The time dependence of the reduction of the surface tension of HPMC by SHS, SOS, 
and SOes has been studied by Avranas et al (2003) who found there was a lag time 
to a steady state value depending on the polymer concentration. Lower 
concentrations took a longer time to reach equilibrium surface tension values. In 
this study, these surfactants were measured until the surface tension profile 
exhibited an eqUilibrium value in which successive values varied by less than 
±0.5%. 
Figure 5.3 and Table 5.3 show that the potency of each surfactant in the 
homologous series to reduce the surface tension of HPMC solution and undergo 
association with HPMC was in a rank order of alkyl chain length: 
SOS > SOeS > SOS > SHS 
The longer alkyl chain length surfactants, which are more hydrophobic, have more 
potential to reduce the surface tension of water and HPMC solution, and exhibited 
lower cmc and CAC values. 
Both HPMC and surfactants are surface active and decrease surface tension, but 
these results also provide evidence for an interaction between HPMC and these 
alkyl sulphate surfactants. This is shown by the plateau phase, in which there is no 
further decrease of surface tension when adding the surfactants. For SHS, the 
onset of association requires higher surfactant concentrations than the others. It 
needs up to 500mM concentration for self-association and SHS-HPMC association. 
In the case of SOS, SOeS and SOS, the surfactant-HPMC association happened at 
lower concentrations than surfactant self-association in water (CAC<cmc). This 
suggests that the polymer (HPMC) can induce surfactant aggregation, and a lower 
concentration of surfactant is needed for solubilisation of polymer. A discussion of 
their effects is provided in Section 5.5.2. 
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5.5.1.2 The effect of surfactants on the density of HPMC solutions 
Figure 5.4 shows how concentration of surfactants affected the density of water 
and HPMC solution. The density of water and HPMC solutions increased with 
increasing surfactant concentration. This can be explained through Equation 5.1. 
m 
p= V Equation 5.1 
where p is the density, m is the mass, V is the volume. 
Interestingly, the alkyl chain length of surfactants exhibited the reverse effect from 
Equation 5.1 which the density of water and HPMC solutions decreased with 
increasing surfactant alkyl chain length. At low surfactant concentration, there 
was no difference in density, but at high surfactant concentration, the density 
varied in a rank order of chain length. This might be a result of increasing 
hydrophobicity of surfactant which affects their ability to form micelles with 
HPMC. The longer chain length surfactants can form micelles more quickly which 
will be discussed in more detail in Section 5.5.2. The surfactant:polymer 
association cause the conformation change of polymer (HPMC) in solution from 
the condensed coil to straight line and less compact. 
The density of the solution can directly influence the surface tension of the 
solution determined by a pendent drop method. This shape is given by the Gauss-
Laplace equation, which provides a relationship between the curvature of a liquid 
meniscus and the surface tension, as shown in Equation 5.2. 
Equation 5.2 
Where y is the surface tension, Rl and R2 are the main radii of curvature, ~ P o o is the 
pressure difference in a reference plane, £1p is the density reference, g is the 
acceleration due to gravity, and h is the vertical height of the drop measured from 
the reference plane. From Equation 5.2 and Figure 5.4, the longer chain length 
surfactants exhibited lower density difference ( ~ p ) , , and hence the lower surface 
tension (y) occurs as found in Section 5.5.1.1. 
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Figure 5.4 The effect of surfactant concentration on the density of (a) water, (b) 
0.1 %w jw HPMC solutions in the presence of a homologous series of alkyl sulphate 
surfactants. The density was measured at 200 e. Mean (n=3). SO bars are smaller than the 
symbols. 
211 
ChapterS 
5.5.1.3 The effect of surfactants on the sol:gel transition temperature 
(SGTT) of HPMC solutions 
The sol:gel transition temperature values (SGIT) of 1 %w /w HPM C solutions 
containing various concentrations of alkyl sulphate surfactants (SHS (C6), SOS 
(C8), SOeS (CI0), and SOS (C12» were determined turbidimetrically by cloud 
point temperature (CPT) measurements (Section 5.4.4). SGTI is represented by 
cloud point temperature in these studies. 
Figure 5.5 and 5.6 show how surfactant concentration influenced the CPT of HPMC 
solutions. The graphs are biphasic, and the effects were described as pre-micellar 
and post-micellar, coinciding before or after the temperature minimum. At low 
concentrations of surfactant (in the pre-micellar phase), alkyl sulphate surfactants 
depressed the CPT of HPMC solutions. After adding more surfactant, a progressive 
elevation of CPT was detected (this is the post-micellar phase). The lowering of 
CPT suggests these ionic surfactants exert a Hofmeister effect at pre-micellar 
concentrations, in which there is ion-mediated depletion or restructuring of water 
in the polymer hydration sheath around the hydrophobic, methoxyl-rich, regions 
of HPMC. When micellar concentrations are reached, the tensiometry suggests 
polymer:surfactant associations intervene, resulting in an increase in polymer 
molecular hydration through solubilisation of the hydrophobic regions of the 
polymer. Figure 5.5 shows that the critical concentration is around 6mM which is 
between the CAC value (4mM) and the cmc (8mM) determined by tensiometry in 
Section 5.5.1.1. This relationship holds for the other surfactants in the 
homologous series. Because of this, these alkyl sulphate surfactants at 
concentrations above their CAC can elevate the CPT of HPMC solutions, by 
association with the polymer. If this association converts the neutral HPMC into a 
polyelectrolyte then more water will be attracted to the polymer hydration sheath 
and the CPT will rise. 
Figure 5.6 and 5.7 show the potential ofthis homologous series to elevate the CPT 
of HPMC solutions in the post-micellar phase. This potential is in rank order of 
alkyl chain length: SOS (C12) > SOeS (CI0) > SOS (C8) > SHS (C6) 
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Figure 5.5 The effect of SDS concentration on the cloud point of 1 O/OW /w HPMC E4M 
solutions. 
Temperature ramp rate of loSoC/min. Mean (n=3). 
80.00 
70.00 
60.00 
6 
!?.... 
.... 
Il. 
0 50.00 
- -+ 1% HPMC E4M + SHS (C6) 
- 1% HPMC E4M +SOS (C8) 
40.00 
__ 1% HPMC E4M +SDeS (C10) 
-- 1% HPMC E4M +SDS (C12) 
30.00 
0 50 100 150 200 250 300 350 400 450 500 
surfactant concentration (mM) 
Figure 5.6 The effect of the concentration of a homologous series of alkyl sulphate 
surfactants on 1 O/OW /w HPMC E4M solution. 
Temperature ramp rate of loSoC/min. Mean (n=3). 
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Figure 5.7 The ability of a homologous series of alkyl sulphate surfactants to elevate 
CPT of 1 %w /w HPMC E4M solution at the post-micellar phase. dCPT obtained from 
the slope of the post-micellar curve with respect to surfactant concentration from figure 
5.9. Temperature ramp rate of l.s°C/min. Mean (n=3). 
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5.5.1.4 The effect of surfactants on the rheological properties of HPMC 
solutions 
Frequency sweep experiments were conducted at 200C. The effect of SOS 
concentration on the rheological properties of 2%w/w HPMC solutions is shown 
in Figure 5.8. Figure 5.8(a) shows the frequency dependence of the complex 
viscosity. This reflects the viscoelastic response of polymer-SOS mixtures. HPMC 
solutions containing SOS below the CAC (-4mM) exhibited a lower complex 
viscosity than those without SOS, whereas HPMC solutions containing SOS above 
the CAC exhibited higher complex viscosities. The higher the concentration of SOS, 
the higher complex viscosity. This suggests that with increasing concentrations of 
SOS, HPMC solutions exhibit more elastic-like behavior, suggesting a strong 
interaction between SOS and HPMC. 
Figure 5.8(b) and (e) show the frequency dependence of the storage modulus (G') 
and loss modulus (G") for HPMC solutions containing various concentration of 
SDS. In the presence of 2mM SDS (below the CAC), G' and G" values were 
decreased, suggesting that low amounts of SOS suppress the viscoelastic 
properties of HPMC solutions. In contrast, above the CAC (6, 8, 12mM SDS), there 
was an increase in these mechanical moduli, showing that both elastic and viscous 
properties ofHPMC solutions were being enhanced. 
From these experiments, HPMC solutions containing SOS below the CAC appear to 
be behaving as a physically entangled gel with a relatively free movement of 
polymer chains. In contrast, HPMC solutions containing SOS above the CAC, show 
enhance the gel structure in both elastic and viscous properties relative to HPMC 
alone, and resulting from surfactant:polymer associations. The higher the SOS 
concentration, the the greater the enhancement of gel structure over the SOS 
concentrations we examined. 
Tan l) values represent the ratio of G" to G' and provide further evidence of the 
changes in viscoelasticity. When tan l) <1, this indicates a shift in the sample to 
towards gel-like behaviour. SDS concentrations above CAC show this shift (Figure 
5.8(d)). 
215 
(a) Complex viscosity 
100.00 
~ ~
'iii 
o 
~ ~ 10.00 
. ; 
)( 
Q) 
Ci 
E 
o 
o 
• 
• 
• 
• 
• 
• 
• 
• 
• 
.. 
• • AI 
.. • .. 
• • 
.. 
• .. 
• 
• • • • .. 
• • • 
2mM SOS 
. 6mM SOS 
BmM SOS 
. 12mM SOS 
. no SOS 
• 
.. 
.. 
.. 
.. 
.. 
.. 
• • 
.. 
• • 
.. • 
• • • • • 
.. • • • • • • • • • • • • • • • 1.00 + - - - - - - - - - - , - - - - - - - - ~ ~ ~
10 100 
Angular frequency (1/s) 
(b) Storage modulus, G' 
------
100.00 • • 
• • • 
• • • 
• • • • 
• • • • • 
.. 
.. • • • 
.. 
.. • • .. 
"' 
.. 
• • • .. ~ ~ 10.00 .. • • • .. (, 
• • 
.. • 2mM SOS • 
.. 
.. • • .. 
. 6mMSOS 
• • • • 
BmM SDS 
• • 
. 12mM SOS 
• 
. noSOS 
• • • 
1.00 
10 100 
Angular frequency (1/s) 
Chapter 5 
216 
(e) Loss modulus, Gil 
100.00 
• 
• Ii 
• ~ ~ 10.00 
.. .. 
• • • .. .. .. .. • 
• .. • • 
• .. .. • 
.. 
.. .. • • • 
.. .. • • • 
.. • • .. 
.. • • 
• • • C> • • .. 
• .. 
• • 
• 
1.00 
1 10 
Angular frequency (1/s) 
(d) tan 0 
- - - ~ ~ - -
100.00 
c.o 
c::: 10.00 III • ... .. 
• 
.. 
• • • • • • • .. .. .. • • • • • • • • .. • • • • .. .. .. 
• • • • • .. t .. t t • .. t t 1.00 
10 
Angular frequency (1/s) 
• 
.. 
• 
.. 
• .. 
• 
• • 
• 
2mM SOS 
. 6mM SOS 
. SmM SOS 
. 12mM SOS 
. no SOS 
2mM SOS 
&6mM SOS 
BmM SOS 
& 12mM SOS 
. noSOS 
100 
100 
Chapter 5 
Figure 5.8 The effect of SDS concentration on the frequency dependence of the 
(a) complex viscosity (b) G' (c) Gil and (d) tan 0 for 2%w /w HPMC solutions. 
Geometry = PPSO. Temperature = 20°C. Strain = 1% 
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5.5.2 The mechanism of interaction between surfactants and HPMC in 
solution 
The results in Section 5.5.1 allow us to postulate a mechanism of interaction 
between these ionic surfactants and HPMC. This scheme is illustrated in Figure 5.9 
and 5.10. 
At pre-micellar concentrations. Figure 5.9. ionic surfactants probably exert a 
Hofmeister effect in which there is ion mediated depletion of water in the polymer 
hydration sheath around the hydrophobic regions of HPMC. resulting in a salting-
out effect. This is supported by the downward slope in the CPT curves seen in 
Section 5.5.1.3. When adding more surfactant to the system. increasing 
polymer:surfactant associations intervene and there is an inflection in the CPT 
curve. At post-micellar concentrations. surfactants start to form micelles around 
the methoxyl rich region (hydrophobic region) of HPMC. resulting in an increase in 
polymer molecular hydration through solubilisation of the hydrophobic regions. 
Moreover. the hydrophilic part of these micelles converts the neutral HPMC into a 
polyelectrolyte which attracts more water. This postulate is supported by the 
tensiometric and turbidimetric studies in Section 5.5.1.1 and 5.5.1.2 which show 
polymer:surfactant association evidence and a progressive increase in solubility of 
HPMC in solution. 
An increase in hydrocarbon chain length of surfactants usually results in a 
decrease in the cmc value. and for compounds with identical hydrophilic head 
groups this relationship is expressed by the linear equation 
log[cmc] = A-Bm Equation 5.3 
where m is the number of hydrocarbon atoms in the chain. A is a constant for 
particular ionic head and B is approximately 0.3 (for a homologous series) (Prieto 
et a11994; Maza et al 1999; Florence & Attwood 2009). Lunkenheimer et al (1995) 
also found the same relationship which differed distinctly between even and odd 
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number of carbon atoms. The corresponding increase in micellar size with 
increase in hydrocarbon chain length of surfactant is also noted (Florence & 
Attwood 2009). These support the investigations in Section 5.5.1 which show that 
increasing alkyl chain length of surfactant is associated with decreasing cmc and 
CAC in HPMC solutions containing surfactant. The main reason for micelle 
formation is to attain a state of minimum free energy so that hydrophobic part of 
the ampiphile will be removed from the aqueous environment by becoming the 
core of the micelle. A longer alkyl chain length surfactant is more hydrophobic so 
that the self-aggregation, polymer:surfactant association and micelle formation 
will occur more quickly than with a shorter chain, and exhibit a lower cmc and 
CAC. Moreover, the increase in alkyl chain length of surfactant raises the CPT of 
HPMC solutions because the longer alkyl chain surfactant has a lower cmc and 
CAC, leading to a greater solubilising effect on HPMC. 
The postulated mechanism in Figure 5.10 also shows that when alkyl sulphate 
surfactants form micelles with methoxyl rich region of HPMC and convert neutral 
parts of the HPMC molecule into charged regions, making the polymer chain a 
polyelectrolyte. The increasing alkyl chain leads to a bigger size of micelle and the 
negative charge repulse could stretch HPMC from a condensed coil to an extended 
chain, resulting in the increase in viscosity of the HPMC solution. The rheological 
studies in Section 5.5.1.4 support this. Higher concentrations of surfactant appear 
to enhance rheological properties. 
If surfactants make HPMC more hydrophilic and more viscous then in matrix 
tablets the gel layer might form more quickly and the layer may be more viscous. 
This could result in drug release from matrix tablets showing greater retardation. 
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Figure 5.10 Illustration of the postulated interaction mechanism between HPMC 
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5.5.3 The effect of surfactants on HPMC matrices 
5.5.3.1 Compression pressure - hardness profile ofHPMC matrix tablets 
Including surfactants can alter the properties of the tablet compact, and Figure 
5.11 shows how the inclusion of SOS in our formulation influenced the hardness 
(crushing strength) of the HPMC matrix tablet. The presence of SOS in the tablet 
decreased the tablet crushing strength, but this effect did not appear to correlate 
with the amount of SOS added. Other surfactants exhibited similar effects (data 
not shown) and Figure 5.12 shows how different members of the homologous 
series decreased the crushing strength of HPMC matrix tablets. There appeared to 
be no dependency on chain length although the potential of 10% SHS to decrease 
the crushing strength appeared slightly less than 10% SOS, 10% SOeS or 10% SOS. 
These effects suggest that all the surfactants investigated reduced interparticulate 
bonding within the tablet structure but without any concentration dependency in 
the range studied. 
Although these surfactants decreased the hardness of the tablets, little effect on 
drug release is expected. Daly et al (1984) amongst others have reported that 
compaction pressures in the range of 50-200 MPa do not significantly alter drug 
release rates from HPMC tablets. Appendix 4 shows that HPMC matrices of our 
formulation compressed over a wide range of pressures (80-320MPa) did not 
show any difference in their drug release profiles. 
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Figure 5.11 Compression pressure - hardness profiles for HPMC matrix tablets 
containing the different amounts of SDS 
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5.5.3.2 The effect of surfactant content on the matrix drug release profile 
Matrices containing a range of 0.5-15%w/w SOS, SOes and SOS exhibited 
diffusional-based release mechanism (n-0.4-0.5) (Table 5.4). Figure 5.13 and 
Table 5.4 show how the amount of the alkyl sulphate surfactant incorporated in 
the matrix influenced the drug release time profile. Figure 5.13(a) shows that 
with 0.5%-1 5%w /w SOS (C8), drug release was accelerated in comparison with 
the control (without surfactant). SOS is a soluble ingredient, which we might 
expect would quickly dissolve in the gel layer. The results suggests it somehow 
influences the barrier properties of the gel layer, possibly by suppressing polymer 
swelling and gel formation as seen with other salts (8ajwa et al 2006), leading to 
faster ingression of dissolution medium into the tablet and acceleration of drug 
release. Figure 5.13(b) and (c) show that low amounts (0.5-5%w/w) of SOeS 
(CI0) and SOS (C12) all accelerated the drug release. In contrast, 15%w/w SOeS, 
10% and 15%w /w SOS retarded drug release compared with the control as seen 
with their slower release rate (k) (Table 5.4). These results suggest that if the 
amount of surfactant is high enough to induce the surfactant:HPMC aggregation, 
which would enhance HPMC solubility and viscosity, then greater retardation of 
the drug release can occur. 
Figure 5.14 compares the ability of the different alkyl sulphate surfactants to 
influence the release performance of HPMC matrices. With low amounts (0-
5%w/w surfactant), there is no difference between these surfactants. However 
with higher amounts (10%w/w surfactant or more), their ability to influence the 
release performance of HPMC is more clearly differentiated. The rank order effect 
on drug release kinetics was 
SOS (fastest) > SDeS > SOS (slowest) 
These results can be explained in that the longer alkyl chain length surfactants 
have a greater ability to induce surfactant:polymer association and micelle 
formation (as discussed in Section 5.5.2), and can enhance the solubility of HPMC, 
leading perhaps to quicker gel layer formation and a more viscous gel layer, 
resulting in greater retardation of drug release. 
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Surfactants Teo,," K n r2 
Control 206 6.65 0.477 0.9982 (no surfactant) 
S!1S. 
0.5% 176 10.43 0.401 0.9990 
2% 177 9.82 0.414 0.9988 
5% 180 9.06 0.427 0.9991 
10% 162 9.67 0.425 0.9990 
15% 194 6.60 0.480 0.9987 
SDJ:S. 
0.5% 176 10.37 0.402 0.9990 
2% 179 9.07 0.428 0.9992 
5% 173 9.08 0.412 0.9992 
10% 195 7.60 0.451 0.9978 
15% 204 6.02 0.488 0.9969 
SDS. 
0.5% 184 9.87 0.407 0.9989 
2% 178 8.11 0.450 0.9993 
5% 174 8.97 0.430 0.9979 
10% 222 4.02 0.557 0.9978 
15% 218 3.68 0.568 0.9970 
Table 5.4 The effect of surfactant content on drug release kinetics using the 
modlfted power law. Modified power law is described by Ford et al (1987) and was fitted 
up to 80% cumulative release. 8mm, 250mg matrices, 280MPa containing 30% HPMC 
E4M, 10% caffeine anhydrous, x% surfactant, qs. Dextrose. Tao,," is the time to 80% 
cumulative drug release. k is the kinetic constant. n is the diffusional exponent. r2 is 
determination coefficient. 
limi:: SHS was not Included in this section because of the limited amount of material 
available (The product was being no longer manufactured) 
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Figure 5.13 The effect of surfactant content (a) SOS, (b) SDeS or (c) SDS on drug 
release from HPMC matrices. 8mm, 250mg matrices contain 300/0HPMC E4M, 
100/0caffeine anhydrous, x% surfactants, qs Dextrose. USP I , 100rpm, 37°C in water. 
Mean(n=3)± lS.0. 
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Figure 5.13(cont.) The effect of surfactant content (a) SOS, (b) SDeS or (e) SDS on 
drug release from HPMC matrices. 8mm, 2S0mg matrices contain 30%HPMC E4M, 
10%caffeine anhydrous, x% surfactants, qs Dextrose. USP I , 100rpm, 37°C in water. 
Mean(n=3)± lS.D. 
T ~ ( m i n ) )
250 
200 
150 
100 
50 
..... SOS 
..... SDeS 
SDS 
o ---- -,- -------r--------, 
o 5 10 15 
% surfactant 
Figure 5.14 The effect of surfactant content on T80% drug release. 8mm, 250mg 
Matrices contain 30%HPMC E4M, 10%caffeine anhydrous, x% surfactant, qs Dextrose. 
USP I, 100rpm, 37°C in water. Mean(n=3)± lS.D. T80% is the time to 80% drug 
release. 
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5.5.3.3 The effect of tablet dUuents on drug release from HPMC matrices 
containing surfactants 
Matrices with all diluents in this study exhibited diffusion-based release 
mechanism (n-0.4-0.5) (Table 5.5). Matrices incorporating dextrose as a soluble 
diluent exhibited a clear sensitivity to the presence of incorporated surfactants 
and surfactant chain length had a rank order effect on drug release kinetics (Figure 
5.15(a)). In contrast, HPMC matrices containing Starch1500 as an intermediate 
solubility diluent showed few differences in release profile with surfactant chain 
length (Figure 5.15(b) and (c)). Starch1500 may have a protective effect on HPMC 
matrices so that the release performance ofHPMC matrices containing Starch1500 
is less sensitive to external influences. Figure 5.16(a) illustrates the effect of 
replacing dextrose with Starch1500 in the HPMC matrix tablet formulation. At 
starch levels of 25% and 50%, surfactant chain length had little influence on Tao%. 
The faster release in comparison with the control suggests that the surfactants 
were merely acting as soluble diluents. 
Matrix behaviour was also different when the tablet diluent was wholly insoluble 
(microcrystalline cellulose, MCC) or was a 50:50 mixture of MCC and dextrose. 
The control showed an unusual result Figure 5.15(d) shows how drug release was 
extremely accelerated in HPMC matrix tablets containing MCC as a diluents : this 
may be a result of its dintegrant properties. By adding 10%w/w of an alkyl 
sulphate surfactant. the matrices then became retarded, but the alkyl chain length 
had no influence. When using a 50:50 mixture of MCC and dextrose, the effect of 
alkyl chain length of surfactants on the release profile can be differentiated in a 
same rank order as when using dextrose alone (Figure 5.1S(e)). Figure S.16(b) 
shows the effect of the replacing dextrose with MCC102 in the HPMC matrix tablet 
formulations. All alkyl sulphate surfactants retarded drug release in comparison 
with a control containing MCC and no surfactant. Surfactant chain length had a 
rank order effect on drug release in tablets containing 25%w /w MCe, but not in 
those containing 50%w/w MCC. This suggests that using soluble diluents either 
alone or mixture with insoluble can differentiate the effect of alkyl chain length of 
surfactants more clearly than using only insoluble diluents. 
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SHS SOS SOeS SOS 
Formulations 
1'80 k n r2 7'80 k n r2 1'80 k n r2 1'80 k n r2 
A 167 9.83 0.419 0.9992 166 9.67 0.425 0.9990 192 7.60 0.451 0.9978 222 4.02 0.557 0.9978 (dextrose) 
B 339 4.37 0.504 0.9996 332 4.18 0.513 0.9996 324 3.93 0.525 0.9993 317 3.59 0.543 0.9996 
(Starch1500) 
C 258 S.lS 0.500 0.9994 250 5.06 0.505 0.9994 256 5.10 0.501 0.9990 266 4.03 0.540 0.9994 
(Dextrose+ 
Starch1500) 
D 294 6.12 0.457 0.9997 298 5.67 0.471 0.9990 271 6.49 0.454 0.9994 283 4.04 0.534 0.9994 
(MCC) 
E 164 11.38 0.390 0.9985 168 10.78 0.400 0.9991 196 8.63 0.428 0.9984 248 4.57 0.520 0.9977 
(Dextrose+ MCC) 
Table S.S The effect of diluents on drug release kinetics of HPMC matrices containing surfactants using the modified power law. Fitted up to 
80% cumulative release. Modified power law is described by Ford et al (1987). The detail offormulation A, B, C, D and E is in Table S.2. Tao%is the 
time to 80% drug release. k is the kinetic constant n is the diffusional exponent r 2 is coefficient of determination. 
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Figure S.15 The effect of a homologous series of alkyl sulphate surfactants on the 
drug release profile of HPMC matrices containing (a) dextrose, (b) Starch1500, (c) 
dextrose: Starch1500 (1:1), (d) MCC or (e) dextrose:MCC (1:1) as diluents. 8mm, 
2S0mg Matrices contain 300/0HPMC E4M, 100/0caffeine anhydrous, 10% surfactants, qs 
diluents. U5P I, 100rpm, 37°C in water. Mean(n=3)± 15.0. 
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(c) dextrose: Starch1500 (1:1) 
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Figure 5.15 (cont.) The effect of a homologous series of alkyl sulphate surfactants 
on the drug release profile of "PMC matrices containing (a) dextrose, (b) 
Starch1500, (c) dextrose: Starch1500 (1:1), (d) MCC or (e) dextrose:MCC (1:1) as 
diluents. 8mm, 250mg Matrices contain 30%H PMC E4M, 10%caffeine anhydrous, 10% 
surfactants, qs diluents. USP I , 100rpm, 37°C in water. Mean(n==3)± 15.0 . 
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(e) dextrose:MCC (1:1) 
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Figure 5.15 (cont.) The effect of a homologous series of alkyl sulphate surfactants 
on the drug release profile of HPMC matrices containing (a) dextrose, (b) 
Starch1500, (c) dextrose: Starch1500 (1:1), (d) MCC or (e) dextrose:MCC (1:1) as 
diluents. 8mm. 2S0mg Matrices contain 30%HPMC E4M. 10%caffeine anhydrous. 10% 
surfactants. qs diluents. USP I . 100rpm. 37°C in water. Mean(n=3)± 1S.D. 
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Figure 5.16 The effect of replacing Dextrose with (a) Starch1500 or (b) MCC on 
the drug release profile of HPMC matrices containing surfactants. 8mm, 250mg 
Matrices contain 30%HPMC E4M, 10%caffeine anhydrous, 10% surfactant, 50% 
diluents. USP I, 100rpm, 37°C in water. Mean(n=3)± 15.0. T80% is the time to 80% 
drug release. 
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5.5.3.4 The early gel layer development of HPMC matrices containing SDS 
Figure 5.17 shows confocal microscopy images of early gel layer development in 
an HPMC matrix tablet containing a soluble diluent (dextrose) with and without 
SDS. Figure 5.17(a) HPMC matrix tablets containing dextrose showed significant 
swelling within 1 minute and gel layer formed within 3-5 minutes. The gel was 
thick but in the early stages there were deep channels in the gel layer. This 
suggested that the gel layer of HPMC matrices containing dextrose is not a good 
barrier to further water ingress and might explain the relatively moderate 
retardation of drug release in HPMC matrices using dextrose as a diluent. In 
addition. discrete particles were visible in the gel layer during the entire test. 
Figure 5.17(b) In the case of HPMC matrix tablets containing 10% SDS (also with 
dextrose as a diluent). HPMC matrices showed a similar pattern. However the final 
gel layer (at 15 minutes) was more uniform and coherent in appearance, and the 
earlier pictures showed less major channelling of the gel layer. In addition the dry 
core of the matrix tablets showed less water ingress compared to the dextrose 
control. 
These results suggest that with 10%w/w 50S, HPMC matrices may form a better 
gel layer which is better barrier to the water ingress. 
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Figure 5.17 Early gel layer formation at the boundary of hydrating "PMC matrices 
(a) O%wjw SDS (b) 10%wjw SDS. Matrices contained dextrose as a diluent 
Matrix contains 30%HPMC E4M, lO%caffeine anhydrous, (a)no SDS (b)lO% SDS, qs dextrose. 
Confocal fluorescence imaging at Ex 488/Em >SlOnm, Experiments conducted at 37±loC using 
water containing O,008%w/v Congo red as a visualisation aid. Images are coded for fluorescence 
intensity (highest=white, lowest=black) in accordance with the greyscale bar. Dotted white lines 
represent the dry matrix boundary at t=O minutes. Scale bar SOOJ.lm. 
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5.5.4 The effect of alkyl chain length of surfactants on HPMC 
Table 5.6 shows the dependence of HPMC solution and matrix drug release 
properties on alkyl chain length of a homologous series of the alkyl sulphate 
surfactants. Surfactant alkyl chain length had a rank order effect on CAC, SGTI, 
and also on the drug release kinetics of matrices. The effect of alkyl chain length of 
surfactants on CAC and SGTI has been discussed previously in Section 5.5.2. The 
longer chain length surfactants are more hydrophobic and induce the 
surfactant:polymer aggregation more quickly, leading to the more solubilising 
effect on HPMC. 
The correlation between the ability of surfactants to elevate SGTI (or CPT) of 
HPMC solutions at the post-micellar phase and their alkyl chain length is 
exponential increase (r2 = 0.9899) (Figure 5.18). This means the longer chain 
length of surfactants, the more ability to elevate SGTI or enhance HPMC hydration. 
In contrast, the correlation between CAC of surfactants in HPMC solutions and 
their alkyl chain length is exponential decrease (r2 = 0.9906) (Figure 5.19). This 
means the longer chain length of surfactants, the less concentration required to 
associate with HPMC. There was a direct correlation (r= 0.997) (data not be 
shown) between the inflexion in the SGTT curve and CAC, and the rate of SGTT 
elevation at post-micellar concentrations, correlated directly with the carbon 
chain length of the surfactant. The relationship between different chain length 
surfactants. their ability to solubilise HPMC and to raise SGTT, reflects their 
increasing ampiphile nature as carbon chain length is increased. 
Figure 5.20 show the effect of alkyl chain length of surfactants on drug release 
from HPMC matrix tablets containing different diluents. Only the matrices 
containing dextrose or a mixture of dextrose and MCC (1:1) exhibited an effect 
with respect to the alkyl chain length of surfactant. In these matrices, longer chain 
surfactants elicited greater retardation of drug release rate, and in these systems 
polymer:surfactant interactions may be influencing the diffusion barrier 
properties of the matrix gel layer. The longer chain length surfactants have more 
ability to solubilise HPMC, leading to faster gel layer formation. Moreover, if alkyl 
sulphate surfactants form micelles around methoxyl rich regions of HPMC, the 
235 
Chapter 5 
neutral HPMC is converted into a polyelectrolyte. The negative charges will repel 
and this will expand the condensed coil of HPMC, leading to an increased viscosity 
of HPMC solution. This viscous and quickly formed gel layer would be expected to 
show good retardation of drug release. 
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Alkyl Surfactant concentration (mM) *Drug release 
Surfactant sulphate at T80% 
chain length CAC SGTT (min) 
SHS 6 500 300 167 
SOS 8 130 100 162 
SDeS 10 30 22 195 
SOS 12 4 6 222 
Table 5.6 Dependence of HPMC solution and matrix drug release properties on 
alkylsulphate chain length (Results from Section 5.5.1.1, 5.5.1.3 and 5.5.3.3) 
*Matrices contained 10% surfactant and dextrose as diluent 
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Figure 5.18 The correlation between the ability of surfactants to elevate SGTT of 
1 %w jw HPMC solution and their alkyl chain length (Results from Section 5.5.1.3) 
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Figure 5.19 The correlation between the CAC of surfactants in a O.l%w/w HPMC 
solution and their alkyl chain length (Results from Section 5.5.1.1) 
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Figure 5.20 The effect of alkyl chain length of surfactants on drug release from 
HPMC matrix tablets containing different diluents (Results from Section 5.5.33) 
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5.6 Conclusions 
Tensiometric and turbidimetric studies suggest that this homologous series of 
alkyl sulphate surfactants, including SHS (C6), SOS (C8), SDeS (Cl0), and SOS (C12) 
can associate with HPMC above their CAC, and solubilise HPMC. These results also 
suggest that micellar association between alkyl sulphate sUrfactants and HPMC is 
strongly influenced by surfactant chain length. Amongst the surfactants studied 
the effects were greatest with SOS (C12). Rheological studies also provided 
evidence that at SOS concentrations higher than the CAC the surfactant:polymer 
interaction can enhance the viscoelastic properties of HPMC solutions. 
The interaction between these alkyl sulphate surfactants and HPMC are postulated 
to be a surfactant:polymer association. The ionic surfactants might form micelle 
around the methoxyl rich region (hydrophobic area) of HPMC and convert the 
neutral HPMC into a polyelectrolyte. The negative charge repel can also stretch 
HPMC from a condensed coil to an extended configuration, leading to more viscous 
solutions. 
Surfactants influenced the extended release performance of HPMC matrices 
containing soluble diluents (dextrose), insoluble diluents (MCC102), and mixture 
of diluents (dextrose and MCC102 (1:1» but not those containing Starch1500. 
However, to obtain the retardation effect of drug release, the surfactant amount 
incorporated into HPMC matrix tablets should be high enough to induce 
surfactant:polymer aggregation in the gel layer. 
From these studies, the release retarding effects of SDS suggest it may have 
application as an ingredient to improve the release performance of HPMC 
matrices. This will be studied and discussed in the next chapter. 
239 
Chapter 6 
The Recovery ofHPMC matrices using SDS 
6.1 Rationale 
In the previous study of the effect of alkyl sulphate surfactants on HPMC (Chapter 
5), it was postulated that a surfactant:HPMC interaction might influence the 
diffusion barrier properties of the matrix gel layer by micellar solubilisation of the 
polymer. At the surfactant content above 100/0w/w, sodium dodecyl sulphate 
(SOS) could retard the drug release from HPMC matrix using dextrose or MCC as 
diluents. This suggests SOS may be useful in improving the release performance of 
HPMC matrices in particular cases. In this chapter, SOS will be investigated 
whether SOS can be used as a 'magic' ingredient to recover HPMC matrices (a) in 
failing formulations and (b) under challenging conditions. 
6.2 Introduction 
6.2.1 The previous studies ofSDS and HPMC 
Combinations of sodium dodecyl sulphate (SOS) with HPMC or other cellulose 
ethers have been widely studied. Studies of solution interactions between SOS and 
HPMC showed how SOS can alter the hydrophobic-hydrophilic balance of HPMC 
through micellar solubilisation of hydrophobic region of the polymer (Nilsson 
1995). The addition of SDS was also found to enhance the viscosity of a modified 
HPMC (Synchron) solutions, and 15%SOS incorporated in matrix tablets elicited a 
considerable retardation of drug release rate. The proposed mechanism was that 
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anionic surfactants were able to bind to non-ionic polymers such as HPMC, and to 
increase the viscosity of the matrix gel layer (Daly et al 1984). In another study 
increased SDS concentration was found to decrease the release rate of propanolol 
hydrochloride from HPMC matrices. In this case, SDS, an anionic surfactant was 
believed to form an ion pair complex with propanolol, a cationic drug (Ford et al 
1991b, Nokhodchi et al 2002). A different study showed how the retarding effect 
of ionic surfactants on matrix drug release was found to depend on the 
concentration of surfactant molecules and was effective only when both 
surfactants and the drug were ionised and had opposite charges (Feely & Davis 
1988). 
Other studies have found conversely, that incorporated surfactants can cause 
increases in matrix drug release rate (Efentakis et al 1991). The mechanisms 
postulate were (i) that surfactants reduced the interfacial tension between drug 
and dissolution fluid, and (ii) surfactants dissolve to form pores which aid the 
access of dissolution fluid and facilitate the egress of dissolved drug. The 
surfactant may also reduce interparticle adhesion within HPMC matrix tablets, 
leading to increases in dissolution rate through enhanced disintegration. 
Nokhodchi et al (1999) found that SOS increased the release rate of theophylline 
from HPMC matrices. 
It is important to also note that SOS has been used in dissolution media for HPMC 
matrix tablets which the release rate of the insoluble drugs was increased by the 
wetting characteristics of SOS (Maggi et al 1996). 
6.2.2 Previous studies of the failing HPMC matrix formulations and under 
challenging conditions 
Many additives, tablet diluents and drugs have been found to influence the 
extended release performance of HPMC matrices. In this section we will briefly 
review only those which can accelerate the drug release, or in extreme cases, 
destroy the extended release performance of HPMC matrix tablets. Here is a 
summary of effects reported in the literature, with their postulated mechanisms: 
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Highly soluble drugs can act as pore formers, forming micro-cavities and making 
the gel structure more porous and weaker, hence leading to increased drug release 
rates (Yang & Fassihi 1997). An increased content of microcrystalline cellulose 
can, in some cases, change the dissolution profile by accentuating the burst effect. 
Non-swellable insoluble fillers, for example, 10% dicalcium phosphate can 
completely destroy sustained release properties of HPMC matrix tablets in low 
polymer content tablets (Alderman 1984). Likewise, high valency ionic salts can 
prevent polymer hydration increasing matrix erosion (Pygall et al 2009). In low 
polymer tablets, a 10% concentration of various ionic salts was found to interfere 
with gel layer formation, leading to premature dissolution, the effect being 
proportional to the valency of the salt (Alderman 1984). An increase in ionic 
strength resulted at first in dissolution rates decreasing to a minimum, before 
giving rising to a 'burst' release profile (Mitchell et al 1990a). Other dissolved 
materials in the dissolution media such as glycine, ethanol and dissolved sugars 
can also adversely influence extended release characteristics. Glycine in 
dissolution media lead to the increase in the dissolution rate of HPMC matrix 
tablets. Once glycine concentration reached a critical level between O.SM and 1.0M 
the formulation failed and 'dose dumping' was observed (Foster 2004). 
Increasing ethanol level in the dissolution media has been found to increase the 
aspirin release from HPMC matrices. Cloud point studies suggest that ethanol 
retard polymer hydration (Roberts et al 2007). 
A range of dietary sugars have been found to influence the drug release 
performance of HPMC matrices (Methocel™ K4M CR). They retarded drug release 
at lower sugar concentrations, but markedly accelerated drug release above a 
critical sugar concentration (SCRIT). Studies of early gel layer formation suggested 
that sugars suppress HPMC particle swelling and coalescence of the gel layer, and 
reducing the diffusion barrier properties ofthe gel layer (Williams et al 2009). 
The effect of a combination of sugar and salts has been investigated by Williams et 
al (2010b) who found that each solute suppress HPMC hydration, and their effects 
reflect a rank order of Hofmeister series. However, there was no evidence of 
synergy or antagonism. In dissolution tests, sodium chloride and trisodium citrate 
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reduce the SCRIT of sucrose. Williams et al (2010a) have been tried to improve the 
resistance of HPMC matrices to dissolved sugar by using variable diluents and 
HPMC grades. They found that matrices containing MCC as the sole diluent 
provided the extended release for 10 h, and small particle size HPMC (HPMC 
K100M and K100LV) also improve the sugar resistance. 
In Chapter 4, organic salts were also found to influence the drug release 
performance of HPMC matrices (Methocel™ E4M CR, 6 3 - 9 0 ~ m m sieved fraction). 
The small hydrophilic molecules accelerated drug release by removing water from 
polymer hydration sheath of HPMC, and hence poor gel layer formation or even 
disintegration. Sodium acetate and disodium succinate showed the potential to 
destroy the extended release performance of HPMC matrix tablets, and induce the 
burst release. 
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6.3 Chapter Alms and Objectives 
In this chapter, the ability of SDS as an internally added ingredient to improve or 
recover the extended release performance of HPMC matrices (i) in failing 
formulations, and (ii) under challenging conditions are investigated. In particular, 
the experimental work in this chapter, investigates the effect of SDS on: 
• 'Failing formulations': The extended release performance of HPMC matrices 
containing sodium acetate and disodium succinate, organic salts which were found 
to accelerate drug release or exhibited burst release for fractionated HPMC E4M 
matrices (Chapter 4). 
• 'Challenging conditions': The extended release performance of HPMC matrices 
in dissolution medium containing sucrose which was found to suppress matrix gel 
layer formation and accelerate drug release with high sugar concentration 
(Williams et at 2009). 
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6.4 Materials and Methods 
6.4.1 HPMC matrix tablet 
The composition of the matrix tablets used in this work is shown in Table 6.1 and 
6.2. HPMC USP Type 2910 (Methocel™ E4M CR Premium EP /USP) and details of 
other materials used in the matrices are given in Appendix 1. They were 
manufactured by the method described in Section 6.4.4. 
6.4.2 Failing formulations 
Sodium acetate and disodium succinate were selected to incorporate in HPMC 
matrix tablets as they exhibited the most potential to accelerate drug release or 
exhibited burst release for fractionated HPMC E4M matrices (Chapter 4). The 
sources and batch numbers of these materials are documented in Appendix 1. 
Fractionated HPMC E4M and dextrose were used in the formulation because this 
combination exhibited the most clearly effect of organic salts on HPMC matrices. 
This was investigated and discussed in Chapter 4. 
6.4.3 Challenging conditions 
Dietary sugars have been found to influence the drug release performance of 
HPMC matrices (Methocel™ K4M) as described previously. Sucrose was selected 
for its high potential effect. Williams et al (2009) found that the concentration 
required to SCRIT of sucrose is 0.7M, so in this study a range of sucrose 
concentrations from 0.2M to 2.0M was used in the dissolution media. Deionized 
water was used as a control dissolution medium. The source and batch numbers 
of these materials are documented in Appendix 1. 
6.4.4 Manufacture of matrix tablets 
Matrix tablets weighing 250 ± 5 mg were manufactured using a Manesty F3 single 
punch tablet press (Manesty, Liverpool, UK) at a compression pressure of 280MPa, 
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using 8 mm flat-faced punches (I Holland. Nottingham. UK) as described in section 
2.2.6. The formulations of HPMC matrices used in the studies shown in Table 5.1 
and 5.2. 
Weight Composition (%w /w) 
Ingredients 
A B Control 
Caffeine anhydrousa 10.0 10.0 10.0 
HPMCb 30.0 30.0 30.0 
SDS 10.0 10.0 
Sodium acetate 10.0 
Disodium succinate 10.0 
Dextrose 40.0 40.0 60.0 
Table 6.1 The formulation of HPMC matrix tablets used in the 'failing matrices' 
studies . 
• <12SJlm sieve fraction. b63-90,.,m sieve fraction. Full details of aU materials are provided 
in Appendix 1. 
Ingredients Weight Composition (%w /w) 
C D E Control 
Caffeine anhydrousa 10.0 10.0 10.0 10.0 
HPMC 30.0 30.0 30.0 30.0 
SDS 1.0 5.0 10.0 
Dextrose 59.0 55.0 50.0 60.0 
Table 6.2 The formulation of HPMC matrix tablets used in the 'challenging 
conditions' studies. 
• <12S,.,m sieve fraction. Full details of all materials are provided in Appendix 1. 
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6.4.5 Dissolution testing 
Drug release profiles of HPMC matrices were determined at 37±O.5°C in 900ml of 
degassed dissolution media (water for failing formulations studies; water and 
sucrose solutions for challenging conditions studies) using USP dissolution 
apparatus I (basket) at 100rpm (Dissolutest, Prolabo, France). Full details of the 
method are provided in section 2.2.7. 
UV detection of caffeine in the presence of sucrose has been studied 
spectrophotometrically by Williams et al (2009). Increasing sucrose concentration 
can cause an increase in UV absorbance at 273nm, the wavelength used for 
caffeine detection. To avoid the interference from sucrose absorbance, sucrose 
medium (without drug) was used as the blank in each dissolution test to correct 
for the background absorbance of the sugar. The final determination of the drug 
concentration at the end of the test was conducted to confirm the 100% release of 
all matrices. 
6.4.6 Photography of hydrating HPMC matrix tablets 
The hydrated matrix tablets taken from USP dissolution baskets during the 
dissolution test were imaged at Omin, 10 min, 1hour, and 8hours using a handheld 
digital microscope (Celestron LLC, Torrance, CA, USA) and a digital camera (Canon 
Ixus55, Oita, Japan) 
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6.S Results and Discussion 
6.5.1 Does SDS enhance the extended release properties of the 'failing 
formulation'? 
Figure 6.1 and 6.2 show the effect of adding 5% and 10%w /w SOS to HPMC matrix 
tablets containing 10% acetacte Na and 10% succinate diNa. These two organic 
salts the markedly accelerated drug release from fractionated HPMC E4M matrices 
almost certainly through Hofmeister effects, in which ion rearrangement HPMC 
and suppressing particle swelling and matrix gel layer formation, leading to the 
burst release (Cacace et a11997; Cho et al 2006). Matrices containing either 5% or 
10% SOS exhibited burst release, and also released faster than those with acetate. 
This might because (i) SOS solubilise caffeine so that drug released more quickly, 
(ii) there was a high content of soluble ingredients in the matrices (-70%w/w 
including caffeine, dextrose, organic salt and surfactant) which might suppress 
polymer swelling and gel formation (Bajwa et al 2006), and induce rapid water 
penetration into the matrix system, possibly through osmotic pressure (Maderuelo 
et al 2011). As fractionated HPMC E4M is slow hydrated so that the matrices 
exhibited burst release before the gel layer could be formed. 
Some authors found that matrices containing high solubility and high content 
drugs exhibited high release rate or burst release as the drug may remain at the 
matrix surface which can release immediately after the matrix tablet exposed to 
the dissolution medium (Batycky et al 1997; Velasco et al 1999; Huang & Brazel 
2001). Carlsson et al (1986; 1988) reported that there was synergistic effect 
between SOS and NaCI which adding a small amount salt to EHEC:SOS solutions 
resulted in a first dramatic reduction of the cloud point. However, this occurred at 
much below the cmc. This might support our study which matrices containing 
organic salts and SOS exhibited burst release without gel layer formation. 
In this case, SOS could not enhance the extended release properties of HPMC E4M 
matrices containing succinate diNa and acetate Na. 
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Figure 6.1 'Failing formulations' study: The effect of SDS on the release profile of 
HPMC matrices containing sodium acetate. USP I , 100rpm, 37°C in water. Matrix 
composition in Table 6.1. Mean(n=3)± 1S.D. 
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6.S.2 Ooes SOS enhance the extended release properties of HPMC matrices 
under challenging conditions? 
6.S.2.1 The effect of Incorporating SOS on the extended release 
performance of HPMC matrices in sucrose media 
In Chapter 5, the release over an 8 hour period of the matrices in water was shown 
in absence of SOS and in the presence of 1, 5 and 10%SOS. These release profiles 
showed significant curvature suggesting a diffusion-based release mechanism 
(n-0.4-0.5) as shown in Table 6.3. 
In sucrose dissolution media, drug release from the matrices excluding SOS 
became accelerated compared to drug release in water as shown in Figure 6.3. 
The rate of drug release was in a rank order of sucrose concentration, except in 
1.5M and 2.0M sucrose: 
1.0M - 0.8M - 0.7M - 0.6M - 0.5M > (1.5M) > 0.4M > (2.0M) > 0.2M > OM (water) 
Incorporating SOS into the HPMC matrix tablets could show the capability to 
improve the matrix release profiles in sucrose media as shown in Figure 6.4, 6.5 
and 6.6. 
Amount of 1 %SOS retarded matrix drug release in 0.2M and 0.4M sucrose medium 
when compared to the control (O%SOS) (Figure 6.4). Orug release rate (k) of 
matrices is lower with incorporated SOS (Table 6.3). However, in sucrose 
concentration above 0.5M these matrix tablets exhibited immediate release of 
100% drug content within 30 minutes whether or not SOS was present. 
In the presence of 5%SOS, the progressively slower drug release occurred and 
extended release for over 10 hour period in sucrose concentration up to 0.6M 
(Figure 6.5 and Table 6.3). Release profiles also exhibited the reduce curvature in 
comparison to those in water. In sucrose concentration above 0.8M, the matrix 
tablets both with and without 5%SOS exhibited immediate release of 100% drug 
content within 1 hour. 
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Therefore. 1 %SOS and 5%SOS can recover the extended release performance of 
HPMC matrices in sucrose dissolution media up to O.4M and 0.7M respectively 
when compare to the control matrix tablets which have no SOS. but when compare 
to the drug release in water. 1 %SOS and 5%SOS can maintain the retardation only 
in 0.2M sucrose and up to 0.6 sucrose respectively. 
Moreover. 10%SOS can recover the extended release performance of HPMC 
matrices in sucrose dissolution media up to 2.0M when compare to the control 
matrix tablets which have no SOS (Figure 6.6 and Table 6.3). The progressively 
slower drug release occurred and extended release for over 15 hour period in 
sucrose concentration between 0.2M and 1.0M. When compare to the drug release 
in water. the same effect was found. In sucrose concentration l.5M. the drug 
release acceleration was however found until ..... 3hours and then retardation 
occurred afterwards which exhibited biphasic dissolution profile. This can be 
considered as a critical concentration as there may have more factors affecting the 
drug release from above this concentration. The saturation approach of the 
dissolution media may be one possibility. The release profile in 2.0M sucrose 
exhibited the same pattern as in 1.5M sucrose. but there was very small rate of 
release (k=1.53) since the beginning, and hence exhibited extended release over 
16 hour. 
Interestingly. drug release in 2.0M sucrose exhibited a delayed immediate release 
profile. but again. there was no difference between a matrix with or without SOS 
(Figure 6.4 and 6.5). This delayed immediate release might be a result of the 
decrease of drug solubility in sucrose medium as they exhibited a greater 
erosional release mechanism (n-l) (Figure 6.3). However. with 10% SOS the 
matrices exhibited progressively retarded release compared with control (Figure 
6.6) although there was the great erosional contribution release mechanism either 
with or without SOS. This might because 10%SOS could enhance the erosion 
resistance of the gel layer. 
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O%SDS 1%SDS 5%SDS 10%SDS 
Sucrose concentration (M) 
k n r2 k n r2 k n r2 k n r2 
water 6.65 0.477 0.9982 9.73 0.4126 0.9993 8.97 0.430 0.9979 4.02 0.557 0.9978 
0.2 15.17 0.342 0.9988 7.75 0.443 0.9994 4.87 0.514 0.9976 
0.4 43.77 0.190 1.0000 6.47 0.550 0.9941 8.51 0.405 0.9982 4.30 0.519 0.9984 
0.5 (a) (a) (a) (b) (b) (b) 
0.6 (a) (a) (a) (a) (a) (a) 6.45 0.458 0.9983 4.72 0.474 0.9975 
0.7 (a) (a) (a) 17.49 0.367 0.9995 5.22 0.450 0.9963 
0.8 (a) (a) (a) (b) (b) (b) 
1.0 (a) (a) (a) (b) (b) (b) 10.94 0.321 0.9832 
1.5 (b) (b) (b) 18.93 0.276 0.9589 
2.0 3.82 1.337 0.9979 1.00 1.043 0.9958 1.56 1.094 0.9893 1.53 0.845 0.9340 
Table 6.3 'Challenging conditions studies: The effect of incorporated SDS into HPMC matrices on drug release kinetics in different sucrose concentration 
using the modified power law. Fitted up to 80% cumulative release. Modified power law is described by Ford et al (1987). Matrix composition in Table 6.2. k is 
the kinetic constant n is the diffusional exponent r 2 is determination coefficient 
(a) Drug release >80% within 15 min. (b) Drug release >80% within 30 min. 
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Figure 6.3 'Challenging conditions' study: The drug release performance of HPMC 
matrices without SDS (control) in a range of sucrose dissolution media. Matrix 
composition in Table 6.2. USP I, 100rpm, 37°C in water. Mean (n=3)± lS.D. 
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6.5.2.2 The effect of SDS on the appearance of HPMC matrices in sucrose 
media 
The appearance of various matrix tablets during the dissolution tests is 
documented in Table 6.4. 
Matrix tablets without SOS and with 1 %SOS in water and 0.2M-0.4M sucrose 
exhibited a clear gel layer, while the matrix tablets in above 0.5M sucrose did not 
appear to form gel layer at all. This would explain their immediate release profile. 
With 5%SOS, the good gel layer formation of HPMC matrix tablets occurred in 
sucrose concentration up to 0.6M, leading to the retardation of drug release. In 
0.7M sucrose, the poorer gel layer was formed, and the drug release was 
accelerated although it is better than control matrix without SOS. 
Containing 10%SOS in the matrices demonstrated the good gel layer formation of 
HPMC matrix tablets in water and sucrose concentration up to 1.5M, leading to the 
retardation of drug release. The photographs of the matrix tablets hydrated in 
water, 0.6M and 2.0M sucrose taken from USP dissolution baskets at different 
times during the dissolution test are also shown in Figure 6.7 and 6.8. Between 
O.6M and 1.5M sucrose, there was a clear gel mass left in the end of the dissolution 
test as shown in Figure 6.9. In 1.5M sucrose, the gel layer was formed, and there 
was better extended release performance than control matrix without SOS, but the 
drug release was accelerated until .... 3hours and then became retard afterwards. 
In 2.0M sucrose, there was no gel layer formation, but the drug release mechanism 
was mainly through erosion and exhibited the extended release profile. 
These results comply with the study of William (2009) who concluded that 
sucrose can suppress HPMC (Methocel™ K4M CR) particle swelling and 
coalescence, leading to gel structures with poorer diffusion-barrier properties and 
a reduced resistance to physical erosion. In the present study, HPMC E4M was 
used instead of HPMC K4M, and dextrose was used as a diluent instead of lactose. 
HPMC E4M has a higher level of methoxyl substitution than K4M, and will 
therefore be more discriminative. 
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In the lower amount of sucrose, there was less potential to suppress the gel layer 
formation of HPMC, and hence SOS had chance to form micelles and solubilise 
HPMC, leading to better gel layer formation. 5%SOS has more potential than 
1 %SOS to conduct micellar solubiIisation with HPMC, and hence 5%SOS provided 
a better recovery effect in sucrose concentration up to 0.6M. 
In the higher amount of sucrose, sucrose had more potential to suppress HPMC 
particle swelling and coalescence, while 1 %SOS and 5%SOS still had less potential 
to undergo micellar solubilisation with HPMC, the matrices then became 
accelerated or even immediate release in sucrose concentration above 0.2M and 
0.7M respectively. 
On the other hand, 10%SOS exhibited high potential to undergo micellar 
solubilisation with HPMC in a wide range of sucrose concentrations (O.2M-2.0M), 
leading to better gel layer formation. This suggests that 10%SOS is a good key to 
recover the extended release performance of HPMC matrices and induce the 
resistance of the matrix tablets in sucrose media. 
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media 
Water 
0.2M sucrose 
0.4M sucrose 
O.SM sucrose 
0.6M sucrose 
0.7M sucrose 
0.8M sucrose 
1.0M sucrose 
1.SM sucrose 
2.0M sucrose 
0% SOS matrices 
Clear gel layer 
Clear gel layer 
Clear gel layer, swonen core 
No gel layer, complete erosion in 
to min 
No geJJayer, complete erosion in 
to min 
t % SOS matrices 
Clear gel layer 
Clear gel layer 
Clear gel layer, swollen core 
Thin clear gel layer, swollen 
core, depleted in 30 min 
No gel layer, complete erosion 
in to min 
No gel layer, complete erosion in -
to min 
No gel layer, complete erosion in -
to min 
No gel layer, complete erosion in -
to min 
No gel layer, mostly eroded 
within 10 min 
Started erosion after 10 min, and Started erosion - to min 
depleted by 60 min 
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5% SOS matrices to% SOS matrices 
Clear gel layer Clear gel layer 
Clear gel layer 
Clear gel layer, clear gel mass Clear gel layer 
left in the end of the test 
Clear gel layer, clear gel mass 
left in the end of the test 
Clear gel layer, swollen core 
and eroded 
Thin clear gel layer, swollen 
core and eroded 
No gel layer, mostly eroded 
within 30 min 
Swollen core, started erosion 
after 10 min 
Clear gel layer, clear gel mass 
left in the end of the test 
Clear gel layer, clear gel mass 
left in the end of the test 
Clear gel layer, clear gel mass 
(jelly-like) left in the end of 
the test 
Clear gel layer, small clear gel 
mass left in the end of the test 
Tablets floated, started 
erosion after 30-45 min, no 
gel left in the end of the test 
Table 6.4 'Challenging conditions' study: The observed appearance of HPMC matrix tablets with 0%, 1%, 5%, and 10% SDS during 
dissolution tests in ditIerent sucrose media. 
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Figure 6.7 'Challenging conditions' study: The photographs of HPMC matrix tablets containing 10% SDS taken from USP dissolution 
baskets at at different times during the dissolution test. Matrices hydrated in (a) water, (b) 0.6M sucrose, or (c) 2.0M sucrose. 
260 
Chapter 6 
(a) water (b) O.6M sucrose (c) 2.0M sucrose 
Omin 
lOmin 
Ihour 
Figure 6.8 The microscopic photographs of HPMC matrix tablets containing 10% 
SOS taken from USP dissolution baskets at at different times during the dissolution 
test. Matrices hydrated in (a) water, (b) O.6M sucrose, or (c) 2.0M sucrose 
Figure 6.9 The photograph of the gel mass left in the end of the dissolution test 
taken from USP dissolution baskets at 8 hours. A matrix tablet contains 10%SDS and 
hydrated in O.6M sucrose 
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Table 6.4 summarizes the capability of the different amount of SOS to recover the 
extended release performance ofHPMC matrices in sucrose media. 
However. there are other possibilities to enhance the extended release 
performances of HPMC matrices, for examples, using variable diluents and HPMC 
grades. Williams et al (2010a) also designed HPMC matrices to improve the 
resistance to dissolved sugar by using variable diluents. They found that matrices 
containing MCC as the sole diluent provided the extended release for 10 h, and 
small particle size HPMC (HPMC K100M and K100LV) also improve the sugar 
resistance. 
% SOS in Max. concentration of sucrose media which SOS can recover 
HPMC matrices (M) 
When compare to the When compare to control 
release in water tablets (without SOS) 
1 0.2 0.4 
5 0.6 0.7 
10 2.0 2.0 
Table 6.5 'Challenging conditions' study: The capadty of SDS to recover HPMC 
matrices (with Dextrose as a diluent) in sucrose dissolution media. Matrix 
composition in Table 6.2. USP I , lOOrpm, 37°C in water. Mean (n=3)± IS.D. Dissolution 
media: distilled water; sucrose solution (a range ofO.2M-2.0M) 
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6.6 Conclusions 
In the 'failing formulations' studies, SOS could not recover or improve the 
extended release performance of HPMC matrices. This might because there were 
too high content of soluble ingredients in matrices which might suppress polymer 
swelling and gel layer formation, leading to the rapid water penetration and the 
burst release before gel layer formation. However, SOS may be useful in the 
formulations containing less soluble substances or different diluents. The further 
study needs to be conducted. 
In the 'challenging conditions' studies, 1 %SOS exhibited the low potential to 
recover the extended release performance of HPMC matrices in sucrose media, 
while 5%SOS provided more potential and useful to recover the extended release 
of HPMC matrices in sucrose concentration up to 0.7M. 10%SOS is the best for 
using to recover the extended release performance of HPMC matrices in sucrose 
media as it could retard the matrix drug release in sucrose concentration up to 
2.0M. However, the high dose of SOS is not suitable for oral administration. The 
normal level of incorporation of SOS is 0.5-2.5% for oral preparations. It is a 
moderately toxic material with acute toxic effects including irritation to the skin. 
eyes. mucous membranes, upper respiratory tract, and stomach. The further 
studies of using different diluents are interested. The usage of other surfactants 
will also be useful. 
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Overall Discussion and Conclusions 
7.1 Overall discussion 
7.1.1 Organic salts 
This study has revealed the impact of organic salts used as drug counter-ions on 
HPMC solutions and matrices. Within the limited range of salts studied, the effects 
on HPMC solution properties (Chapter 3) and HPMC matrix release performance 
(Chapter 4) appear to be dependent on their molecular structure. They can be 
categorised both by their effects, and the proposed mechanisms, into 3 groups: 
(i) 0Cianjc salts with 1-4 C-atoms 
These salts (e.g. acetate Na, propionate Na, butyrate Na) depressed the sol-gel 
transition temperature (SGTT) of HPMC solutions, but had little effect on the 
polymer surface activity. They accelerated matrix drug release, in comparison with 
a control matrix in which dextrose was substituted for the salt.. The mechanism of 
interaction with HPMC is proposed to be that these small hydrophilic molecules 
act as kosmotropic ions in the Hofmeister series. They compete for, and remove 
water from the polymer hydration sheath due to their strong water interactions 
(Alderman 1984; Cacace et al 1997; Cho et al 2006; L6pez-Le6n et al 2007; Yang 
2009). This leads to an enhanced tendency for methoxyl-rich regions of the HPMC 
chain to associate, in accordance with the model of Haque and Morris (1993). The 
consequence is a lowering of SGTT or precipitation of HPMC by 'salting out'. In 
matrices, this mechanism would lead to inhibition of particle swelling, a slOwing of 
the rate of polymer hydration and of matrix gel layer formation. 
264 
Chapter 7 
Divalent salts (e.g. fumarate diNa, maleate diNa, succinate diNa, tartrate diNa, 
malate diNa) exhibit a greater ability to depress SGrr and accelerate matrix drug 
release. This suggests they have a greater ability to potentiate methoxyl 
aggregation and phase separation because divalent salts are more highly charged, 
and further up the Hofmeister series. This is supported by previous studies of the 
effects of multivalent ions such as phosphate and citrate (Mitchell et a11991; 
Kujawinski 2000; Liu et al 2008; Pygall et al 2009). 
(ii) OrKanic salts with 5-8 C-atoms 
Aliphatic organic salts containing 5-8 C-atoms elevated the SGTI, reduced the 
surface tension of HPMC solutions, and retarded matrix drug release in 
comparison with a control matrix. It has been reported previously that octanoate 
Na is able to form micelles with a low aggregation number and at a relatively high 
critical micellar concentration (cmc-0.4M) (Zemb et al 1983; Kuhn et al 2002; 
Ruso et al 2004). These longer-chain salts might act as 'salting in' agents, as 
chaotropic ions in the Hofmeister series (Alderman 1984; Cacace et a11997; Cho et 
al 2006; Lopez-Leon et al 2007). They would enhance the hydration of HPMC 
through micellar solubilisation of methoxyl-rich regions of the polymer chain, 
changing the water structure around these hydrophobic regions into regions 
where water is interacting more extensively with the charged polar groups of the 
micelle. This interaction would therefore promote polymer affinity for water 
during HPMC particle swelling, leading to more rapid gel layer formation in HPMC 
matrices so that matrices containing these salts, would exhibit better extended 
release properties. 
The model of salting out and salting in behaviour on HPMC in solution has been 
described in previous studies of ionic solutes (Mitchell et al 1990a, Mitchell et al 
1991), amino acids (Richardson et al 2006) inorganic salts (Alderman 1984; 8ajwa 
2006; Liu et al 2008) sugars (Williams 2009) and drugs such as ibuprofen (Ridell 
et a11999) 
A homologous series of aliphatiC organic salts influenced solution and matrix 
properties in a rank order of hydrocarbon chain length. The increased chain 
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length corresponds to the more hydrophobicity. This can be implied that their 
ability to alter HPMC hydration depends on their hydrophobicity. This supports 
the study of amino acid which found that the effect on SGIT showed the strongest 
relationship with amino acid hydrophobicity (Richardson et al 2006). 
(iii) OrKanic salts contajnjn& an aromatic species 
The aromatic organic salts studied (benzoate Na, besilate Na and salicylate Na) all 
elevated SGIT, enhanced the viscoelastic behaviour of HPMC solutions, but 
exhibited no influence on polymer surface activity. In this study, matrices 
containing 60%w /w aromatic salts exhibited retarded release with respect to the 
control whereas those containing 1 O%w /w salts generally did not (only 10%w /w 
besilate could retard drug release). 
Aromatic compounds commonly self-associate in water to form stacking rings 
through tr-tr interactions (Balasubramanian et al 1989; Sindkhedkar et al 2000; 
Waters 2002; Sasaki et al 2006; Desai & Parikh 2009; Hao et al 2012). In our study, 
the aromatic salts are amphiphiles in which their aromatic stacking rings provide 
the hydrophobic part, and the carboxylic or sulfonic groups, the hydrophilic part. 
These aromatic compounds (known as hydrotropes) can induce tr-stacking 
aggregation, a configuration that can considerably enhance the aqueous solubility 
of organic substances if present at a sufficient concentration (Matero 2002). Many 
studies have used these hydrotropes to solubilise poorly water-soluble drugs 
(Prakash et a12009; Jayakumar et al 2010; Kim et a12010; Shete et al 2010). 
Our hypothesis is therefore that aromatic organic salts interact directly with HPMC 
(as a result of their amphipathic characteristics) through n-stacking aggregation, 
thereby solubilising hydrophobic sites on the polymer. This might be the reason 
why these aromatic salts elevated the SGTT. (The paper by Richardson et al (2006) 
showed the same effects with aromatic amino aCids.) However, the amount of 
these salts must be high enough to allow molecular aggregation and enhance 
HPMC hydration (Matero 2002). This is perhaps why 10%w/w salts did not 
retard drug release from HPMC matrices whereas 60%w/w did. Moreover, 
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because the properties of these aromatic stacks depend on the ring substituents, 
and besilate has better self-assembly through intermolecular fC-7r and sulphur-
sulphur interactions, this may explain why only this salt could retard drug release 
at 10%w/w. The hydrophobic regions become negatively charged as a result of 
solubilisation and absorption of the aromatic salts onto the polymer. These 
regions of negative charge would repel each other, straightening and extending the 
polymer chain, making the solution more viscous, and gel-like entanglements 
more frequent. This would explain the observed rise in G' and Gil. 
Touitou & Oonbrow (1982b) found that salicylate Na and benzoate Na raised SGTT 
of HPMC solutions which they explained that these ions are adsorbed onto the 
macromolecule and increase the polymer hydration with their carrying water 
molecules. 
7.1.2 Alkyl sulphate surfactants 
A homologous series of alkyl sulphate surfactants, including SHS (C6), SOS (C8), 
SOeS (C10), and SOS (C12), all elevated SGTT and reduced the surface tension of 
HPMC solutions. The interaction between these alkyl sulphate surfactants and 
HPMC are postulated to be surfactant:polymer association. Tensiometric, 
turbidimetric and rheological studies suggested that these alkyl sulphate 
surfactants associate with HPMC at concentrations above their critical aggregation 
concentration (CAC), and they may solubilise HPMC through micellar 
solubilisation. The results also suggested that micellar association between alkyl 
sulphate surfactants and HPMC was strongly influenced by surfactant chain length. 
Amongst the surfactants studied, the effects were greatest with SOS (C12). 
Avranas & lIiou (2003) also found that the chain length of anionic surfactant 
influences polymer adsorption at an interface. 
There is evidence that ionic surfactants form micelles around hydrophobic 
methoxyl-rich regions of HPMC (Nilsson 1995). This would convert the neutral 
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HPMC into a polyelectrolyte. The acquired negative charges would repel, and this 
would stretch HPMC from a condensed coil to an extended configuration, leading 
to more viscous solutions (Kulicke & Clasen 2004). With sufficient negative 
charges, the molecule might behave like NaCMC which is highly resistant to 
dehydration (Doelker 1993). Dou and Colby (2004) have studied how charge 
density impacts the rheology of polyelectrolyte solutions. They found that neutral 
polymers have the lowest viscosity and shortest relaxation time, and weakly 
charged polyelectrolytes have the highest viscosity and longest relaxation time. 
The behaviour of more highly-charged polyelectrolytes lies between these limits. 
This evidence suggests that a low density of charged regions such as would happen 
with adsorption of SDS, might considerably alter the polymer behaviour and 
viscosity of HPMC in the gel layer. 
HPMC matrices containing small amounts of surfactants were found to accelerate 
drug release (this was also found by Cao et al (2005)). Turbidimetric studies 
indicated that these surfactants could solubilise HPMC at post-micellar 
concentrations and it could be implied that SDS would only improve the extended 
release performance of HPMC matrices when there is enough concentration to 
form micelles. This postulate is supported by the study by Silva et al (2011) which 
suggested the influence of surfactant on HPMC hydrogels occurs in three separate 
phases depending on the surfactant concentration. 
Nokhodchi et al (1999) found that theophylline release from HPMC matrices was 
accelerated by incorporated SDS because of a changing contribution from erosion. 
However, there here have been many more reports that SDS can retard drug 
release, when incorporated into HPMC matrices. The mechanisms suggested have 
been (i) an (unspecified) binding of anionic surfactant to the non-ionic polymer 
(Daly et al 1984) (ii) ionic interactions between the oppositely charged drug and 
surfactant which leads to the formation of a low solubility complex (Feely & Davis 
1988; Ford et al 1991b; Nokhodchi et al 2002). In our current study, caffeine the 
model drug, is neutral and therefore ionic interactions between drug and 
surfactant cannot occur. The effect therefore appears to be related to an influence 
of the surfactant on the polymer. 
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Overall, these studies suggest that SOS may be a useful additive with which to 
improve the extended release performance of and HPMC matrix. In chapter 6, the 
effect of incorporating SOS into 'problem' HPMC matrices was investigated (i) in 
formulations that barely sustained release and (ii) matrices failing under 
challenging dissolution conditions. In these experiments matrices containing 
HPMC E4M and succinate diNa and acetate Na were used. These formulations 
exhibit burst release, possibly because the content of soluble ingredients (caffeine, 
dextrose, organic salt and surfactant) is very high -70%w/w. Many authors have 
reported that matrix formulations containing a high content of solubles release a 
considerable amount of drug immediately after the matrix tablet is exposed to the 
dissolution medium (Batycky et a11997; Velasco et a11999; Huang & Brazel 2001; 
Maderuelo et al 2011). In this study, SOS could not improve the extended release 
performance of HPMC matrices containing acetate and succinate. 
To provide challenging dissolution conditions, the matrices were exposed to high 
concentrations of sucrose. A previous study had showed how, at concentrations 
>0.7M, sucrose accelerates HPMC matrix drug release, by suppressing HPMC 
hydration., leading to poorer gel layer integrity and reduced resistance to erosion 
(Williams et al 2009). 
In our studies, 1 %w /w SOS in HPMC matrices did not help extended release and 
whilst 5%w/w SOS showed potential, 10%w/w SOS was required to provide a 
significant improvement. When 10% SOS was incorporated matrices that would 
have failed in 0.7M sucrose, showed extended release in sucrose concentrations up 
to 2.0M. Unfortunately this amount of SOS is not suitable for oral administration 
because although 10%w /w SOS in a 250mg HPMC tablet is only 25mg/tablet, far 
below the human lethal oral dose (0.5-5 g/kg), the normal usage of SOS in oral 
preparations is 0.5-2.50/0, and higher doses can have laxative effects 
Williams et al (2010a) have designed HPMC matrices with improved resistance to 
dissolved sugar without the use of SOS. They varied the diluent and HPMC grade, 
and found that matrices containing MCC as the sole diluent, a small particle size of 
HPMC anda very high viscosity grade (HPMC KIOOM) improved sucrose resistance 
up to -1M. 
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7.2 Overall conclusions 
The studies in this thesis reveal how organic salts incorporated into HPMC 
matrices influence drug release in a rank order that corresponds to their 
modulation of the polymer hydration sheath in solution. 
A homologous series of aliphatic acid sodium salts influenced solution and matrix 
properties in rank order of hydrocarbon chain length. Monovalent salts containing 
1 to 4 C atoms had little effect on polymer surface activity but depressed sol:gel 
transition temperatures (SGTT) and accelerated matrix drug release compared 
with a dextrose control. Divalent salts were more potent, corresponding with 
other studies of multivalent anions (Kujawinski 2000; Pygall et al 2009). These 
salts appear to exert Hofmeister effects in which kosmotropic anions compete for 
available water and dehydrate the polymer hydration sheath, leading to 'salting 
out' of the polymer (Touitou & Donbrow 1982b; Cacace et al 1997; Cho et al 2006). 
In matrices this action has been shown to suppress particle swelling and matrix gel 
layer formation (Pygall et al 2009; Williams et al 2009). Organic monovalent salts 
from 5 to 8 C atoms increasingly influenced polymer surface activity, elevated 
SGTT values, and retarded matrix drug release in comparison with a dextrose 
control. This suggests these salts enhance HPMC hydration, possibly through 
interaction with hydrophobic regions (Nilsson 1995). It suggests that the ability of 
the charged ion to destabilise the polymer hydration sheath is opposed, with 
increasing chain length, by the ability of the hydrophobic chain to interact with 
and enhance polymer molecular hydration. The effects on matrix drug release also 
show that the presence of these ions impacts on the water:polymer interactions 
which would be important to the formation and diffusion barrier properties of the 
gel layer. In the case of monovalent salts, drug release showed a significant linear 
correlation with L\CPT (r=0.938, p<O.Ol), where L\CPT reflects the ability of the 
anion to disrupt or enhance polymer hydration and is a function of ionization and 
hydrophobicity. which oppositely affect polymer hydration sheath stability 
(Richardson et al 2006). In the case of divalent anions, these proved more potent 
in depressing CPT, and all salts investigated accelerated drug release reflecting 
similar effects seen with other multivalent inorganic salts (Alderman 1984). 
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These findings provide guidance for the future formulation of HPMC matrix tablets. 
For example, high dose drugs with a strongly hydrophilic organic counter-ions 
should be avoided, and hydrophobic or amphipathic salts might be better to 
maintain, modulate or even improve extended release properties. 
The studies then moved to a series of alkyl sulphate surfactants. The effects of SOS 
and its homologous series on the sol:gel transition temperature (SGTT) and the 
surface tension of HPMC solution can be divided into pre-micellar and post-
micellar concentration effects. At pre-micellar concentrations these surfactants 
depressed SGTT in a similar way to monovalent carboxylic acids. Above the critical 
aggregation concentration (CAC) however, these surfactants decreased the 
interfacial tension between HPMC and water probably by forming micelles around 
the hydrophobic regions of HPMC, and hence they elevated SGTT. As mentioned 
above, these surfactants improve HPMC molecular hydration at post-micellar 
concentrations, and these effects suggested that SOS might be able to improve the 
extended release performance of HPMC matrices when there is sufficient SOS in 
the matrix to form micelles. 
Subsequent studies showed that by incorporating 10%wjw SOS, it allowed HPMC 
matrices that would have otherwise failed in O.7M sucrose to tolerate 
concentrations up to 2.0M. This result suggests surfactants may be worth further 
investigation as extended release co-adjuvants to HPMC in hydrophilic matrix 
tablets. 
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7.3 Future work 
The following future work would support the studies presented in this thesis, and 
would also progress our understanding of how organic salts and surfactants 
influence HPMC properties and matrix release performance: 
» The investigation of the impact of these organic salts on the early gel layer 
formation on HPMC matrices by confocal laser scanning microscopy (CLSM). 
This would provide more profound understanding of their impact on gel layer 
formation. 
» Studies of gel strength by rheology and texture analysis. This would provide 
additional insights into the physical consequences of the interactions on gel 
layer resistance to erosion. 
» An investigation of counter-ions in combination with drugs for which they are 
used as salts. 
» An investigation of early gel layer formation, gel strength and release 
properties in SDS media used for dissolution testing. 
» The use of SDS to further improve other formulations or performance under 
other challenging conditions. 
» A study of longer chain-length alkyl sulphates and other pharmaceutical 
surfactants. Some surfactants will be better tolerated physiologically, require 
to be present in smaller amounts or may show interesting results in improving 
the matrix gel layer and the release performance of HPMC matrices. 
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Appendices 
Appendix 1 
Materials 
Material Brand name/grade Manufacturer Batch No 
Caffeine anhydrous Analytical grade Sigma-Aldrich. Dorset. UK 1308874 
HPMC MethoceITME4M CR Colorcon Ltd. Dartford. QF11012N03 
Premium Kent, UK TD09012N11 
Methocel™K4M CR 
Premium 
Organic salts 
Sodium formate Analytical grade Sigma-Aldrich. Dorset. UK 00702KC 
Sodium acetate. anhydrous Analytical grade Alfa aesar 10116203 
Sodium propionate Analytical grade Sigma-Aldrich. Dorset. UK 035K0039 
Sodium butyrate Analytical grade Alfa aesar 10120013 
Sodium pentanoate Analytical grade Merck SOO089620 
Sodium hexanoate Analytical grade Sigma/ Fluka 362265/1 
Sodium octaonate Analytical grade Sigma-Aldrich. Dorset. UK 123K0205 
Sodium mesilate Analytical grade Sigma-Aldrich. Dorset. UK 06002EB-286 
Diodium fumarate Analytical grade Alfa aesar 10129838 
Sodium hydrogen fumarate Analytical grade Alfa aesar 10099719 
Disodium tartrate Analytical grade Alfa aesar D7342A 
Sodium salicylate Analytical grade Sigma-Aldrich. Dorset. UK 1301292 
50107034 
Disodium succinate Analytical grade Sigma-Aldrich. Dorset. UK 00615CA-176 
Sodium benzoate Analytical grade Alfa aesar 10115540 
Sodium besilate Analytical grade Sigma-Aldrich. Dorset. UK 1164882 
31807231 
Disodium oxalate Analytical grade Alfa aesar A1897A 
Disodium malate. Analytical grade Fisher / Acros organics A0241923 
monohydrate 
Disodium maleate Analytical grade Sigma-Aldrich. Dorset. UK A0241924 
Sodium hexyl sulphate Analytical grade Acros organics A0205516 
Sodium octyl sulphate Analytical grade Alfa aesar 10144221 
Sodium decyl sulphate Analytical grade Acros organics A0273453 
Sodium dodecyl sulphate Reagent plus Sigma-Aldrich. Dorset. UK 046KOO85 
~ 9 8 . 5 % %
A1 
Appendices 
Material Brand name/grade Manufacturer Batch No 
Tablet diluents 
Dextrose monohydrate Meritab® Tate and Lyle, Aahst, 053733538 
Belgium 
Lactose monohydrate Fast-flo Foremost Farms, Baraboo, DLOOO08709 
USA 
Microcrystalline cellulose Avicel PH102 7G29497 
Magnesium stearate Technical grade Sigma-Aldrich, Dorset, UK 
Partially pregelatinized Starch 1500® Colorcon Ltd, Dartford, DT200778 
starch Kent, UK 
Dissolution media 
Sodium chloride Analytical grade Fisher scientific, 0737716 
Leicestershire, UK 
Sucrose Analytical grade Fisher scientific, 0954097 
Leicestershire, UK 
Deionized water USF, Elga, 
Buckinghamshire, UK 
CLSM 
Congo red Sigma-Aldrich, Dorset, UK 126H2510 
Sigmacote® Sigma-Aldrich, Dorset, UK 103K4360 
Water Maxima HPLC grade USF, Elga, 
(maximum Buckinghamshire, UK 
conductance 18.2 
Mn.cm) 
A2 
Appendix 2 
The moisture content of the principal HPMC batch 
monitored over the duration of work in this thesis 
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Appendices 
Figure A1 The percentage (% wjw) moisture content of the Methocel™ E4M CR 
premium (Batch number) used in this study with respect to storage time. 
Mea urements were made every -4 months. Mean (N=3) ± 1 s.d. 
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Appendix 3 
The effect of compression force on HPMC matrices using 
dextrose as a diluent 
HPMC matrices using dextrose as a diluent with compression force in the range of 
4-16KN do not show any different in the drug release profiles. 
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Figure A2 The effect of compression force on the dissolution profile of HPMC 
matrices using dextrose as a diluent. 8mm, 250mg matrices contain 300/0HPMC, 
100/0caffeine anhydrous, qs diluents. USP I , 100rpm, 37°C in water. Mean (n=3) ± lS.D. 
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Appendix 4 
Presentations 
The work presented herein has given rise to the following presentations: 
Oral presentations: 
Mongkolpiyawat J. & Melia CD. HPMC solution properties and extended release 
performance of HPMC matrices containing a homologous series of alkyl sulphate 
surfactants. 
UKPharmSci, Nottingham, UK, September 2010. 
Selected poster presentations: 
Mongkolpiyawat J. & Melia CD. The Influence of organic ions on polymer 
hydration and Drug release in HPMC matrices 
AAPS, New Orleans, USA, November 2010. 
Mongkolpiyawat J. & Melia CD. HPMC solution properties and extended release 
performance of HPMC matrices containing a homologous series of alkyl sulphate 
surfactants. 
UKPhramSci, Nottingham, UK, September 2010. 
Mongkolpiyawat J. & Melia CD. The Effect of OrganiC Acid Counter-ions on HPMC 
Matrices 
BPe, Manchester, UK, September 2008. 
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